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Abstract 
 
Research into organocatalysed asymmetric reactions has been a rapidly growing and 
competitive field in recent times, wherein aminocatalysis is widely used for the asymmetric 
functionalisation of carbonyl compounds. Since its simultaneous publication by List and 
Jørgensen, the organocatalysed α-amination reaction has become a key method for 
asymmetric heteroatom functionalisation of carbonyl compounds. Herein we report the first 
application of this methodology to acetals, with the ultimate goal of applying the methodology 
to the asymmetric desymmetrisation of bis-acetals as a novel contribution to this growing 
field. 
 
Following extensive optimisation, acidic reaction conditions for the reaction were established  
in which dibenzyl azodicarboxylate (DBAD) was used as the aminating agent and (S)-(-)-5-
(2-pyrrolidinyl)-1H-tetrazole as the preferred organocatalyst. The desired aminated products 
were obtained in high yields and enantioselectivities. The reaction showed broad substrate 
scope in its application to ketals, dioxolanes and lactols.  
A hydrazide N-N bond cleavage methodology was also developed for the aminated products 
in oxazolidinone form. This methodology is based on Magnus’ alkylation / E1CB strategy. 
The novel contribution here is using ditheyl bromoacetate as an alkylating agent and as a 
better elimination partner.  
A range of bis-acetals were synthesised via three synthetic routes using malonate-, sulfone- 
and cyclopentene-based synthesis strategies. The acetal reaction was used for the 
desymmetrisation of two of these bisacetals as a proof of concept. This is a feat not 
achieved with the more reactive dicarbonyl analogue. 
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Chapter 1: Organo(Amino)catalysis in Asymmetric Synthesis 
 
1.1 Introduction 
Chirality is a symmetry property of objects in three-dimensional space in which an object is 
referred to as “chiral” if it cannot be superimposed on its mirror image. Chemically speaking, 
compounds can be found in two forms where they are constitutionally equivalent but the 
three-dimensional arrangement of atoms differs. In such a case the two molecules are 
termed “stereoisomers”. If these two stereoisomers are mirror images that cannot be 
superimposed on one another, then the compounds are both chiral and they are related as 
“enantiomers”. The cause of non-superimposability (chirality) is the lack of molecular SN 
symmetry (improper axis of rotation/reflection symmetry), and there are three stereogenic 
structural elements that can cause this referred to as chiral centre, axis or plane. In each 
case a universal system to distinguish stereogenicity as either left-handed or right-handed 
has been developed called the Cahn-Ingold-Prelog nomenclature after three doyens in the 
field of stereochemistry, and in each case a stereodescriptor “R” or “S” is then used to 
distinguish handedness between the two enantiomers. Figure 1.1 below depicts the two 
enantiomers of alanine, a chiral amino acid, as an example. Enantiomers have identical 
chemical and physical properties bar one, except in the presence of an external chiral 
influence (for example a chiral stationary phase in chromatographic separation). The one 
property in which two enantiomers differ is optical activity in which they differ in the direction 
in which they rotate the plane of plane-polarised light. If the enantiomer rotates the plane of 
polarised light in a clockwise direction it is denoted as “(+)”, while “(-)” corresponds to an 
anti-clockwise direction. Net rotations of a mixture of enantiomers are additive and so the net 
measured rotation is used as a guide to determine enantiomeric composition.1     
 
 
Figure 1.1: The two enantiomers of alanine. 
 
However, the significance of chemical chirality goes beyond just optical activity. Indeed the 
world around us is chiral and most of the building blocks of biological macromolecules occur 
as single enantiomers. Thus, when a biologically active chiral molecule (perhaps a drug) 
interacts with its chiral receptor site, each enantiomer may react differently and lead to 
different effects. A classic (and tragic) example of this is the drug thalidomide, Figure 1.2, 
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which was administered as a mixture of both enantiomers. Both enantiomers led to the 
desired sedative effect but the (-)-enantiomer resulted in foetal deformities. Furthermore, 
even if the pure (+)-enantiomer had been used there still would have been issues since the 
two enantiomers interconvert (racemise) under physiological conditions.  
 
 
Figure 1.2: (-)-Thalidomide 
 
For a compound with more than one chiral carbon (stereogenic centre), there are more than 
two stereoisomeric forms. In this case a maximum of 2n stereoisomers are possible (where n 
is the number of stereogenic centres), and such isomers are called diastereoisomers or 
diastereomers for short. These are defined as stereoisomers that are not mirror images. In 
contrast to enantiomers, diastereomers have different chemical and physical properties and 
thus can be separated in a simpler manner (via crystallisation or chromatography using the 
usual achiral stationary phase). An example of diastereomers is the artificial sweetener 
aspartame (shown in Figure 1.3), which has two stereogenic centres and thus four 
stereoisomers since there are no simple mirror planes. Analysis of (a)-(d) stereochemically 
leads to the conclusion that there are two diastereomers which each have an enantiomer. 
However, each stereoisomer has two diastereomeric relationships with other compounds 
and one enantiomeric relationship. In this case, only diastereomer (a) is sweet whilst the 
other diastereomers are slightly bitter and must be avoided in the synthetic process. This 
example highlights the importance of synthesising chiral compounds in a stereoselective 
manner, not only to obtain stereoisomers with the desired effects, but also to prevent 
wastage in the synthetic procedure and improve atom-efficiency. 
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Figure 1.3: The four stereoisomers of aspartame. 
 
Since the concept of chirality was recognised and its significance was discovered, organic 
chemists have become increasingly interested in asymmetric synthesis, defined as the 
assembly of simple and readily available starting materials into asymmetric products 
selectively, and is one of the ultimate goals of modern organic chemistry.2 The broad value 
of homochiral (i.e. single enantiomer) molecules as pharmaceuticals, as probes of biological 
function, as polymer components with novel properties, and in electronic and optical devices 
has spearheaded the prominence of asymmetric synthesis.3 Thus the influence of 
asymmetric synthesis has gone beyond the academic environment. This is illustrated by the 
role it has played in the pharmaceutical industry, since chiral drugs represent close to one 
third of all drug sales worldwide, and where regulatory considerations demand that great 
care and attention is paid to generating and evaluating drugs as pure enantiomers.4 
 
Asymmetric synthesis methodology can be classified into two main groups: 1) 
diastereoselective substrate-controlled processes, and 2) enantioselective reagent-
controlled processes. The objective is to produce enantioenriched products with defined 
relative stereochemistry if there are more than two stereogenic elements. 
 
1.1.1 Diastereoselective Substrate-Controlled Methodology 
These approaches involve the reaction of a chiral substrate. The reaction occurs at a 
prochiral site near the controlling chiral centre to produce one predominant diastereomer as 
a single enantiomer. 
 
a) Chiral pool synthesis 
Chiral pool synthesis involves an enantiomerically pure natural source functioning as the 
chiral source. The “chiral pool” is thus a group of readily available, chiral natural sources or 
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products in which amino acids and sugars dominate. Scheme 1.1 illustrates how the 
naturally occurring sugar 2-deoxy-D-ribose can be used to synthesise (R)-sulcatol, a beetle 
pheromone, as a pure enantiomer.5 In chiral pool synthesis chirality may be added or 
removed to make the chiral target. 
 
 
Scheme 1.1: Chiral pool synthesis of (R)-sulcatol. 
 
b) Auxiliary-controlled methods 
Auxiliary-controlled reactions are similar to chiral pool ones in that the controlling chirality 
originates from the substrate in a diastereoselective process. However, here the chirality in 
the substrate is deliberately introduced and is removed after serving its purpose. Successful 
methodologies demand a high diastereoselectivity and if a single diastereomer can be 
isolated, a single enantiomer product is ultimately obtained following auxiliary removal. 
Between the 1970’s and 1990’s most of the asymmetric synthesis methodologies reported 
fell into this category. Although highly useful, the need for additional attachment and removal 
steps is the major drawback of this asymmetric synthesis strategy. Scheme 1.2 illustrates an 
example in the synthesis of carbon-14 labelled Pravastatin based on one of the most famous 
and reliable auxiliary-controlled methodologies, David Evans’ oxazolidinone enolate 
chemistry.6  
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Scheme 1.2: Synthesis of carbon-14 labelled Pravastatin using a chiral auxiliary. 
 
1.1.2 Reagent-Controlled Methods 
a) Stoichiometric methods 
In these methods an achiral substrate is converted to a chiral, non-racemic product by use of 
a stoichiometric amount of chiral reagent. Reactions involve an intermolecular control of the 
asymmetric induction. An example of this is enantioselective deprotonations using a chiral 
amide base, Scheme 1.3.7 The major advantage of this methodology is the wider choice of 
starting materials possible as well as not having to attach and remove an auxiliary. However, 
stoichiometric amounts of the chiral reagent are required. 
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Scheme 1.3: Enantioselective deprotonation using chiral lithium amide bases. 
 
b) Enantioselective Catalyst-controlled methods  
In contrast to the above reaction, in this category an achiral substrate containing one or 
more prochiral centres reacts with the reagent in the presence of a chiral catalyst in sub-
stoichiometric amounts. This results in enantioselective production of a chiral product via 
catalyst turnover. Peter Dalko et al. put it best: “Undoubtedly, the more elegant and 
economically most attractive way to introduce chirality into a molecule is by using a catalytic 
amount of a chiral controller to induce the chiral transformation…”.4 As such, these methods 
have become the most popular ways to synthesise chiral compounds. The three main types 
of enantioselective catalysis are biocatalysis, transition-metal catalysis and organocatalysis. 
 
Biocatalysis 
Biocatalysed asymmetric synthesis involves introduction of chirality into an achiral substrate 
through the influence of an enzyme.8 These enzymes are sourced from animal and plant 
cells either by extracting or recovering them from cell exudates using protein and genetic 
engineering techniques. Enzymes act as chiral catalysts since almost all of them are 
peptides comprising chiral amino acid building blocks. Scheme 1.4 shows how yeast can be 
used as a catalyst for the enantioselective reduction of a ketone. In fact, enzymes are more 
than just highly evolved catalysts – catalytic efficiency, selectivity, and high turnover form 
only part of their sophisticated systems, which comprise built-in feedback mechanisms and 
subtle intra- and intermolecular cooperation.9 One drawback, though, can be substrate 
specificity ie finding the right enzyme for a particular substrate. 
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Scheme 1.4: Biocatalysed enantioselective ketone reduction. 
 
Transition-Metal Catalysis 
The emergence of homogeneous enantioselective organometallic catalysis has had a pivotal 
impact on the development of enantioselective reactions. The development of the first potent 
organic ligands for rhodium complexes served as the foundation for the expansion of 
enantioselective catalytic hydrogenation reactions. Thus asymmetric catalysis has become 
almost synonymous with the use of metals in a chiral environment.4 An important example is 
the Nobel Prize winning Sharpless epoxidation (Scheme 1.5), where a titanium Lewis acid 
catalyst is used in the presence of L-(+)-diethyl tartrate (L-(+)-DET) as a chiral ligand.4,10,11  
 
 
Scheme 1.5: Metal-catalysed asymmetric Sharpless epoxidation. 
 
Metal complexes undoubtedly have considerable advantages: molecular and structural 
diversity due to higher coordination numbers and oxidation states, and a large array of 
reactivity patterns tuned by varying ligands. However, these tremendous advantages are 
coupled with challenging disadvantages such as high price, toxicity, pollution, waste 
treatment, product contamination and the depletion of our planet’s natural metal reserves.4,12 
Therefore these days, in view of the Green Chemistry revolution, there is also an increasing 
tendency to develop methodologies that are sustainable, ie allow for regeneration of the 
chiral reagents. Also, functions that are typically associated with metals (for example, as 
Lewis acids / bases and as redox agents) can also be carried out efficiently by organic 
compounds.4,13,14 Thus, methods based exclusively on metal-free chiral organic catalysts 
have become in vogue.  
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Organocatalysis  
Organocatalysis is the use of small organic molecules (as opposed to protein enzymes) to 
catalyse organic transformations.15 The preparative advantages of using organic molecules 
are impressive since: the reactions can often be performed under an aerobic atmosphere 
with wet solvents; catalysts are inexpensive and they are often more stable than bioorganic 
catalysts; these relatively small organic molecules can be anchored to a solid support and 
reused more conveniently than organometallic/bioorganic analogues; the organic molecules 
have shown adaptability to high-throughput screening and process chemistry; and lastly, 
organocatalytic procedures are easier and result in reduction of chemical waste.4 These 
advantages arise from the following simple facts, as David MacMillan puts it:15 1) organic 
molecules are generally insensitive to oxygen and moisture in the atmosphere, and therefore 
don’t need special reaction vessels, storage containers and experimental techniques, or 
ultra-dry reagents and solvents; 2) a wide variety of organic reagents such as amino acids, 
carbohydrates and hydroxy acids, are naturally available as single enantiomers, and thus 
simple organocatalysts are usually cheap to prepare and readily accessible in a quantity 
suitable for either small-scale reactions or industrial-scale reactions; 3) small organic 
molecules are typically non-toxic and environmentally friendly thus increasing the safety of 
catalysis in research across all research settings. This combination of factors has 
substantially lowered the entry costs for researchers interested in developing asymmetric 
organocatalytic reactions and has led to the recent tremendous innovation of new 
organocatalytic systems. 
 
Although chemical transformations utilising organocatalysts have been documented 
intermittently over the past century (for example the benzoin condensation reaction 
catalysed by cyanide anion, first described in the late 1830s),16,17 it was not until the late 
1990s that this field truly took shape, coalescing around a small number of articles that 
inspired an explosion of research. MacMillan considers three factors that were crucial to the 
sudden and rapid development of the field of organocatalysis: 15 first, the conceptualisation 
of the field; second, the advantages of organocatalytic research; and third, the discovery of 
generic modes of catalyst activation, induction and reactivity. Between 1968 and 1997, there 
were only a few reports of the use of organic molecules as catalysts for asymmetric 
reactions and these studies were viewed more as unique chemical reactions than as integral 
parts of a larger, interconnected field. In the early 1970s Hajos18 and Wiechert19 published 
the first and highly enantioselective catalytic aldol reactions using the simple amino acid 
proline as the catalyst (Scheme 1.6). However in these early publications, there was no 
suggestion by the authors that the use of organocatalysts could be a principal concept in 
organic synthesis.  
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Scheme 1.6: The Hajos-Parrish-Eder-Sauer-Wiechert reaction. 
 
This began to change in the late 1990s when the groups of Yian Shi20 Scott Denmark21 and 
Dan Yang22 independently demonstrated that enantiomerically pure ketones could catalyse 
the enantioselective epoxidation of alkenes. Thereafter, Eric Jacobsen23 and Elias J. 
Corey,24 described the first examples of hydrogen bonding catalysis, in an asymmetric 
Strecker reaction, while Scott Miller25 introduced the concept of using peptides for the 
enantioselective kinetic resolution of alcohols. All these contributions demonstrated for the 
first time that small organocatalysts could be used to solve important problems in chemical 
synthesis. However, it was not until 2000 that the field of organocatalysis was effectively 
launched by two almost simultaneous publications: one from Carlos Barbas, Richard Lerner 
and Benjamin List26 on proline-catalysed aldol reactions; and the other from David 
MacMillan,27 on an enantioselective Diels-Alder reaction catalysed by (2S)-imidazolidinone 1 
as his first-generation catalyst (Scheme 1.7).  
 
 
Scheme 1.7: The two reactions that launched the field of organocatalysis.  
 
Barbas, Lerner and List’s work was very important since it showed that the underlying 
mechanism of the Hajos–Parrish reaction could be extended and applied to transformations 
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of broader applicability. Moreover, it showed that small organic molecules (such as proline) 
could be as effective as enzymes in catalysing the same chemical reactions through similar 
mechanisms. During this period, MacMillan states that his work conceptualised 
“organocatalysis” in three important ways: by outlining how organocatalysts could provide 
economic, environmental and scientific benefits; by describing a general activation strategy 
that could be applied to a broad range of reaction classes; and by introducing the term 
organocatalysis to the chemical literature.15 
Perhaps most crucial to the success of organocatalysis in the past decade has been the 
invention or identification of generic modes of catalyst activation, induction and reactivity.15 
Generic activation modes identify reactive species that can participate in many reaction 
types with consistently high enantioselectivity (as opposed to one or two unique transfor-
mations). Such reactive species arise from the interaction of the chiral catalyst with a simple 
functional group (aldehyde, ketone, alkene or imine) in a highly organised and predictable 
manner. Thus once these activation modes were established they became a platform for 
designing new enantioselective reactions. As a result, most of the organocatalytic reactions 
that have been reported since 1998 are founded directly on only a handful of activation 
modes.15 Iminium catalysis (first reported in 2000) is one such case,27 together with 
enamine catalysis (which was demonstrated to be a generic activation mode by its 
application to the Mannich reaction in 2000).28 Similarly, Jacobsen and Wenzel29 were the 
first to demonstrate that hydrogen bonding catalysis had multiple reaction utility, in 2002. 
Iminium and enamine activation modes are the leaders in aminocatalysis (to be discussed in 
Section 1.2), whilst hydrogen bonding is prominent in the realm of cinchona-alkaloid and 
thiourea-based catalysis (Figure 1.4).  
 
 
Figure 1.4: Hydrogen bond activation with a thiourea catalyst. 
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Organocatalysts can be derived naturally or synthetically. For the former, relatively few 
alkaloids possess a naturally occurring antipode that allows their convenient use in 
enantioselective synthesis. Cinchona alkaloids are the exception, as they are available in 
pseudoenantiomeric forms, both of which produce impressive results in enantioselective 
reactions. Cinchona alkaloids were the first chiral amines to be used in asymmetric catalysis, 
in the pioneering work of Pracejus from the 1960s on disubstituted ketene alcoholysis.30 The 
cinchona alkaloid family consists of two pairs of diastereomers, namely, 
cinchonine/cinchonidine and quinidine/quinine (Figure 1.5) while all four are readily available 
in large quantities from chemical suppliers, albeit they are expensive. In such cases the 
hydroxyamine portions of the molecules are responsible for imparting selectivity. The past 
few years have witnessed an explosion of interest in the development of other classes of 
amine-based catalysts from the cinchona alkaloid chiral scaffold. Furthermore, chiral 
versions of common amines, such as DMAP derivatives and non-cinchona derivatives of 
quinuclidine have been successfully developed for use in asymmetric synthesis. 
 
Figure 1.5: Cinchona alkaloid pseudoisomers. 
 
Amino acids have been used as organocatalysts for a long time in asymmetric synthesis, 
with proline as the champion. In proline catalysis,31 this simple natural amino acid efficiently 
imitates the concept of enzymatic catalysis and is often referred to as the “simplest enzyme” 
in nature.32,33 However, there are several other reasons why proline has assumed such a 
prominent role in organocatalysis.31 Firstly, it is an abundant, cheap and readily available 
chiral molecule. Secondly, mechanistically, proline is bifunctional (with a carboxylic acid and 
an amine portion) and these functionalities can act both as acid or base facilitating chemical 
reactions in concert similar to enzymes. Whilst all these criteria clearly apply to all amino 
acids, proline is a secondary, cyclic, pyrrolidine-based amino acid, which results in an 
elevated pKb value in its amine portion. It has unique nucleophilicity due to this portion, 
which allows the formation of iminium ions and enamines more readily than other amino 
acids and amines (including cyclic piperidine). In addition, the carboxylic acid portion aids 
organocatalysis by acting as a Bronsted acid cocatalyst. Thus proline has not only acted as 
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a fantastic organocatalyst, but its structure has formed the basis of other new 
organocatalysts with varying reactivities and applications. Oligopeptides have also been 
used in organocatalysis. This is primarily because their reactivity can be tuned by varying the 
nature of the amino acids via combinatorial synthetic methods. Furthermore, their structural 
simplicity contrasts the complexity of enzymes and thus renders easier mechanistic 
investigations. Finally, they afford greater flexibility since it is easy to prepare the peptide 
sequence that can produce the opposite enantiomer or its epimer. Figure 1.6 displays 
various organocatalysts developed from amino acids and peptides. Many of the other 
synthetic molecules known to be efficient organocatalysts originate from ligand chemistry. 
This class of catalyst may include phosphorus-containing compounds, where phosphorus 
has the advantage of being able to act as both a Lewis base and a nucleophile, as well as 
providing a stereogenic centre.  
 
 
Figure 1.6: Catalysts derived from amino acids and peptides. 
 
As a final point, organocatalytic reactions are of great use to medicinal chemists and this has 
led to their applications in industry. Medicinal chemists are the largest body of industrial 
synthetic chemists and they need to find rapid, broadly applicable ways of constructing new 
candidate drugs for testing. Thus the most important considerations for a catalyst are its 
generality, convenience and robustness. Organocatalysts meet all of these criteria and they 
have already been taken up by some medicinal chemists in the pursuit of therapeutic agents 
targeting a single enantiomer.34 As the realisation grows that organocatalysts are highly 
efficient, easily manipulated and have important “green” advantages, asymmetric 
organocatalysis may catch up with or even surpass the remarkable advances in 
enantioselective transition-metal catalysis.3 Furthermore, Dalko et al. have pointed out an 
interesting dichotomy between organic and organometallic/bioorganic catalysis with respect 
to their reactivity and applications. On the one hand, organocatalytic reactions have evolved 
essentially from the ligand chemistry of organometallic reactions (many of these ligands 
have shown activity in these reactions in the absence of a metal).35 On the other hand, 
organocatalytic reactions can be more closely related to enzyme-catalysed reactions since 
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these molecules often act as artificial enzymes36 or enzyme mimetics and show some 
characteristic features of bioorganic reactions. However, this apparent similarity hides major 
differences in the mode of action. Enzymes act essentially by stabilising the transition-state 
of the reaction by the subtle orchestration of a number of functions, whereas organic 
molecules promote the reactions as simple reagents. Thus it would be naive to promote 
organocatalysts as competitors of organometallic or bioorganic catalysts. Rather, they 
complement current methods, and offer conceptually novel ideas that open new horizons in 
synthesis.4 
 
1.2 Aminocatalysis 
The vast majority of organocatalytic reactions are amine-based. The term ‘‘aminocatalysis’’ 
was first coined in 2001 by List,37 which he defined as the asymmetric catalysis of carbonyl 
transformations using chiral amines as organocatalysts.38 Aminocatalysis comprises 
reactions catalysed by secondary and primary amine functionalities of organic molecules via 
enamine and iminium ion intermediates.37–39 In this form of asymmetric catalysis, amino 
acids, peptides, alkaloids and synthetic nitrogen-containing molecules have been used as 
chiral catalysts.3 In particular, the application of chiral secondary amines as catalysts in 
transformations of carbonyl compounds has seen an incredible development in recent 
years.40 In these reactions the amine catalyst initiates proceedings by first acting as a 
nucleophile. Once incorporated into the substrate, it provides chirality for the reaction either 
as a nucleophilic chiral enamine or an electrophilic chiral iminium ion.13,14,30 These 
intermediate species are involved in biomimetic strategies common to class I aldolase and 
ketoacid decarboxylase enzymes, and the proline-catalysed intramolecular Hajos–Parrish–
Eder–Sauer–Wiechert reaction involving a chiral enamine was the first example in organic 
synthesis (see earlier in Scheme 1.6).18,19,41 Westheimer, in his studies of amine catalysis in 
biology (which paved the way for the formulation of the class I aldolase mechanism), led to 
the conclusion that it involves iminium ion and enamine intermediates.39,42 His ideas 
stemmed from Emil Knoevenagel who earlier found that primary and secondary amines, as 
well as their salts, catalyse the aldol condensation of β-ketoesters or malonates with 
aldehydes or ketones. Knoevenagel realised that his amines were truly catalytic 
(“Contactsubstanz”), and he achieved remarkably high turnover numbers; see Scheme 1.8 
for his reaction. More importantly, in the case of imines - and in the case of β-ketoesters also 
with enamines—he suggested the same intermediates that Westheimer later proposed in his 
retro-aldolisation studies.43,44 Benjamin List accordingly commented: “Thus Knoevenagel’s 
discovery and mechanistic interpretation of his reaction over 100 years ago laid the historical 
foundation for the development of modern aminocatalysis”.,26,27,39 
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Scheme 1.8: Knoevenagel’s reaction depicted as a modern catalytic cycle.39 
 
Knoevenagel’s work set the stage for the Hajos and Wiechert’s aldolisations in which their 
“catalyst design” is apparent: piperidinium and pyrrolidinium salts were established achiral 
catalysts of inter- and intramolecular aldolisations45 and amino acids had already shown their 
potential,46–48 thus proline was an obvious choice as an abundantly available chiral 
secondary amino acid catalyst. However, it is striking to consider (as List points out) 39 that in 
contrast to Knoevenagel more than 70 years earlier, Hajos and Parrish never discussed any 
mechanism nor realised or at least mentioned that their process was an early example of 
asymmetric catalysis. In fact, an enamine mechanism was rejected by Hajos. He opted for a 
mechanism involving the reaction of a weakly nucleophilic enol with a weakly electrophilic 
and sterically hindered hemiaminal (with retention of configuration!). Thus it’s fair to say that 
real progress in a mechanistic understanding and generalisation of aminocatalysis was not 
made during these years. List poses possible reasons why:39 1) the Hajos-Parrish reaction 
was developed in an industrial setting, where the “academics” of a discovery are rarely fully 
explored; 2) the suggested mechanism by Hajos was counterintuitive and could not easily be 
generalised; 3) the scope of highly enantioselective aldol variants appeared to be very 
narrow; and finally 4) the trends of the time were different and the like of Sharpless’ studies 
on transition-metal catalysis led to a whole new era of asymmetric synthesis research - a 
field that has inspired and fascinated organic chemists deeply to the extent that catalysis 
with “their own” purely organic molecules may have appeared less exciting for a few 
decades. In his rationlistion of why the Hajos-Parrish mechanism remained an enigma for 
decades, Carlos Barbas III suggests that the compartmentalisation of chemist and 
biochemist ideas as separate may be another reason. As such, chemists like Hajos and his 
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counterparts never turned to the teachings of Westheimer to elucidate the mechanism of 
their reaction.49 
List and Macmillan’s independent and deeper investigation of the Hajos-Parrish mechanism 
and seminal work in 2000 led the way for the generalisation of aminocatalysis and perhaps 
the explosion of asymmetric organocatalysis as a research field. How did this come about? 
The research group of Lerner and Barbas III (of which List was a member) was involved in 
the design of catalysts from aldolase antibodies that were able to promote intermolecular 
aldol reactions – thus combining organic chemistry ideas with biochemistry.50–52 These 
enzyme catalysts use an enamine-based mechanism to catalyse the aldolisation of two 
carbonyl compounds.53 Their findings highlighted a close mechanistic analogy between 
proline- and enzyme-catalysed aldol reactions, as enamine activation was central to both 
strategies. They thus suggested the potential employment of proline as a catalyst for the 
direct asymmetric intermolecular aldolisation of unmodified carbonyl compounds. Since then, 
asymmetric aminocatalysis has become a well-established and powerful synthetic tool for 
the chemo- and enantioselective functionalisation of carbonyl compounds. This research 
area has grown at such an extraordinary pace that it is now recognised as an independent 
area of synthetic chemistry, where the goal is the preparation of any chiral molecule in an 
efficient, rapid, and stereoselective manner.33 The large number of concepts developed 
independently (and almost simultaneously) by different research groups has generated 
tremendous scientific competition which has guided asymmetric aminocatalysis towards 
amazing levels of development, and opened up new synthetic opportunities that were 
previously considered inaccessible. This “aminocatalytic gold rush”, as Melchiorre coined it, 
emphasises an important aspect of scientific research and discovery: “progress depends on 
human effort”.33 
 
1.2.1 Secondary Amines 
Although primary amine catalysis has its place in asymmetric organocatalysis, most experts 
in the field define aminocatalysis as organocatalysis with secondary amine compounds.38,40 
Jørgensen elegantly described four distinct outcomes based on aminocatalysed carbonyl 
functionalisations, two applying aldehydes and two using α,β-unsaturated aldehydes 
(Scheme 1.9). 
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Scheme 1.9: Diagram taken from Jørgensen’s review on aminocatalysis mechanisms.40 
 
The above activation modes are based on active intermediates generated by the 
condensation of chiral cyclic amines with a carbonyl group. Thus in Melchiorre’s view, the 
principle for aminocatalytic activation emulates the mechanism of the activation of carbonyl 
compounds by Lewis acids, Scheme 1.10. This well-established strategy for enantioselective 
catalysis involves rate acceleration through the reversible binding of the Lewis acid to π-
systems. This in turn results in a redistribution of the electronic density toward the positively 
charged metal centre. The reversible condensation of a chiral secondary amine with 
carbonyl compounds to form positively charged iminium ion intermediates mimics the 
electronic situation of the π-orbitals in Lewis acid catalysis, where the energy of the lowest 
unoccupied molecular orbital (LUMO) is effectively lowered. For conjugated π-systems, the 
electronic redistribution prompted by the iminium intermediates allows nucleophilic additions, 
including conjugate additions and pericyclic reactions (LUMO activation). In the case of 
isolated π-systems, the lowering of the LUMO energy increases the acidity of the α-proton, 
which prompts a fast deprotonation and leads to the generation of the enamine - a 
nucleophilic enolate equivalent (highest occupied molecular orbital (HOMO) activation). Here 
too, the raising of the energy of the HOMO leads to activation of the carbonyl compounds, 
similar to the generation of activated nucleophiles by Lewis acids.33  
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Scheme 1.10: Melchiorre’s comparison of the activation of carbonyl compounds by a Lewis 
acid and by aminocatalysis.33 E = electrophile, Nu = nucleophile. 
 
Viewing this, one might say that aminocatalysis follows basic mechanistic principles from 
introductory organic chemistry. Yet, closer mechanistic study of the aminocatalytic 
functionalisations of aldehydes and α,β-unsaturated aldehydes shows that the reaction 
mechanisms are often more complex than anticipated (often including subtle intra- and 
intermolecular bonding interactions), and their study reveals new, fascinating aspects of the 
reaction sequences.  
 
It is clear that enamine and iminium aminocatalysis are based on the same origin, i.e. 
iminium-ion formation. This is what List has coined as the “ying and yang” of aminocatalysis 
where the two catalytic intermediates are opposites, yet interdependent, and they consume 
and support each other.38 The understanding of this principle has given rise to the 
asymmetric functionalisation of a broad range of carbonyl compounds at different positions, 
which certainly has spurred on the exponential growth of this field. Therefore, the different 
activation modes of aminocatalysis will now be discussed. 
 
α–Functionalisation 
MacMillan’s aminocatalysed (imidazolidinone 1) Diels-Alder reaction (see Scheme 1.7) 
reported in 2000 was the first demonstration of the effectiveness of his well-designed 
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imidazolidinone catalyst 1 in the activation of α,β-unsaturated aldehydes. In the same year, 
following studies on the Hajos-Parrish reaction, Barbas, List and co-workers showed that the 
proline-catalysed asymmetric intermolecular aldol reaction with aldehyde acceptors could be 
successfully extended to different types of unmodified ketone donors, including cyclic 
substrates (Scheme 1.11). An excess of the ketone allows the isolation of the cross-aldol 
products in good yields and high enantiomeric excess. The enantioselectivity depends on 
the nature of aldehyde substituents, in which aliphatic aldehydes produce ees of 
approximately 90%, and aromatic aldehydes give ees of approximately 70%. When 
hydroxyacetone was used as the donor a highly diastereo- and enantioselective product was 
obtained. This powerful procedure affords access to synthetically useful anti-1,2-diols, which 
complements the Sharpless syn-dihydroxylation of these important building blocks.54–56  
 
 
Scheme 1.11: Proline-catalysed intermolecular aldol reaction of unmodified aldehydes and 
ketones. 
 
Subsequently, Northrup and MacMillan reported the first direct enantioselective proline-
catalysed cross-aldol reaction of two aldehydes as another powerful transformation.57 Using 
DMF as solvent and a slow addition (syringe pump) of the aldehyde donor, they supressed 
the formation of by-products arising from product dehydration or self-aldolisation. Thus in the 
presence of proline (10 mol%) chemo- and diastereoselective aldol cross-coupling of α-alkyl 
aldehydes furnished highly enantioenriched anti-aldol products. 
 
List applied the enamine activation strategy to achieve the first, direct, catalytic and 
asymmetric Mannich reaction between an aldehyde and a ketone, without prior formation of 
an enolate or imine (Scheme 1.12). The Mannich reaction constitutes one of the most 
powerful organic transformations for the construction of chiral nitrogen-containing molecules. 
This organocatalytic approach first established the possibility of indirectly using electrophiles 
other than aldehydes, and thus represents a cornerstone in the area of proline catalysis. 
Under mild conditions of proline catalysis, which allows the in situ generation of the imine, 
the direct three-component Mannich reaction of various ketones has been accomplished to 
furnish the desired products in high yield and enantioselectivity; the aldol derivatives were 
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not detected. Notably, the use of α-oxygenated ketones results in complete regioselectivity 
for the hydroxy-substituted alkyl chain, and allows the highly chemo-, diastereo-, and 
enantioselective synthesis of syn-1,2-amino alcohols.28,58  
 
Scheme 1.12: The proline-catalysed Mannich reaction. 
 
List et al.,59 as well as Barbas and co-workers,56 independently demonstrated that Michael 
acceptors such as nitro olefins react with ketones under proline catalysis (Scheme 1.13). 
Enantioselectivities were poor, although the reaction paved the way for future optimisations 
using proline60 or different secondary amine catalysts.61–64 Furthermore, these studies 
highlighted the necessity for the hydrogen bonding interaction between the electrophilic 
components and the carboxylic moiety of proline to enforce excellent stereocontrol. The 
interaction is not optimal in the case of Michael acceptors, resulting in very modest 
enantioselectivity.33 
 
 
Scheme 1.13: The first aminocatalysed Michael reaction using a ketone as the nucleophile. 
 
In 2002 Barbas and co-workers described the proline-catalysed direct self-aldolisation of 
acetaldehyde to afford (S,E)-5-hydroxy-2-hexenal in 90% ee.65 From that point on, the 
involvement of aldehyde donors in proline catalysis had a profound impact on asymmetric 
aminocatalysis, encouraging the development of new aldehyde-based methodologies with a 
wide range of electrophiles. Thus aldehydes gained a central role in organocatalysis due to 
their high reactivity in reactions catalysed by enamines and iminium ions and because of 
their great versatility as building blocks.33 
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In nearly all areas of organic chemistry, an essential role is played by chiral molecules 
containing a stereogenic carbon atom attached to a heteroatom adjacent to a carbonyl 
moiety. In 2002, Jørgensen66 and List67 independently and almost simultaneously reported 
an efficient and simple method for the highly enantioselective α-amination of aldehydes and 
ketones using an azodicarboxylate as the electrophilic nitrogen source with 10 mol% proline 
(Scheme 1.14). This is the main reaction of this PhD thesis and will be reviewed in detail in 
Section 1.3.  
 
Scheme 1.14: The proline-catalysed α-amination reaction.  
 
Subsequently in 2003 the direct asymmetric α-oxygenation of aldehydes (Scheme 1.15) was 
achieved with nitrosobenzene as the electrophilic oxygen source. Here a hydrogen bond in 
the transition-state is formed between the basic nitrogen atom of nitrosobenzene and the 
carboxyl hydroxyl-group hydrogen of proline. This accounts for the high regio-control of the 
reaction. Three different research groups separately exploited the possibility of controlling 
both the O/N selectivity and enantioselectivity of the direct α-oxygenation of aldehydes.68–70 
An analogous α-aminoxylation was developed using a different secondary amine catalyst, 
Jørgensen’s TMS-protected diphenylprolinol catalyst 2, which precludes an acid-base 
interaction between the nitroso nitrogen, since no carboxylic acid functionality is present in 
the catalyst.71,72 However, oxygenation can be achieved when catalyst 2 is used in the 
presence of a Bronsted acid. 
 
 
Scheme 1.15: The α-oxygenation of aldehydes. 
 
Optically active halogen compounds are also important in various scientific fields for use in 
further manipulations or because the stereogenic C–halogen centre has a unique property 
that is of specific importance for a given molecule. The increasing importance of these 
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functional groups in medicinal chemistry and materials science has led to an increased 
search for catalytic asymmetric C–halogen bond-forming reactions.73 The first 
aminocatalysed α-chlorination reaction made an impact in three ways: firstly, the reaction 
expanded the scope of enamine catalysis to intermolecular nucleophilic substitution 
reactions, secondly, it conclusively demonstrated that enamine catalysis is not limited to 
proline,33 and finally, the reaction provided easy access to a large number of simple but 
extremely versatile building blocks and has since led to the synthesis of naturally occurring 
compounds.74 Scheme 1.16 shows the excellent results obtained with the MacMillan catalyst 
1 in combination with a perchlorinated quinone,75 and with 2,5-diphenylpyrrolidine 3 when N-
chlorosuccinimide is the chlorine source. Interestingly, the simple prolinamide 4 also shows 
very good reactivity and good enantioselectivity.76 The authors showed that the products 
could easily be converted into terminal epoxides (via carbonyl reduction and ring closure), as 
well as amino acids, or amino alcohols, while maintaining a high enantiomeric excess. These 
successful α-chlorinations became the inspiration for, and the beginning of, a series of 
enantioselective α-halogenations of both aldehydes and ketones. 
 
 
Scheme 1.16: The influential α-chlorination of aldehydes with catalysts other than proline.  
 
For α-bromination, the easily synthesised and air-stable 4,4-dibromo-2,6-di-tert-
butylcyclohexa-2,5-dienone turned out to be the best reagent for aldehydes 
(enantioselectivities range between 68% and 96%) and for preparation of chiral α-
bromoketones (73–94% ee).77 This culminated in the successful α-fluorination of aldehydes. 
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Fluorination is a particularly challenging (and therefore intriguing) transformation since the 
large electronegativity and small van der Waals radius of the fluorine atom clearly 
differentiates it from the other halogens. Another strong incentive for achieving 
aminocatalysed asymmetric α-fluorination is the potential application of the fluorinated 
products, since fluorine substituents usually affect the overall physicochemical properties of 
a molecule (e.g. the addition of a fluorine atom to a biologically active compound can 
significantly improve its metabolic stability).33,78 Direct enantioselective α-fluorination of 
aldehydes was presented within a few weeks in 2005 by four different research groups. 
Enders and Huttl,79 Jørgensen and co-workers,80 Barbas and co-workers81 and Beeson and 
MacMillan.82 Enders and Huttl described how different chiral amines catalysed the α-
functionalisation of carbonyl compounds by using selectfluor as the electrophilic fluorine 
source with moderate enantioselectivity. The three other approaches - using N-
fluorobenzenesulfonimide (NFSI, 5) as the fluorination reagent - were more successful, with  
Jørgensen utilising (S)-2-[bis(3,5-bistrifluoromethylphenyl) 
trimethylsilanyloxymethyl]pyrrolidine 6 as a catalyst, Barbas using MacMillan’s 
imidizolidinone catalyst 1 and MacMillan using the same catalyst in the presence of 10 mol% 
of dichloroacetic acid (DCA) and iso-propanol (Scheme 1.17). 
 
 
Scheme 1.17: The first asymmetric aminocatalysed α-fluorinations of carbonyls. 
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Chiral compounds having a free thiol functionality are very interesting as potent inhibitors of 
zinc-containing enzymes.83,84 In 2005 Jørgensen extended the list of existing sulfenylating 
agents by preparing 1-benzylsulfanyl-1,2,4-triazole. Application of this reagent with his 
prolinol catalyst 6 to aldehydes resulted in a highly enantioselective process, Scheme 1.18.85 
Product racemisation was avoided by simple and quantitative in situ derivatisations 
(reductive amination and reduction). 
 
 
Scheme 1.18: The α-sulfenylation of aldehydes. 
 
α-Functionalisation by Singly Occupied Molecular Orbital (SOMO) Catalysis 
MacMillan86,87 and Sibi88 almost simultaneously introduced a new aminocatalytic activation 
concept in 2007, termed singly occupied molecular orbital (SOMO) catalysis in which 
activation is based on radical intermediates. Importantly, it links the distant research areas of 
organocatalysis and radical chemistry. Thus, this approach allows a shift from processes 
involving charged intermediates to those involving radical catalysis by exploiting the 
susceptibility of the transient enamine to undergoing selective oxidation relative to other 
reaction components. This generates a radical cation with three π-electrons and a SOMO, 
which is activated toward subsequent nucleophilic attack.33,40 Scheme 1.19 diagrammatically 
explains this interesting concept. 
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Scheme 1.19: The principle of SOMO activation in aminocatalysis. 
 
Sibi and Hasegawa exploited aminocatalytic SOMO activation for the stereoselective α-
oxygenation of aldehydes with TEMPO, a reliable radical reagent, to intercept the radical 
cationic species thus generating an oxygenated adduct in moderate to high 
enantioselectivity (Scheme 1.20). They used the MacMillan imidazolidinone catalyst 1 and a 
catalytic amount of FeCl3 as a cheap single-electron transfer (SET) reagent in the presence 
of a NaNO2 / O2 mixture as a cooxidant in order to avoid having to use a stoichiometric 
amounts of FeCl3.88 This method is based on studies by Liang et al. who showed that the 
NaNO2 / O2 combination activates FeCl3 by oxidising the Fe2+ back to the reactive Fe3+, 
which in turn oxidises the enamine to a radical cation.89 Although the similar oxygenated 
products are accessible via the highly stereoselective proline-catalysed addition of 
aldehydes to nitrosobenzene or molecular oxygen, 90,91,92 this study represented a significant 
proof of concept for SOMO catalysis.33 
 
 
Scheme 1.20: SOMO catalysis for aldehyde oxygenation. 
 
MacMillan and co-workers demonstrated the real value of this novel SOMO activation 
strategy by applying it to the highly enantioselective α-alkylation of aldehydes.86,87 Here, a 
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radical cation is generated by oxidation of the enamine with cerium ammonium nitrate 
(CAN), which is followed by reaction with an allylsilane as a π-electron-rich allyl nucleophile. 
A second oxidation by CAN (present as 2 equivalents) then removes the silyl group as a 
cation (Scheme 1.21). These reactions display high enantioselectivities with MacMillan’s 
second-generation imidazolidinone catalyst 7, the development of which will be discussed in 
the next section. In these transformations it should be noted that the α-carbon atom of the 
aldehyde reacts as if it is the electrophile. Thus this activation mode formally reverses 
(umpolung) the normal polarity of enamine intermediates, and in so doing introduces new 
reactions previously not possible with established catalysis concepts.33 
 
 
Scheme 1.21: SOMO-catalysed α-functionalisations using MacMillan’s second –generation 
catalyst 7. 
 
Another important SOMO transformation is MacMillan’s first asymmetric catalytic α-vinylation 
of aldehydes using vinyl trifluoroborate salts as coupling reagents for radical-based 
processes.93 They also reported the α-amination of aldehydes with a nitrogen radical in 2013 
– the first α-amination through SOMO acticvation.94 
 
β-Functionalisation 
As previously mentioned, α,β-unsaturated carbonyl compounds are activated by lowering the 
LUMO energy of the system, making them more electrophilic, acidic, and prone to certain 
pericyclic reactions38 This organocatalytic activation mode exploits the reversible 
condensation of a chiral amine catalyst, such as 1, with an unsaturated aldehyde to form an 
iminium ion intermediate, which lowers the LUMO energy of the π-system and enhances its 
susceptibility toward nucleophilic attack. Central to the success of MacMillan’s 
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imidazolidinone 1 as a stereoselective iminium activator is its ability to effectively and 
reversibly form the reactive iminium ion with high levels of both configurational control and 
π-facial discrimination (Scheme 1.22). The activated iminium predominantly exists in the 
Eiminium-geometry to minimise nonbonding interactions between the iminium double bond C-
substituents and the gem-dimethyl groups on the catalyst (although reaction temperature, 
solvent, catalyst and the iminium counter-ion may affect the E:Z ratio).95,96 The selective π-
facial blocking by the imidazolidinone benzyl group leaves the re face of the iminium ion 
exposed for nucleophilic attack, resulting in a highly enantioselective bond formation.33 
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Scheme 1.22: The control of configuration of the iminium ion by imidazolidinone catalyst 1.33 
 
In this regard, MacMillan’s asymmetric Diels–Alder reaction between α,β-unsaturated 
aldehydes and various dienes catalysed by catalyst 1 represents a milestone for asymmetric 
organocatalysis, since it introduced the novel catalytic activation concept termed iminium 
catalysis, which in turn led to the development of a wide range of asymmetric 
transformations involving unsaturated carbonyl compounds. Furthermore, studies on LUMO-
lowering organocatalysis by MacMillan and co-workers established the effectiveness of the 
readily available chiral imidazolidinone 1 to promote mechanistically distinct transformations 
of α,β-unsaturated aldehydes in a highly enantioselective fashion. Scheme 1.23 shows 
examples of MacMillan’s impressive methodologies: the seminal Diels-Alder reaction27 and 
the Friedel-Crafts alkylation of pyrroles.97 It is also important to note that the nature of the 
anion of the catalytically active salt is essential for modulating both the reactivity as well as 
the stereoselectivity of these reactions (although there is precedence of effectively using the 
imidazolidinone catalyst alone as a neutral species). 
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Scheme 1.23: MacMillan’s important methodologies using iminium ion activation 
 
The organocatalytic Friedel–Crafts strategy was extended to heteroaromatic indole and 
furan derivatives (less-activated pi-nucleophiles compared to pyrrole) with less impressive 
results in terms of both yield and ee.98,99 This highlighted the need for a new, more reactive, 
and versatile amine catalyst for iminium activation, which would allow for the 
enantioselective catalytic addition of less reactive nucleophiles. Kinetic studies on the 
reaction with imidazolidinone catalyst 1 suggested that the rate of formation of the iminium 
ion as well as that of the C-C bond-forming step both influenced the reaction rate. On this 
basis, it was theorised that the reaction rate and tendency to form an iminium ion could be 
improved by replacement of the trans-methyl group (with respect to the benzyl moiety) with a 
hydrogen atom in order to reduce steric hindrance on the participating free lone pair of 
electrons on the nitrogen atom (Scheme 1.24). Furthermore, replacement of the cis-methyl 
group with a larger tert-butyl moiety provided increased control over the geometry of the 
iminium ion and better coverage of the blocked si-enantioface. The removal of the methyl 
group also allowed the nucleophile to approach the re face of the formed chiral iminium ion 
without steric hindrance.100 Since its introduction in 2002, the imidazolidinone catalyst 7 has 
been applied successfully to the catalysis of a wide range of asymmetric transformations of 
unsaturated aldehydes including conjugate additions with different nucleophiles,101,102 [4+3] 
cycloadditions103 and intramolecular Diels-Alder reactions104,105.33 
 
 
Scheme 1.24: The development of MacMillan’s second-generation imidazolidinone catalyst 
7.33 
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The catalytic aza-Michael addition reaction is also important within synthetic organic 
chemistry, given the significance of the biologically and synthetically interesting products 
(such as β-amino acids and β-lactams) that result. Since the first example published by 
Jørgensen et al. in 1996,106 a number of chiral catalyst systems (including metal-based 
catalysts) have been developed for this reaction. The first organocatalysed asymmetric aza-
Michael addition was reported in 2006 by MacMillan and co-workers (Scheme 1.25).102 N-
silyloxycarbamates were applied as nitrogen nucleophiles, as they possess enhanced 
nucleophilicity due to the neighbouring silyloxy group via an α-effect. The non-basic 
carbamate N-H moiety enables the permanent loss of the nucleophile proton after the 1,4-
addition, thus limiting the reverse reaction. The reaction produces β-amino-aldehydes in 
good to excellent yields and excellent enantioselectivities, thereby providing a simple, direct 
and highly stereoselective way to access both cyclic and acyclic, chiral, nitrogen-containing 
compounds under mild reaction conditions.107 
 
Scheme 1.25: MacMillan’s maiden organocatalysed aza-Michael addition. 
 
Iminium catalysis can deliver unique, orthogonal, or complementary selectivities compared 
to metal-catalysed transformations. This is exemplified by the synthesis of butenolides by the 
Mukaiyama–Michael addition of silyloxyfurans to enals using the (2R)-enantiomer of 
MacMillan’s second-generation catalyst 7 (Scheme 1.26).108  
 
 
Scheme 1.26: Synthesis of butenolides by the Mukaiyama–Michael addition. 
 
Perhaps the most impressive validation of this concept has been the organocatalytic 
asymmetric transfer hydrogenation of α,β-unsaturated aldehydes, since the metal-catalysed 
hydrogenations of double bonds are by far the most predominant metal-based asymmetric 
transformations applied in industry. In fact, their usefulness was recognised with the award 
of the Nobel Prize in Chemistry to Knowles and Noyori in 2001 (who jointly shared half of the 
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prize with Barry Sharpless). The development of organocatalytic hydrogenations would thus 
be useful to solve toxicity concerns associated with metal-catalysed processes. The 
research groups of MacMillan and List demonstrated that iminium catalysis is a suitable 
strategy for accomplishing the highly enantioselective reduction of enals by using synthetic 
Hantzsch dihydropyridines as hydride donors (Scheme 1.27).109,110 List and co-workers 
employed MacMillan’s second-generation imidazolidinone 7 as the catalyst, whereas 
MacMillan and co-workers designed the even newer organocatalyst 8.33 
 
 
Scheme 1.27: Aminocatalysed transfer hydrogenation. 
 
Similarly, stereoselective reactions of α,β-unsaturated ketones tend to be very challenging in 
organocatalysis. This is due to inherent problems of forming highly substituted iminium ions 
from ketones, as well as the more difficult aspect of controlling the configuration of the 
iminium ion. These factors have thus complicated the development of an efficient chiral 
organocatalyst for them.33 The first advance in this area came from MacMillan’s research 
group, with the development of a new imidazolidinone catalyst 9 that allowed the first 
catalytic Diels–Alder reaction with simple α,β-unsaturated ketones.111 This catalyst allowed 
enantioselective access to substituted cyclohexenyl ketones, although it did not demonstrate 
a wide generality as a ketone activator.112 An important contribution to this challenging field 
came from Jørgensen and co-workers, who introduced chiral secondary amine catalysts 10 
and 11.113 These readily available organocatalysts have broad applicability, as they promote 
the highly enantioselective addition of different carbogenic nucleophiles such as 
nitroalkanes,113 malonates,114 and β-keto-esters115 as well as sulfones to the unsaturated 
ketone,116 thus providing access to useful chiral building blocks. The catalysts’ utility as 
iminium activators has been further verified by the one-pot direct synthesis of 
enantioenriched biologically active compounds, such as the anticoagulant warfarin.117 
Scheme 1.28 displays these new catalysts and the warfarin synthesis with catalyst 11. 
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Scheme 1.28: New catalysts for the activation of α,β-unsaturated ketones. 
 
Phosphorus has also been effectively used as a nucleophile in the aminocatalysed Michael 
addition reaction of α,β-unsaturated aldehydes. For example, Cordova’s hydrophosphination 
with diphenylphosphine, catalysed by Jørgensen’s prolinol catalyst 2, was achieved in good 
to excellent yields and enantioselectivities (76-99% ee).118  
 
The imidazole-assisted, proline-catalysed intramolecular Baylis–Hillman reaction of an α,β- 
unsaturated aldehyde has also been achieved in good yield and excellent enantioselectivity. 
The high ee was attributed to hydrogen bonding between the carboxylic acid, a water 
molecule, and the aldehyde (Scheme 1.29).119,120  
 
 
Scheme 1.29: The aminocatalysed, imidazole assisted Baylis-Hillman reaction. 
 
γ-Functionalisation 
Jørgensen and co-workers121 reported that under conditions generally used for 1,4-additions, 
the concentration of the iminium ion formed in the reaction between prolinol catalyst 6 and 
(E)-pent-2-enal was so low that it could not be detected by 1H NMR spectroscopy. This was 
because the negatively charged counterion could easily abstract the γ-proton of the iminium 
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ion such that the electron-rich dienamine was the most abundant species in solution 
(Scheme 1.30).  
 
Scheme 1.30: The activation of α,β-unsaturated aldehydes to form dienamines. 
 
Based on the above observations, Jørgensen and co-workers developed the first γ-
amination of α,β-unsaturated aldehydes (Scheme 1.31).121 Prolinol 6 catalyses the γ-
functionalisation of α,β-unsaturated aldehydes with diethyl azodicarboxylate (DEAD). The 
products were obtained in moderate yield and with high enantioselectivity (88–93% ee). On 
the basis of the experimental evidence and computational investigations, the authors 
proposed that this outcome was the result of a Diels-Alder reaction between the (E-s-cis,E)- 
dienamine conformer and DEAD. Hydrolysis of the cyclic intermediate resulted in the release 
of the catalyst and the chiral γ-aminated product. 
 
 
Scheme 1.31: The γ-amination of α,β-unsaturated aldehydes. 
 
Subsequently, Barbas and co-workers demonstrated regioselectivity control with the 
dienamine 122,123 in its reaction with imines, which gave the α−product exclusively instead of 
adding the electrophile at the γ-carbon atom (Scheme 1.32). The product obtained equated 
with that from an aza-Morita–Baylis–Hillman (MBH) reaction, albeit formed via a different 
mechanism, and was formed in moderate yields but with excellent enantioselectivities (up to 
99% ee). 
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Scheme 1.32: The proline-catalysed aza-Morita–Baylis–Hillman (MBH) reaction 
 
Similarly, in 2014 Jørgensen et al. reported the use of prolinol catalyst 2 for generating a 
dienamine from the exocyclic enal shown in Scheme 1.33. This then reacted with an enone 
dienophile to effect a Diels-Alder route to the synthesis of 14β-steroids in high 
diastereoselectivity (up to 20:1 dr) and high enantioselectivity (up to >99% ee). There is also 
a chemoselective aspect to this reaction since the catalyst undergoes faster condensation 
with the enal compared to the enone. This new reaction has the attraction of allowing for 
several substituents in the A ring in a simple one-step approach (Scheme 1.33).124 
 
Scheme 1.33: The use of γ-functionalisation to synthesise 14β-steroids. 
 
Thus the high reactivity of these conjugated enamines can be controlled by a careful choice 
of catalyst, reagents, and conditions. The few examples reported in this review show that the 
highly enantioselective γ-functionalisation of α,β-unsaturated carbonyl compounds can be 
achieved via a [4+2] cycloaddition or as a result of a direct nucleophilic γ-addition. 
 
Aminocatalysis activation has also been extended to trienamines to give ε-
functionalisation.125 A collaboration between the Jørgensen and Chen research groups first 
established this HOMO-raising strategy.126 The condensation of 2 or its triethylsilyl analogue 
with 2,4-heptadienal leads to the transient formation of an iminium ion, which rapidly 
equilibrates to the trienamine intermediate. Calculations have found the all-trans trienamine 
as the lowest energy isomer. Such trienes undergo highly stereoselective Diels–Alder 
processes at the β- and ε-carbons with olefinic dienophiles, such as methyleneindolinones or 
olefinic cyanoacetates (Scheme 1.34) with impressive control over the regio-, diastereo-, and 
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enantioselectivity. The cycloaddition’s regio- and endo-selectivities were controlled by orbital 
factors and secondary orbital interactions, while the enantioselectivity was governed by the 
ability of chiral secondary amines to ensure effective π-facial discrimination through steric 
control. The scope of this Diels–Alder reaction was then successfully extended to include 
nitroalkenes with an exo-selectivity (Scheme 1.34).127 
 
 
Scheme 1.34: Trienamine Diels-Alder transformations. 
 
Soon afterwards, Jørgensen and co-workers introduced the concept of cross-trienamines 
generated from cyclic enals.128 Thus, asymmetric Diels–Alder reactions proceed through a 
cross-trienamine intermediate in preference to the more stabilised linear trienamine 
intermediate. Jørgensen was able to show that cross-trienamine activation can also be 
applied to Michael additions. Thus cyclic 2,4-dienals form the cross-trienamine which then 
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undergoes a Michael addition with a vinyl bis-sulfone to give products in high yield and 
excellent enantioselectivities (up to 99% ee), Scheme 1.35. 
 
 
Scheme 1.35: Cross-trienamine aminocatalysis used in a Michael addition. 
 
These results illustrate how asymmetric aminocatalysis still, remains a highly active area of 
chemical research, providing innovative strategies to successfully overcome difficult 
challenges related to the synthesis of complex chiral molecules.129 
 
Tandem Reactions 
Combining the “ying and yang” aminocatalysis principles in tandem sequences is an 
attractive prospect in organocatalysis.38 Multi-step sequences involving the synthesis, 
isolation and purification of intermediates are usually required to synthesise complex chiral 
molecules. In contrast, the biosynthesis of complex natural products is achieved by highly 
regulated catalytic domino reactions that do not require time-consuming and costly 
operations. Thus, with the efficiency of nature as inspiration, the design of catalytic 
enantioselective domino transformations has become an essential goal. Another big 
operational and economic advantage of organocatalytic cascade reactions is that they don’t 
need protecting groups. The knowledge accumulated on the mechanism of enamine and 
iminium catalysis has allowed the integration of these activation modes into more elaborate 
reaction sequences. Such tandem sequences can be very powerful for the generation of 
molecular complexity in a simple one-flask operation, particularly if they are combined into 
double, triple, and even multiple cascades. 
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While Robinson annulations (following the Hajos-Parrish reaction) are well known with 
enones, the first example of a domino reaction involving α,β-unsaturated aldehydes was 
presented in 2004 by the MacMillan research group130 in which indole C-3 addition to an 
enal-derived iminium ion using chiral imidazolidinone 1 (Scheme 1.36) resulted in a highly 
enantioselective formation of a quaternary stereocentre. The intermediate indolinium ion 
then underwent trapping by the appended alcohol or protected amino moiety to form an 
optically active pyrroloindoline, which could be accessed in high yield and in excellent 
diastereomeric and enantiomeric ratio in a single and simple operation. Many analogues of 
naturally occurring compounds were then accessed using this transformation. (-)-
Flustramine B is an example, as it was synthesised in just five steps starting from the 
product of an organocatalytic reaction.  
 
Scheme 1.36: Domino conjugate addition / cyclisation reaction leading to the synthesis of  
(-)-Flustramine B. 
 
Around about the same time, Barbas and co-workers started investigating the coupling of 
three components through sequential Knoevenagel and Diels–Alder reactions.131–134 Scheme 
1.37 shows their approach132 involving first a Knoevenagel condensation between the 
aldehyde and Meldrum’s acid to form a dienophile, which reacts with the chiral dienamine 
intermediate formed by condensation of 5,5-dimethyl-thiazolidinium-4-carboxylate 12 with 
the enone. The chiral product of the resultant Diels–Alder reaction was obtained in excellent 
yield and up to 99% ee after hydrolysis of the catalyst.  
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Scheme 1.37: Asymmetric Knoevenagel / Diels-Alder reaction. 
 
Another important example of an organocatalysed domino reaction involving unsaturated 
ketones was reported by Yamamoto et al., Scheme 1.38.135,136 Here, a dien-2-amine was 
formed due to the presence of a quaternary centre at C-4 of the enone, which underwent a 
regioselective Diels-Alder reaction with nitrosobenzene. The authors suggest this to be a 
stepwise sequence involving α-addition to the oxygen of the nitroso group followed by ring 
closure of nitrogen onto the resultant α,β-unsaturated iminium ion, although it is feasible that 
cycloadduct formation involves a concerted process. This is one of the first examples of 
tetrazole catalyst 13 being used. This catalyst was developed and introduced on separate 
occasions by Yamamoto,137 Arvidsson138 and Ley139 as an improvement on proline due to 
greater reactivity and broader solvent scope. 
 
 
Scheme 1.38: A domino enamine/iminium ion reaction catalysed by tetrazole catalyst 13. 
 
Similarly, in 2005 MacMillan and Kunz developed an organocatalysed cyclopropanation as a 
novel domino reaction.140 Shortly after, Jørgensen and co-workers demonstrated that the 
prolinol catalyst 6 can catalyse the direct epoxidation of β-mono-substituted or α,β-di-
substituted α,β-unsaturated aldehydes under very mild conditions.141 Mixtures of E- and Z- 
olefins are transformed with very good stereoselectivity in a stereoconvergent manner. 
Approximately two years after these ground-breaking discoveries, the Cordova research 
group reported the asymmetric aziridination of α,β-unsaturated aldehydes (Scheme 1.39).142 
Key to the success of this reaction was the choice of a Cbz carbamate protecting group on 
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the hydroxylamine nitrogen source. Thus, valuable aziridines with easily removable 
protecting groups were obtained directly and in high enantiomeric excess (90–99% ee) using 
prolinol catalyst 2. Using a similar mechanistic principle, in 2015 Hayashi et al. reported an 
aminocatalysed asymmetric epoxidation of 2-oxoindoline-3-ylidene acetaldehydes with 
hydrogen peroxide in good yield and up to 99% ee.143 
 
 
Scheme 1.39: Organocatalysed aziridination. 
Jørgensen et al. have shown that asymmetric organocatalytic multi-component reactions 
(MCR) can lead to simpler procedures for the formation of multiple stereocentres and thus 
more environmentally-friendly processes.144 They demonstrated the potential of the 
organocatalytic asymmetric MCR by presenting a domino-conjugated thiol addition / 
amination reaction. The soft sulfur nucleophile first reacts with the iminium ion intermediate 
to form an enamine, which then adds to the nitrogen electrophile, giving essentially 
enantiopure products when prolinol 6 was used as the catalyst (Scheme 1.40). Thus a 
simple approach to the synthesis of highly functionalised molecules having two adjacent 
stereocentres with ees mostly >99% was developed.  
 
 
Scheme 1.40: Jørgensen’s MCR catalysed by prolinol 6. 
 
Remarkably, Enders and co-workers found success in the even more ambitious synthetic 
task of controlling four stereocentres in a triple domino reaction involving an exceptional 
sequential enamine/iminium/enamine activation sequence (Scheme 1.41).145–147 The 
diphenylprolinol catalyst 2 first controls a Michael addition of the aldehyde to the nitrostyrene 
derivative, which adds in a second Michael reaction to a chiral enal-derived iminium ion to 
form an enamine. Finally an intramolecular aldol reaction leads to the cyclic six-membered 
product in which the carbonyl group from the original aldehyde acts as the acceptor. In such 
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a way highly functionalised cyclic products are obtained in essentially enantiopure (>99% 
ee) form in a simple single operation.145 
 
Scheme 1.41: Aminocatalysed enamine/iminium/enamine domino reaction. 
 
This cascade provided the inspiration for Hayashi’s elegant organocatalytic asymmetric 
synthesis of (-)-Oseltamivir (Tamiflu) in 2009, Scheme 1.42.148 The synthesis is based on 3 
simple starting materials: an alkoxyaldehyde, a nitroalkene and a diethyl vinylphosphonate 
derivative. As before, addition of the chiral enamine (derived from the aldehyde with prolinol 
2) to the nitroalkene gave a Michael adduct, which underwent a second Michael addition to 
the vinyl phosphonate to generate an ylide that ring closed in a Wittig reaction. Finally, a 
thio-Michael reaction followed by nitro group reduction, and then restoration of the double 
bond rendered enantiopure Oseltamivir in 57% overall yield and an 87% ee. The thio-
Michael step protects the double bond during the nitro-group reduction. The complete 
synthesis involved only three separate one-pot operations and a single chromatographic 
purification.  
 
Scheme 1.42: Domino approach to the synthesis of (-)-Oseltamivir. 
 
In 2014 Constantieux et al. described a new enantioselective three-component reaction 
between β-keto esters, enals and N-(2-aminoethyl)pyrroles to afford novel, fused tricyclic 
piperazines.149 In the same year Enders and co-workers reported the organocatalysed 
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synthesis in one pot of functionalised cyclopentanes bearing an oxindole moiety together 
with several other functional groups. Their reaction involved a triple Michael domino reaction 
catalysed by Jørgensen’s prolinol catalyst 2, followed by a Wittig olefination to form three C-
C bonds and 6-stereocentres, including a quaternary one (Scheme 1.43). The catalyst 
initiates the first Michael addition of the oxindole to the nitro ester at C-4 (C-1 as the ester 
carbon) by acting as a Bronsted base. This intermediate then undergoes a second Michael 
addition with a catalyst-activated cinnamaldehyde iminium ion and finally, the resulting 
enamine initiates the third Michael addition to the α,β-unsaturated ester at C-3. A Wittig 
olefination of the free aldehyde then completes the sequence. 
 
Scheme 1.43: Multicomponent synthesis of cyclopentane-oxindoles. 
 
Predicting how extensive the application of organocatalysed domino reactions will be in 
organic synthesis in the future is almost impossible to predict, since new reports seem to be 
expanding the possibilities of this methodology all the time. As Jørgensen stated: “We 
believe and hope that the future will bring an increased use of organocatalysis in total 
synthesis, as well as in standard transformations. As the toolbox of organocatalytic reactions 
grows, it will bring new transformations that will short-cut established routes to interesting 
molecules.”150 In this view, advances made in tandem organocatalysed reactions are surely 
steps in the right direction.  
 
1.2.2 Primary Amines 
Until 2004 comparatively little attention had been paid to the development of chiral primary 
amine catalysts, even though primary amine catalysis is effectively exploited by natural 
enzymes such as Type I aldolases and decarboxylases.53 The notion of unfavourable imine–
enamine equilibria may have played a role in this,151–153 although it was probably also due to 
the excitement generated by the advent of proline as an organocatalyst resulting in great 
emphasis being placed on cyclic secondary amines as organocatalysts. Even though the 
focus of this thesis is on secondary amine-catalysed reactions, it is still worth mentioning the 
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salient features of this class of organocatalysts since they often compensate for the 
weaknesses of aminocatalysts, especially with hindered or less reactive substrates. 
 
Chiral primary amine derivatives have recently been employed to activate challenging 
classes of unsaturated carbonyl compounds by overcoming the steric restrictions associated 
with the more congested secondary amine catalysis. For instance, the efficient activation of 
α-substituted α,β-unsaturated aldehydes by imidazolidinone catalysts or by prolinol catalysts 
is generally not possible because of steric constraints. The β-functionalisation of unsaturated 
ketones is also hampered by sluggish reaction rates when using secondary chiral amine 
catalysis, probably because of the generation of only small amounts of the catalytically 
active adducts. Primary amines can overcome these limitations. In particular, it was 
demonstrated that the salts of 9-amino-9-deoxyepiquinine (14) and 9-amino-9- 
deoxyepihydroquinine (15) from the Cinchona class (Figure 1.7) are effective catalysts for 
the activation of enones.154–158 By choosing the appropriate counteranions (such as from 
TFA), it was possible to tune the reactivity and the selectivity of the catalyst system, resulting 
in a highly enantioselective conjugate addition of a series of different nucleophiles (C, O and 
S nucleophiles).  
 
Figure 1.7: The primary amine catalysed β-functionalisation of unsaturated ketones. 
 
In addition to their generality as activators in iminium catalysis, primary amine catalysts have 
also been successfully employed for the asymmetric α-functionalisation of ketones via 
enamine intermediates.159–161  
 
Primary amine catalysis therefore allows for the expansion of the range of possible 
electrophiles or nucleophiles that can be stereoselectively introduced into carbonyls, and 
comes close to the excellent levels of efficiency already reached in the secondary amine 
catalysed functionalisation of aldehydes. However, α-functionalisation reactions of α-
substituted α,β-unsaturated carbonyl compounds still represent an important challenge. 
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1.2.3 ACDC 
In 2006, List and co-workers introduced a novel strategy for enantioselective synthesis 
coined asymmetric counterion-directed catalysis (ACDC).162,163 This approach exploits the 
fact that most chemical transformations proceed via charged intermediates or transition-
states. Thus chiral catalysts capable of forming ion pairs can induce high stereocontrol. The 
List research group applied this concept to iminium catalysis. Initially, the asymmetric 
transfer hydrogenation (by a Hantzch ester) of α,β-unsaturated aldehydes was studied, 162 in 
which it was found that a catalytic amount of the ammonium salt 16 with an axially chiral 
phosphoric acid, TRIP, could function as a highly enantioselective iminium catalyst in the 
conjugate reduction of enals (Figure 1.8). The ACDC approach was later extended to the 
asymmetric transfer hydrogenation of α,β-unsaturated ketones with a Hantzch ester, 
involving163 the salt derived from an L-Valine derivative 17 with TRIP, which resulted in an 
improved enantioselectivity. In this enone case, efficient activation relies on the ability of 
primary amines to form iminium ion intermediates from ketones, together with the benefits of 
asymmetric counteranion-directed catalysis.  
 
Figure 1.8: ACDC hydrogenation organocatalysts. TRIP = 3,3’-bis(2,4,6- 
triisopropylphenyl)1,1’-diylhydrogen phosphate. 
 
Zhou and List combined ACDC and Bronsted acid activation in a new triple organocascade 
sequence to give pharmaceutically relevant substituted cyclohexylamines.164 Starting from a 
2,6-diketone or derivative (see Scheme 1.44) and the Hantzsch ester, the combination of an 
achiral primary amine with a catalytic amount of TRIP promoted an aldolisation/dehydration 
reaction via enamine activation. This was followed by an asymmetric conjugate reduction 
proceeding through ACDC, and finally a Bronsted acid catalysed reductive amination to give 
the product. Noteworthy is the fact that both the amine and the phosphoric acid are essential 
for promoting the first two reaction steps. List has also applied ACDC principles to the 
asymmetric epoxidation of enals.165 
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Scheme 1.44: Triple organocascade to synthesise chiral cyclohexylamines. 
 
The power of ACDC was displayed when Lu et al. designed novel ion pair catalysts 
containing a chiral counter-anion for enamine catalysis for the first time. Such catalysts can 
be easily derived by mixing a cinchona alkaloid-derived primary amine catalyst with chiral 
camphorsulfonic acid (CSA), Scheme 1.45.166 These ion-pair catalysts were found to be very 
effective in promoting the direct amination reactions (to be discussed later in subsection 1.3) 
of branched aldehydes with a catalyst loading of as little as 0.5 mol% and forming products 
in up to 95% ee. A gram-scale asymmetric synthesis of biologically-active (R)-
methylphenylglycine was thereafter realised, displaying the great potential of chiral ion-pair 
catalysts for industrial applications.  
 
 
Scheme 1.45: Primary-amine-chiral-acid catalyst system for α-amination via ACDC. 
 
It is not clear why the potential role of the counterion in aminocatalysis was underrated for so 
long. Notably, it has also been demonstrated how the ACDC strategy can be applied not 
only to purely organic catalysts, but also to organometallic systems, thus providing new 
opportunities for asymmetric catalysis.167–169 This illustrates how organocatalysis is positively 
influencing other established synthetic areas. 
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1.3 The α-Amination Reaction 
The amino functionality is ubiquitous and an essential component of building blocks in 
organic synthesis. Since most nitrogen-containing natural products possess an aza-
stereogenic centre, it is vital to develop stereoselective transformations for their preparation 
in an enantioselective manner.170 Therefore, the organocatalysed asymmetric α-amination 
reaction will now be discussed with a particular focus on aminocatalysis. 
 
Since its simultaneous publication by List67 and Jørgensen in 2002,171 the proline-catalysed 
enantioselective α-amination reaction using an azodicarboxylate as the electrophile 
(aminating agent) has become a key methodology for the asymmetric α-heteroatom 
functionalisation of aldehydes.172–176 Importantly, their reactions furnish α-hydrazino 
aldehydes in good yield and high enantioselectivity (Scheme 1.46). Given the tendency of 
the α-aminated aldehyde products to slowly racemize, in situ reduction with NaBH4 is carried 
out leading to configurationally stable 2-hydrazino alcohols. The authors also showed how 
these α-hydrazino compounds can be transformed to useful optically pure compounds such 
as oxazolidinones. 
 
Scheme 1.46: List’s seminal proline-catalysed α-amination reaction.  
 
However, the rather poor solubility of proline in many solvents, which effectively reduces the 
turnover number, resulted in high catalyst loadings (up to 30 mol%).177 This emphasised the 
need for the development of novel organocatalysts with better solubility properties. Thus a 
wide range of secondary amine catalysts have been developed for this reaction. For 
example, Aldolfsson introduced a novel series of (S)-N-arenesulfonyl-2-
aminomethylpyrrolidines, Figure 1.9.177 These were synthesised from proline in a simple 
manner and his procedure allows for introduction of different aryl sulfonyl groups with 
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varying electronic and steric properties. Unfortunately, the enantioselectivities of these 
catalysts did not surpass those of proline. 
 
Figure 1.9: Adolfsson’s novel series of α-amination catalysts 
 
A year after the List and Jørgensen discoveries, Brase et al. showed that quaternary centres 
in chiral, non-racemic form could be accessed using this methodology. Thus α,α-
disubstituted α-amino aldehydes and oxazolidinones were synthesised (with 
enantioselectivities up to 86% ee) starting from racemic aldehydes, using L-proline or L-
azetidine carboxylic acid as catalysts. However, even though up to an 86% ee could be 
obtained, these reactions required a very high catalyst loading (50 mol%). Nevertheless, 
Brase applied his methodology towards an asymmetric synthesis of the bacterial peptide 
deformylase (PDF) inhibitor fumimycin using his methodology as a key step (Scheme 
1.47).178 Later, they developed the thermally accelerated organocatalytic α-amination of 
disubstituted aldehydes under microwave conditions. Compared to the results previously 
obtained at room temperature, both the yield and enantioselectivity could be significantly 
increased and reaction times were significantly reduced. Therefore, this improved protocol 
allowed the fast and efficient synthesis of α,α-disubstituted amino aldehydes, which provided 
the best results for the α-amination of disubstituted aldehydes.170,179  
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Scheme 1.47: α-Amination used towards the total synthesis of fumimycin. 
 
In the same year as the publication of the original aminocatalysed aldehyde α-amination 
reaction, Jørgensen accomplished the same success with ketones.66 This reaction is highly 
regioselective at the more substituted α-carbon atom. It was also found that increasing the 
length of the R’-substituent from methyl to ethyl and benzyl increased the enantioselectivity. 
However, cyclic ketones such as cyclohexanone and its derivatives generally gave poor 
results with proline as a catalyst. The α-amination of cyclohexanone with DEAD or dibenzyl 
azodicarboxylate (DBAD) using Greck’s L-azetidine-2-carboxylic acid as catalyst showed 
improved enantioselectivities of 88–90%.180 Similarly, Hayashi’s 4-silyloxyproline catalyst 18 
(Figure 1.10) proved to be quite a general catalyst for the α-amination of ketones. In addition 
to cyclohexanone derivatives, the catalyst was effective with acyclic ketones and α-branched 
aldehydes as substrates (64–73% yield, 78–96% ee).181 
 
 
Figure 1.10: Hayashi’s proline-based catalyst 18 for the α-amination of cyclic ketones. 
 
To aid catalyst solubility and make the reaction more environmentally favourable, Toma et 
al. probed the potential of ionic liquids as solvents.182 For instance, the α-amination of 
aldehydes (and to a lesser extent, ketones) by DEAD in [bmim]BF4 as an ionic liquid gave an 
ee of up to 94% with 4-hydroxyproline as the catalyst. In general the enantioselectivity was 
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comparable though often a bit lower than that achieved in traditional solvents. Similarly, Zhu 
et al. showed that the α-amination of aldehydes in ionic liquids and in the presence of 
imidazolium ion-tagged L-proline (19) gives excellent enantioselectivities (up to 98% ee) and 
high chemical yields (Scheme 1.48).183 Impressively, their catalyst/[bmim]BF4 system could 
be easily recycled, and retained similar reactivity as well as enantioselectivity after four 
recycles with the ionic solvent. Although showing promise, the success and generality of this 
procedure was hampered by reaction of the ionic liquid with the aminating agent. Later, 
North and co-workers showed that cyclic carbonates could be successfully used as an 
alternative green solvent, in which more favourable results were obtained with ketones, 
although not to the level of success obtained using the usual organic solvents.174  
 
 
Scheme 1.48: α-Amination in ionic liquids. 
 
The utility of the α-amination reaction is illustrated by its application to the synthesis of more 
complicated and useful chiral compounds and natural products. Barbas et al. developed the 
first catalytic asymmetric route to the total synthesis of BIRT-377 (a cell-adhesion inhibitor), 
Scheme 1.49, 184 in which a quaternary α-amino aldehyde was constructed from readily 
available precursors via organocatalysis. Proline gave disappointing results in terms of 
reaction times and enantioselectivity (44% ee), while the more reactive and soluble tetrazole 
catalyst 13 turned out to be a good choice for this enantioselective α-amination reaction, 
forming the desired optically active product in a 95% ee. This method allowed access to both 
enantiomers of BIRT-377. 
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Scheme 1.49: Application of the aminocatalysed α-amination to the total synthesis of BIRT-
377. 
 
AIDA and APICA (structures given in Scheme 1.51) are known antagonists of metabotropic 
glutamate receptors and G-protein-coupled receptors associated with various 
neurodegenerative diseases. Barbas found organocatalysis to be an effective strategy for 
the enantioselective preparation of (S)-AIDA and (S)-APICA in >99% ee, Scheme 1.50.185 
This is impressive since the amination substrate is essentially a branched aldehyde and 
enantioselectivities this high for this type of substrate hadn’t yet been obtained using proline 
(or any other secondary amine organocatalyst) in the absence of microwave irradiation, 
which had been the key to Barbas’ success with branched aldehydes. The synthetic route is 
general and should allow for the preparation of other analogues. Also, the organocatalytic 
route could be readily scaled up, and either (R)- or (S)-products could be obtained using (S)- 
or (R)-proline respectively. 
 
Scheme 1.50: The total synthesis of (S)-AIDA and (S)-APICA. DBAD = dibenzyl 
azodicarboxylate. 
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Takayama et al. reported the first total syntheses of two cernuine-type Lycopodium alkaloids, 
(-)-cernuine and (+)-cermizine D.186 One of the key steps involved organocatalytic α-
amination using Jørgensen’s prolinol catalyst 2 to afford an oxazolidinone following in situ 
cyclisation (Scheme 1.51).  
 
Scheme 1.51: The total synthesis of (-)-cernuine and (+)-cermizine D. 
 
Interestingly, Greck et al. developed a straightforward protocol for synthesising unnatural 
cyclic amino acids using proline in stereoselective formation of the C–N bond, Scheme 
1.52.187 It is noteworthy that (S)-proline was used to synthesise its own enantiomer. (R)-
Pipecolic acid and (R)-proline were obtained, in 50% yield and 94% ee from 6,6-
dimethoxyhexanal, and in 41% yield and 84% ee from 5,5-dimethoxypentanal respectively.  
 
 
Scheme 1.52: Synthesis of (R)-proline and (R)-pipecolic acid. 
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As far as tandem reactions are concerned, Sudalai developed a novel, one-pot procedure 
involving sequential α-amination / Horner−Wadsworth−Emmons(HWE) olefination of an 
aldehyde leading to the enantioselective synthesis of γ-amino-α,β-unsaturated esters in 
excellent yields and high enantioselectivities (Scheme 1.53).188 The resultant products were 
then transformed to 5-substituted 2-pyrrolidinone derivatives in good yields and great 
substrate generality.  
 
 
Scheme 1.53: The proline catalysed tandem α-amination/HWE olefination of aldehydes. 
 
Another expression of tandem reactions appeared in 2012 when Sudalai developed an 
organocatalytic α-amination/Corey-Chaykovsky sequence of aldehydes with 
dimethyloxosulfonium methylide, Scheme 1.54.189 The sequence ultimately afforded 4-
hydroxypyrazolidine derivatives in high yields with excellent enantio- and 
diastereoselectivities via a 5-endo-tet epoxide opening as the final step. 
 
 
Scheme 1.54: Proline-catalysed α-amination/Corey-Chaykovsky sequence 
 
Aminocatalysts, however, have limitations in reactions with ketones, branched aldehydes 
and β-ketoesters.175 To this end, Pihko et al.190 showed the importance of cinchonine and 
cinchonidine alkaloids in the α-amination of β-ketoesters and β-ketolactones. Later, 
Jørgensen et al.191 reported the first quinidine-derived catalyst allowing the amination of 
substituted α-cyanoacetates and β-dicarbonyl compounds, in very high enantioselectivity. It 
has also been shown192 that cinchona alkaloids derived from either quinine and quinidine 
provide easy access to the formation of an aza-quaternary centre by electrophilic amination 
of α-cyanoacetates. Terada rationally developed a family of axially chiral guanidine bases 
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that, through hydrogen bonding, facilitate the highly enantioselective α-amination of 
unsymmetrically substituted 1,3-dicarbonyl compounds with high optical purity (up to 97% 
ee).193 Chen et al. designed and synthesised a series of novel pyrrolidinyl camphor-based 
organocatalysts for asymmetric organocatalysis, Figure 1.11.194 These act as efficient 
bifunctional (both iminium and hydrogen bonding activation modes) organocatalysts in 
asymmetric synthesis as they allow for much lower catalyst loading, faster reaction times 
and excellent enantioselectivity (up to >99% ee). These catalysts could also be applied to 
branched aldehydes although ees dropped to a high of only 76%. Xu has also developed 
secondary amine–thiourea bifunctional catalysts for the α-amination of aldehydes to produce 
products in excellent yields (up to 99%) and enantioselectivities (up to 99% ee).195 
 
Figure 1.11: Chen’s range of bifunctional pyrrolidinylcamphor catalysts.  
 
Greck et al. used cinchona-derived primary amine catalysts for the amination of branched 
aldehydes with high levels of success (up to 99% ee).196 Wang et al. developed a simple, 
cheap and commercially available chiral primary amino acid, 3-(1-naphthyl) alanine 
hydrochloride. This primary amino acid is a highly efficient and enantioselective catalyst for 
the direct asymmetric α-amination of branched and hindered aldehydes (Scheme 1.55) in 
excellent yields (up to 99%) and enantioselectivities (up to 97% ee).197 Furthermore, Chen et 
al. found 9-amino-9-deoxyepicinchona alkaloids (primary amine catalysts) to be excellent 
enamine organocatalysts for the α-amination of aryl ketones.160 Their catalysts showed 
impressive scope and excellent enantioselectivities (88-99% ee). 
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Scheme 1.55: Primary amino acid catalysed α–amination for aza-quaternary centres. 
 
Finally, in 2015 Arvidsson et al. reported the α-amination (as well as α-hydroxylation, α- 
sulfenylation and α-selenylation) of a carbapenem core (Scheme 1.56). This reaction is a 
rare example of an aminocatalyst effectively aminating a hindered carbonyl in high 
stereoselectivity under mild conditions, with a catalyst loading of only 10 mol% (as opposed 
to the high loadings usually required).198 
  
 
Scheme 1.56: The α-amination of carbapenem. 
 
Mechanistic Considerations 
The generally accepted catalytic cycle of the secondary-amine-catalysed α-amination 
reaction is shown below (Scheme 1.57), courtesy of List.67 
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Scheme 1.57: The catalytic cycle for the α-amination reaction.  
 
When Jørgensen applied his diarylprolinol catalysts to the α-amination reaction, he was able 
to mirror proline’s success in terms of yield and enantioselectivity (90 to 97% ee). However, 
despite the same absolute configuration of Jørgensen’s catalysts as that of proline (S), the 
reactions produced the same products as enantiomers. The researchers reasoned that 
these differences could be explained by two different transition-state models, Scheme 1.58. 
Proline is suggested as operating through the dual activation of both the aldehyde (by 
forming a more nucleophilic enamine) and the electrophile (by hydrogen bonding).199 On the 
other hand, Jørgensen’s diarylprolinol catalysts resulted in high enantioselectivities despite 
the absence of functional groups that could participate in hydrogen bonding with the 
aminating agent. It was therefore reasoned that the enantioselectivities observed with these 
catalysts originated from controlling the geometry of the enamine in the same way as with 
proline but now with introduction of steric bias of the two enamine faces by the large 
substituent on the pyrrolidine ring of the catalyst. 40,172,200 However, Seebach, Eschenmoser 
and Blackmond have revealed alternative and more complex mechanistic explanations. 
Chapter 3 will elaborate on all these proposals and how they were applied to the acetal case 
in this thesis.  
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Scheme 1.58: The two catalyst-dependent transition-state models for the aminocatalysed α-
amination reaction.172 
In spite of all these advances, one aspect of enamine organocatalysis that currently requires 
developing is that of finding more chemotypes as starting materials. Following the waning of 
the organocatalysis “Gold Rush” (with all the aminocatalysis activation pathways therein 
discovered) many leaders in the field, particularly Jørgensen, are now focusing on using 
organocatalysis in target-oriented synthesis of biologically relevant compounds (especially 
heterocycles).124 We therefore believe that the expansion of aminocatalysis chemotypes will 
be a useful complement to this trend, thus cementing the future of organocatalysis. The work 
presented in this thesis speaks to this very issue by reporting the first usage of acetals as 
masked carbonyl equivalents in the aminocatalysed enantioselective α-amination reaction. 
This methodology is then applied to a model asymmetric desymmetrisation of prochiral 
substrates. The following Chapters thus discuss these contributions to asymmetric 
organocatalysis.  
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Chapter 2: Asymmetric Desymmetrisation Hypothesis and 
Substrate Synthesis 
 
2.1 Catalytic Asymmetric Desymmetrisation 
Catalytic desymmetrisation of a prochiral substrate via selective chemical modification so as 
to remove the symmetry element has emerged1 as a powerful, efficient and economical 
procedure to create chirality in the substrate in a single step.201,202 A selective modification of 
one of the enantiotopic groups at a prochiral centre results in enantiomers, the efficiency of 
which determines the degree of enantioenrichment in the product. Biocatalysts,203 metal-
based catalysts204,205 and organocatalysts can all be used as the catalytic agent, but In view 
of the topic of this thesis only examples of organocatalysts will be reviewed in the following 
section. 
 
2.1.1 Organocatalysed Asymmetric Desymmetrisation 
At the heart of the organocatalysed desymmetrisation reaction of a prochiral motif is the idea 
that a catalysed reaction takes place faster at one of the enantiotopic groups (or faces) of 
the prochiral substrate thus affording the two enantiomers of the product in unequal 
amounts.203 In other words, as shown in Scheme 2.1, when a chiral organocatalyst 
associates (covalently or otherwise) with a prochiral symmetric substrate, the catalyst-
substrate species formed distinguishes between the two enantiotopic groups because of the 
asymmetric environment provided by the catalyst which dictates the sense of stereoinduction 
of the now diastereotopic catalyst-substrate species (Scheme 2.1). This results in transition-
states in the asymmetric induction step of unequal energy. Detachment of the catalyst thus 
gives the reaction product as two enantiomers, formed at different reaction rates.206 
Furthermore, if the catalytic reaction results in the creation of another stereogenic centre, 
desymmetrised products can be synthesised in a diastereoselective manner. 
 
 
Scheme 2.1: An illustration of the process of asymmetric organocatalysed 
desymmetrisation. 
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The desymmetrisation of meso-diols is probably the most common theme in 
organocatalysed asymmetric desymmetrisations. The very first desymmetrisation reported of 
a meso-diol mediated by a chiral organic compound using Lewis base catalysis was 
described in 1985 by Duhamel et al.207 In his reaction cis-2-cyclopent-en-1,4-diol was 
enantioselectively benzoylated in the presence of different chiral tertiary amines giving a 
maximum ee of 47% when 200 mol% of O-phenylquinidine was used. Here, acyl transfer 
from the quinoline nitrogen takes place. 
 
OHHO (200 mol%)
BzCl / Et3N
N
O
N
OCOPhHO
47% ee
 
Scheme 2.2: Duhamel’s Lewis-base-promoted desymmetrisation of a meso-1,4-diol. 
 
Eleven years later Vedejs et al. reported the use of chiral phosphines in catalytic amounts for 
the monoacylation of meso-1,2-diols.208 However, their results were also disappointing, 
owing to low conversion, diacylation and racemization under the reaction conditions. Since 
then and with the simultaneous organocatalysis “gold rush”,33 increasing research has being 
devoted to the development of efficient organocatalytic methods to perform this 
transformation as a powerful methodology for the preparation of chiral building blocks.209 An 
example of this reaction class is shown in Scheme 2.3 where asymmetric desymmetrisation 
of meso-1,n-diols (n = 2–6) is achieved by acylation in the presence of 5 mol% of a chiral 
DMAP-derived catalyst.210 The DMAP derivative functions as an acyl-transfer catalyst, and 
π-π-interactions between the catalyst pyridinium ring and the thiocarbonyl results in a chiral 
environment in the acyl transfer step, allowing it to distinguish between the two enantiotopic 
alcohol groups. This gave a range of ees (59–97%) depending on the distance and spatial 
disposition of the hydroxyl groups, with the phenyl-1,4-diol below giving the best result. The 
good result obtained with this and other phenyl-containing diols suggests that the phenyl 
moiety offers additional stabilising π-interactions with the catalyst, resulting in a more 
efficient chiral environment for the enantiogroup differentiation step with a lower energy 
transition-state. Other chiral DMAP derivatives that desymmetrise via chiral Lewis base 
catalysis involving other stereogenic types, such as planar chirality in the catalyst, have also 
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been developed with great success wherein Fu’s catalysts lead the pack (Scheme 2.3 shows 
examples).211,212 
 
 
Scheme 2.3: The enantioselective desymmetrisation of a 1,n-diols. 
 
Another important class of organocatalytic desymmetrisation substrates is a prochiral 
dienone. These contain unsaturated functional groups that may be directly transformed into 
more complex structures.213 In 2013, Johnson and Corbett reported a tandem oxa-Michael / 
Michael desymmetrisation of a dienone with Jørgensen’s catalyst 2 to make tetrahydrofuran 
derivatives enantioselectively (Scheme 2.4).214 The mechanism involves the hydroxyl group 
of the dienone nucleophilically adding to the iminium ion formed between 2 and the Michael 
acceptor. The resulting enamine then undergoes Michael addition cyclisation on one side of 
the dienone, also activated as a chiral iminium ion, in a stereocontrolled manner due to the 
steric bulk and facial discrimination afforded by the chiral catalyst. Up to a 99.5% ee and 
20:1 dr was obtained depending on the nature of the R-group, thus displaying how 
aminocatalysis can effectively be applied to desymmetrisations.  
 
 
 
Scheme 2.4: The aminocatalysed desymmetrisation of a dienone. 
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In the same year Wang et al. reported the first catalytic asymmetric synthesis of spirocyclic 
oxindoles via organocatalysed desymmetrisation (Scheme 2.5).201 The resulting products 
contain an all-carbon quaternary centre with an adjacent tertiary stereogenic centre. For this 
Michael addition stereoinduction occurred due to the chiral environment created by the 
bifunctional tertiary amine / thiourea catalytic system which exhibited high reactivity, 
excellent diastereoselectivity (dr > 20:1) and enantioselectivity (up to 95% ee), and broad 
substrate scope.  
 
Scheme 2.5: The asymmetric desymmetrisation of spirocyclic oxindoles. 
 
Meso-anhydrides represent another useful organocatalysed desymmetrisation substrate. 
Roy et al. have recently (2014) achieved the organocatalytic kinetic resolution of racemic 
secondary nitroallylic alcohols with simultaneous desymmetrisation of a prochiral cyclic 
anhydride (Scheme 2.6).215 The enantioselective alcoholysis by one of the enantiomers of 
the racemic allylic alcohol of 3-substituted glutaric anhydrides afforded hemiesters with high 
enantioselectivities (up to 99% ee) in the presence of a cinchonidine-derived thiourea 
catalyst. The high optical enrichment (up to 95% ee) of (S)-nitroallylic alcohols was also 
achieved. They propose that the bifunctional organocatalyst simultaneously activates the 
nucleophile (hydroxyl group) and electrophile (symmetrical anhydride). The tertiary amine of 
the organocatalyst activates the hydroxyl, whilst the appropriately positioned thiourea group 
activates the cyclic anhydride through hydrogen bonding. This results in concomitant kinetic 
resolution of the nucleophile and desymmetrisation of the electrophilic component in a 
stereocontrolled manner. 
 
Scheme 2.6: The organocatalytic kinetic resolution of racemic secondary nitroallylic alcohols 
and simultaneous desymmetrisation of prochiral cyclic anhydrides 
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Besides the popular diols, dienones and meso-anhydrides, a variety of other prochiral 
substrates have been reported to undergo organocatalytic asymmetric desymmetrisations. A 
few interesting examples will now be discussed. One of the earliest examples of 
organocatalysed desymmetrisation was published in 1984 when Agami et al presented the 
proline-catalysed enantioselective desymmetrisation of a prochiral 1,5-diketone in their 
application of the classic Hajos-Parrish reaction (Scheme 2.7).216 ThisHowever, since then 
aminocatalysis has been superseded by the use of tertiary amine catalysts (e.g. cinchona 
alkaloids and DMAP) and chiral phosphines in desymmetrisation reactions. This is primarily 
due to the more efficient asymmetric induction offered by these systems. Nevertheless, the 
mechanism of Agami’s cyclodehydration deserves mentioning since it involves selective 
reaction of one of the enamines formed between proline and an enantiotopic ketone 
carbonyl group. The enamine nucleophilically adds to the carbonyl of the second ketone in 
an aldol fashion followed by dehydration and iminium ion hydrolysis, thus releasing the 
proline catalyst to give the enantioenriched reaction product in 75% yield. Stereocontrol 
occurs through enamine attack on the si-face of the pro-S ketone arm due to hydrogen 
bonding interactions, giving a 43% ee. 
 
 
Scheme 2.7: The desymmetrisation of a 1,5-diketone by the Hajos-Parrish reaction 
 
Agami’s desymmetrisation didn’t receive much attention until 15 years later in 1999 when 
Barbas and List catalysed the same reaction with antibodies instead of proline (Scheme 
2.8).217 In fact, List (a key figure in the development of organocatalysis) states that their 
study of Agami’s reaction introduced him to proline catalysis.39 The prochiral 1,5-diketone 
substrates were synthesised following a route developed by Sakurai et al.218 involving a 
Lewis acid-mediated conjugate addition of allyltrimethylsilane to an α,β-unsaturated ketone. 
The resultant olefin underwent Wacker oxidation to give the desired substrate in modest to 
good overall yields. The biocatalyst gave up to 62% ee, which was an improvement on the 
original Agami result. 
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Scheme 2.8: Barbas’ synthesis of prochiral 1,5-diketones and antibody-catalysed 
desymmetrisation. 
 
In 2008 Ding and co-workers demonstrated the use of a chiral phosphoric acid 20 (a strong 
chiral Brønsted acid catalyst) in the asymmetric Baeyer-Villiger oxidation of 3-substituted 
cyclobutanones with aqueous H2O2.219 This oxidation reaction resulted in the asymmetric 
desymmetrisation of the cyclobutanone to the corresponding γ-lactone in excellent yields 
and up to 93% ee (Scheme 2.9). It is proposed that the asymmetric induction is provided by 
the chiral environment in the Criegee intermediate due to the catalyst bound to the substrate 
covalently and through hydrogen bonding. 
 
 
Scheme 2.9: The asymmetric desymmetrisation of cyclobutanone 
 
Prior to Jørgensen and co-worker’s report in 2012 on the topic, the successful [4+2] 
cycloaddtion involving anthracenes as the 4π-component by direct HOMO-activation of the 
anthracene π-system using an organocatalyst had not yet been achieved. In order to 
overcome the dearomatisation energy barrier, available catalytic methods focused on 
achieving activation of the dienophile (LUMO-lowering).220 However, using a unique 
bifunctional aminocatalyst, 21, the Jørgensen group achieved an aromaticity-breaking 
desymmetrisation of anthracenes in a thermal Diels-Alder reaction (Scheme 2.10) to secure 
products in high yield and excellent enantioselectivity, and at very low catalyst loadings (2 
mol%). Using his original prolinol catalyst 2 gave lower ees, up to 62%. High 
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enantiodiscrimination with 21 was achieved via shielding of one of the anthracene faces by 
the catalyst-substrate complex, leaving the other face unshielded for the approach of the 
dienophile. Mechanistically, the bifunctional catalyst works in the following manner: the 
secondary amine promotes HOMO-raising activation of the anthracene moiety by the 
formation of an enamine involving the aldehyde of the side chain; simultaneously, the 
squaramide directs the attack of the dienophile through hydrogen bonding between the 
enamine and the nitro group of the dienophile, thereby ensuring up to a 98% ee.  
 
 
Scheme 2.10: The desymmetrisation of anthracenes. 
 
As a final example, Mukherjee et al. have developed a catalytic enantioselective 
desymmetrisation of prochiral 1,3-dinitropropanes via an allylic alkylation reaction (Scheme 
2.11).221 Functionalised allylic carbonates were used as the allyl source, and the highly 
functionalised products consisting of two vicinal stereocentres were obtained in up to 20:1 dr 
and up to 99:1 er. The catalyst system used was a bifunctional tertiary amine / thiourea 
cinchona-based catalyst 22. The reaction mechanism is shown below in Scheme 2.10. 
Enantiotopic group differentiation during the nucleophilic attack by the deprotonated 1,3-
dinitropropane is the origin of the stereoinduction, which is as a result of non-bonded 
interactions between the 1,3-dinitropropane and the chiral catalyst. 
 61 
 
N
N
S N
HN
H
CF3
NR3
NR3
CO2Et
OBoc
R'
- CO2
t-BuO
NO2
R
NO2
- t-BuOH
CO2Et
R'
NO2
R
N
R3N
OO
- NR3
R
R'
CO2EtNO2
NO2
22
Organocatalyst
Symmetrical
Substrate
NO2
R
NO2 CO2Et
OBoc
R'
+ R
R'
CO2EtNO2
NO2
Up to 99:1 er
Up to 20:1 dr
22
10 mol%
DCM
  
Scheme 2.11: The enantioselective desymmetrisation of 1,3-dinitropropanes. 
 
As previously mentioned, aminocatalysis only features sporadically in the field of 
organocatalysed asymmetric desymmetrisations. Furthermore, to the best of our knowledge, 
the aminocatalysed α-amination and β-aza-Michael reactions have never been used in 
desymmetrisation reactions. Therefore the aim of this project was to develop conditions for 
such transformations as a novel contribution to this exciting field of research. 
 
2.2 The Asymmetric Desymmetrisation Strategy of this Project 
The desymmetrisation strategy concerned desymmetrising a symmetrical bis-enone A or 
bis-aldehyde B, each bearing a prochiral centre with two enantiotopic “arms” (Scheme 2.12). 
The reactions intended to achieve this were an organocatalysed enantioselective aza-
Michael addition for A and an enantioselective α-amination substitution for B. The β-
functionalisation option will be discussed first. 
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Scheme 2.12: The envisioned desymmetrisation of symmetrical substrates A and B. 
 
2.2.1 β-Functionalisation Strategy 
The first strategy considered was an organocatalysed aza-Michael addition as an example of 
a β-functionalisation reaction. As discussed in Chapter 1, this reaction involves 
stereoselective 1,4-addition of a nitrogen nucleophile to a chiral iminium ion generated from 
an α,β-unsaturated carbonyl compound. The reaction is useful because of the importance of 
the chiral aminated products it generates (such as β-amino acids and β-lactams).107 
Therefore, our hypothesis was to synthesise a symmetrical prochiral substrate A (most likely 
a bis-enone) that could be successfully desymmetrised via this reaction in an enantio- and 
diastereoselective manner. The following design aspects were considered as key: 
 
• The reaction involves three components as: 1) A symmetrical bis-enone (shown in 
Scheme 2.13) assumed to have a zig-zag conformation as its lowest energy form; 2) 
Jørgensen’s prolinol catalyst 2 which had shown excellent enantioselectivities in aza-
Michael additions as mentioned in the review, Chapter 1; 3) a hydroxylamine-based 
nucleophile based on the principle, as applied in the literature,102,222 of raising the 
nucleophilicity of the nitrogen via a HOMO-raising α-effect from the hydroxylamine 
oxygen to increase nitrogen softness in conjunction with the LUMO-lowering formation of 
the electrophilic iminium ion from the substrate and organocatalyst.40 
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Scheme 2.13: The components of the envisioned aza-Michael desymmetrisation. 
 
• In the iminium-ion activation step, since the catalyst is present in catalytic amounts with 
an excess of symmetrical A with respect to the nucleophile, it was reasonable to expect 
that formation of a mono- rather than a bis-iminium ion would dominate. For simplicity’s 
sake in order to reveal enantio-discrimination, we will only consider one of the substrate 
forms (with the R1-group at the prochiral centre wedged) and illustrate the generation of 
two mono-iminium ions formed on the left or the right enantiotopic arms of the 
symmetrical substrate (as shown in Scheme 2.14). From the outset the conformational 
preferences of the vinyl-iminium ion portion of the electrophilic intermediate were 
appreciated as being paramount for success in view of facial selectivity in the addition 
step. According to the literature,40 the dominant species when R = H (aldehyde) as 
shown in Scheme 2.14 would be the mono-iminium ion with an E-geometry and the 
adjacent C-C single bond in an s-trans conformation due to fewer steric repulsions with 
the substrate chain.223 However, if R is an alkyl group (which would be synthetically 
easier to access, as will be shown later), the mono-iminium according to literature is 
predicted to be an E:Z mixture. However, as Seebach has shown, this is dependent on 
the substrate as well as the iminium counterion, reaction solvent and temperature, so it 
was hoped that reaction conditions could be established for achieving a dominant 
conformer leading to high stereoselectivity.95,96 Alternatively, a less hindered primary 
amine catalyst might be more effective in controlling the iminium geometry224 although 
the tetrazole proline analogue 13 has also been shown by Ley and co-workers225–227 to 
catalyse the enone aza-Michael reaction in high enantioselectivity. Thus, in view of 
literature precedent it was thought that generation of a dominant iminium-ion geometry 
would be realised for the bis-enal and likely to be realised in the bis-enone case as well. 
Scheme 2.14 below summarises these ideas. 
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Scheme 2.14: The iminium ions formed from A. 
 
• The next part concerning the stereoselectivity of addition is shown in Scheme 2.15. The 
two mono-iminium ions generated are not equivalent in energy but they are close and 
thus would both be present in approximately equal amounts. Then comes the addition. 
According to the literature, when using Jørgensen’s catalyst, the approach of the 
nucleophile, in this case as a substituted hydroxylamine, would be anti to the face 
bearing the large diphenylsilyloxymethyl substituent. Applying this steric principle to the 
two additions as shown in Scheme 2.15 below leads to the conclusion that addition to 
the right-hand enantiotopic arm to give Y with anti-relative stereochemistry would be 
kinetically favoured over that involving the left to give X with syn relative 
stereochemistry. This conclusion is based on the anticipated lower non-bonded 
interactions between the incoming nucleophile and the R-group at the prochiral centre 
for the right-hand arm, again based on an anti-steric principle operating during the 
addition. Scheme 2.15 depicts these ideas: 
 
 
Scheme 2.15: Kinetic evaluation of the enantioselectivity in the aza-Michael addition. 
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Thus, the upshot would be to desymmetrise in an enantioselective fashion regarding the 
discrimination of the enantiotopic arms, as well as to control the diastereoselectivity to be 
anti in the customary zig-zag conformation. 
 
With the desymmetrisation hypothesis established, a model study was carried out on the 
organocatalysed aza-Michael reaction to crotonaldehyde, using Jørgensen’s catalyst 2. The 
purpose of this study was to test out the literature conditions and to determine the best 
nucleophile in terms of yield and enantioselectivity.  
 
Scheme 2.16 shows how the aza-Michael reaction was conducted using hydroxylamine-
based nucleophile 23, based on Cordova’s work.102,222 The resulting β-aminated aldehyde 
was reduced in situ by NaBH4 (to simplify chromotagraphic separation) to give aminoalcohol 
24. As shown in Scheme 2.16, the nucleophile was the limiting reagent against 3 equivalents 
of crotonaldehyde and the reaction gave a moderate 56% yield. This was lower than the 
yield by Cordova et al. for the same reaction (86%), although our moderate yield agreed with 
yields for other aldehyde substrates in their study.222 A possible reason for the moderate 
yield was thought to be a lack of nucleophilicity in the catalyst (which is solvent dependent, 
as suggested in the literature)228 as well as difficulties encountered in following the 
hydroxylamine nucleophile as the limiting reagent on TLC as a result of the crotonaldehyde-
associated by-products.  
 
 
Scheme 2.16: Our model asymmetric aza-Michael reaction. Reagents and conditions: (i) 
Nucleophile 23 (1 eq), aldehyde (3 eq), 2 (20 mol%), CHCl3, 24 hrs, -22 °C; (ii) NaBH4 (1 eq), 
EtOH, 0 °C to RT 
 
Figure 2.1 shows the 1H NMR spectrum of aminoalcohol 24. All the expected resonances 
were observed including the aromatic and benzyl Cbz resonances, the relatively downfield 
H-2 and H-4 (diastereotopic) resonances (due to deshielding by the adjacent heteroatoms), 
the methoxy singlet and the broad hydroxyl singlet.  
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Figure 2.1: The 1H NMR spectrum (CDCl3, 300 MHz) of 24. 
 
Table 2.1 shows the results obtained from the model study when the R-groups of the 
nucleophile were varied. The Cbz-based nucleophiles (23 and 25) are popular in the 
literature, while the tosyl-protected nucleophile 26 is a novel addition synthesised for this 
project. Moderate yields were obtained (34 – 56%), with 26 giving the lowest yield. Ees were 
determined via HPLC analysis of the aminoalcohols using a Chiralpak AD column. The Cbz-
based nucleophiles promoted an excellent enantioselectivity (94% ee), while the 
sulfonamide nucleophile 26 gave a much lower enantioselectivity of 44% ee. Thus this aza-
Michael model study was successful in demonstrating that nucleophiles 23 and 25 would be 
the best candidates for the desymmetrisation of substrate A, although yield optimisation 
studies would need to be conducted.  
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R-Groups 
Nucleophile 
 
Yield (%) ee (%) 
R = Cbz, R’ = OMe 
 
57 94 
R = Cbz, R’ = OTBS 
 
56 94 
R = Ts, R’ = OTBS 
 
34 44 
 
Table 2.1: Aza-Michael results for different hydroxylamine nucleophiles. 
 
Attention was then turned to the synthesis of symmetrical substrate A, which was conceived 
to be accessible via the retrosynthetic analysis shown in Scheme 2.17. Even though a bis-
enal was a better candidate for the aza-Michael reaction, its bis-enone analogue (with R = 
Me) was considered to be easier to synthesise. Thus in the forward direction the synthesis 
strategy planned on starting with a substituted malonate which, following reduction to the 
diol, could in principle be oxidised and extended iteratively using Wittig methodology. 
 
 
Scheme 2.17: Retrosynthetic analysis of substrate A. 
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In the event (Scheme 2.18), using diethyl phenylmalonate as the starting material (R = Ph), 
double reduction with LiAlH4 afforded the 1,3-diol 27 in a low yield of 24%, believed to be 
due to difficulties encountered during the reaction work-up and product isolation step, since 
the diol was difficult to separate from the lithium by-product salts (despite several work-up 
procedures attempted). The resulting diol was mono-protected with TBDPSCl using 1.1 eq of 
NaH to yield alcohol 28 in an excellent 92% yield following column chromatography. 
Regioselectivity is secured because of the large difference in nucleophilicity between the 
alkoxide ion (mono-deprotonation due to low base equivalents) and the other neutral 
hydroxyl group.  
 
 
Scheme 2.18: Reagents and Conditions: (i) LiAlH4 (2.5 eq), THF, 18 hrs, 0 °C to reflux; (ii) 
a) NaH (1.1 eq), THF, 1 hr, 0 °C to RT, b) TBDPSCl (1.2 eq), 5 hrs, 0 °C to RT. 
 
Figure 2.2 shows the 1H NMR spectrum of 28, which displayed all the expected resonances, 
including the 10 aromatic protons, the downfield H-1 and H-3 resonances (deshielded by the 
adjacent oxygens) and the upfield t-Bu singlet.  
 
 69 
 
 
Figure 2.2: The 1H NMR spectrum (CDCl3, 300 MHz) of 28. 
 
The Swern oxidation to alcohol 28 proved unsuccessful owing to elimination of the OTBDPS 
group during column chromatography purification, although the reaction TLC showed 
promising results. This was attributed to the natural tendency for the β-silyloxyaldehyde to β-
eliminate enhanced by the stabilising nature of the phenyl substituent, helping to increase 
the acidity of the attached benzylic hydrogen (see the mechanism in Scheme 2.19). 
However, even though another purification method could have been attempted, this result 
led to questions about the stability of products further down in the synthetic sequence with a 
phenyl central substituent. It was thus decided that the central substituent should not be an 
electron-withdrawing functional group. 
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Scheme 2.19: β--Elimination of the β-silyloxyaldehyde. 
 
Therefore the starting material was changed to diethyl α-methyl malonate (as shown in 
Scheme 2.20) believing that elimination would be less likely with the methyl group at the 
prochiral position. The resulting 2-methyl-1,3-diol underwent reduction and TBDPS mono-
protection with similar results to its phenyl counterpart as shown in Scheme 2.16. Once 
again, the yield of the 1,3-diol was low.  
 
Scheme 2.20: Reagents and Conditions: (i) LiAlH4 (1.5 eq), THF, 4 d, 0 °C to reflux; (ii) a) 
NaH (1.1 eq), THF, 1 hr, 0 °C to RT, b) TBDPSCl (1 eq), 24 hrs, RT; (iii) a) DMSO (3 eq), 
oxalyl chloride (2 eq), TEA (8 eq), DCM, 2 hrs, -78 °C to RT, b) phosphonate 29 (1.3 eq), 
NaH (1.2), THF, 0 °C; iv) a) NaH (1.2 eq), 29 (1.3 eq), THF, 30 min, 0 °C, b) aldehyde (1eq), 
3 hrs, 0 °C to RT; v) TBAF (2 eq), AcOH (2eq), THF, 18 hrs, 0 °C to RT. 
 
This time, a tandem Swern oxidation/Wittig-Horner (Horner-Wadsworth-Emmons) olefination 
strategy was chosen for accessing the enone. Inspiration for this came from work by Taylor 
and co-workers in their review on tandem oxidation / olefination strategies.229 The Swern 
oxidation was performed as in the previous attempt (Scheme 2.12) but immediately after the 
reaction work-up, a Horner-Wittig-Wadsworth-Emmons olefination was performed with the 
ketone-based phosphonate 29 to give enone 30 in an excellent overall yield (76% over two 
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steps) following column chromatography. The known Swern and Wittig-Horner mechanisms 
are thought to apply here. Happily, the stabilised ylide was not affected by residues from the 
Swern oxidation still present after the work-up. The geometric isomers of 30 were separable 
by column chromatography so the E:Z ratio was determined by product weights, which gave 
an excellent 19:1 E/Z-ratio (as expected from this type of olefination in which the E-isomer is 
dominant). Assignment of the isomers was given by 1H NMR spectral analysis (Figure 2.3), 
which displayed the predicted differences in the vinyl proton resonances.  
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Figure 2.3: The 1H NMR (CDCl3, 300 MHz) spectra of both E- and Z-isomers of 30. 
 
Enone 30 was then deprotected with TBAF. This gave the deprotected hydroxyenone 31 in a 
modest 29% yield following column chromatography due to by-products formed under the 
acidic literature conditions.230 Figure 2.3 depicts the 1H NMR spectrum for 31, which 
displayed the expected absence of TBDPS-related resonances, and the presence of the 
hydroxyl broad singlet and downfield vinyl resonances.  
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Figure 2.4: The 1H NMR spectrum (CDCl3, 300 MHz) of 31. 
 
Thereafter, the tandem oxidation/olefination strategy was attempted again but this time was 
unsuccessful. 1H NMR evidence of elimination to a 3,5-dienone (ie, extra vinyl resonances 
due to a diene in the downfield aliphatic region) during the oxidation step was observed. 
Once again, elimination was likely driven by the high conjugation of the elimination product. 
A similar elimination problem was observed by Barrett et al. in their attempted dioxidation/di-
Wittig strategy using Dess-Martin periodinane (DMP) starting with 1,3-dipropandiol (Scheme 
2.21).231 
 
Scheme 2.21: Barrett’s failed diolefination strategy. 
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In order to avoid the problematic oxidation step, a new strategy was formulated that would 
reverse the sense of the Wittig-Horner disconnection by converting the 1,3-diol into a bis-
iodophosphonium salt (Scheme 2.22). In this case the 1,3-diol was converted to a 1,3-diiodo 
32 in 74% yield using iodine and PPh3 in the presence of imidazole. Thereafter, 32 was 
successfully transformed into Wittig bis-phosphonium salt 33 in a respectable yield of 63% 
using a 2.4 equivalent excess of PPh3 under reflux for four days, and aided by tricky TLC 
monitoring in a DCM / methanol / acetic acid solvent system. The product was purified by 
recrystallisation from a methanol / DCM mixture. Aldehyde 34 (which is commercially 
available) was chosen as the reagent for the double Wittig reaction. This is because the 
dialdehyde and mixed aldehyde-ketone analogues were either difficult to synthesise, or their 
commercially sourced forms were stored in incompatible protic solvents. Thus this strategy 
would allow access to the coveted, more reactive bis-enal. Unfortunately, when the Wittig 
reaction was attempted using 33 with n-BuLi and the ethyl acetal of 34, it proved 
unsuccessful in which solubility issues with the salt were believed to be the cause of the 
failure. 
 
Scheme 2.22: Reagents and Conditions: (i) a) PPh3 (2.2 eq), I2 (2.2 eq), imidazole (2.3 eq), 
CH3CN/Et2O (1/3), 3hrs, 0 °C to RT, b) 1,3-diol (1 eq), 40 min, 0 °C to RT; (ii) PPh3 (2.4 eq), 
CH3CN, 4 days, 85 °C. 
 
As a final attempt at the synthesis of A, a new synthetic strategy was devised (Scheme 
2.23), with the hope that all issues encountered in previous attempts would be avoided. 
Based on the known reaction that reduction of a substituted alkynol with LiAlH4 gives 
exclusively an E-allylic alcohol, a strategy was devised to gain rapid access to the bis-allylic 
alcohol 35, since allylic alcohols are known to be good precursors for MnO2 oxidation.229,232 
Except for the first step, this strategy also relies on simple, established organic reactions. 
The first step involves benzylation of the anion of diiodomethane formed using LiHMDS 
using Charette’s procedure for synthesising gem-diiodoalkanes.233 Thereafter, the iodide is 
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used in a di-alkylation with an acetylide anion to give a di-yne (shown in the Scheme), which, 
following silyl group deprotection, stereoselective reduction with LiAlH4 and finally double 
oxidation with MnO2, on paper at least, should furnish the desired bis-enal. However, a 
change in the focus of this project to the synthesis of B (and the resulting new 
methodologies this led to) unfortunately prevented the testing of this strategy. 
 
 
Scheme 2.23: Final envisioned route to A to be pursued in the future. 
 
2.2.2 α-Functionalisation Strategy 
The desymmetrisation of B was envisioned to take place using an organocatalysed α-
amination reaction. This reaction was chosen as it is a reliable method for introducing both 
nitrogen and chirality into to carbonyl compounds in high yield and enantioselectivity, as 
discussed in Chapter 1.73 To this end, as with the aza-Michael strategy, the objective 
involved synthesising a symmetrical prochiral substrate B (a bis-aldehyde) that could be 
successfully desymmetrised via α-amination in an enantio- and diastereoselective manner. 
Also, as in the β-functionalisation case, the key design aspects were: 
 
• The reaction would involve three components as (shown in Scheme 2.24): 1) A 
symmetrical bis-aldehyde substrate represented in its zig-zag conformation; 2) L-proline 
as the organocatalyst which had shown excellent enantioselectivities in List’s work;67 3) 
an azodicarboxylate Mitsunobu electrophile.  
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Scheme 2.24: The components of the envisioned α-amination desymmetrisation. 
 
• An excess of bis-aldehyde and the addition of a catalytic amount of proline would ensure 
dominance of a mono-enamine in the enamine activation step. As before, for simplicity’s 
sake in order to reveal enantio-discrimination, we will only consider one of the substrate 
forms (with the R1-group at the prochiral centre wedged) and illustrate the generation of 
two enamines formed on the left or the right enantiotopic arms of the symmetrical 
substrate (as shown in Scheme 2.25). According to the literature,40 the dominant species 
would be the mono-enamine with an (E-s-trans)-geometry due to fewer steric repulsions 
with the substrate chain, Scheme 2.25.  
 
 
Scheme 2.25: The enamines formed from B. 
 
• With regards to the stereoselectivity, the two enamines generated are not exactly 
equivalent in energy but were considered close enough so they would both be present in 
approximately equal amounts. According to the literature when using proline as the 
catalyst,40 the amination process involves a syn-addition of the electrophile with respect 
to the proline carboxylate, due to hydrogen bonding between the proline carboxylate and 
one of the azo nitrogens. Implementing this to each iminium ion leads to the conclusion 
that addition to the right-hand enantiotopic arm to give Y with anti-relative 
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stereochemistry would be kinetically favoured over that involving the left to give X with 
syn-relative stereochemistry. As with the bis-enone case (Scheme 2.15), this is based on 
the anticipated lower non-bonded interactions between the approaching hydrogen-
bonded electrophile and the R1 group at the prochiral centre, based on the anti-steric 
principle. Scheme 2.26 depicts these ideas: 
 
 
Scheme 2.26: Kinetic evaluation of the stereoselectivity in the α-amination. 
 
Thus, desymmetrisation would be achieved in an enantioselective fashion regarding the 
discrimination of the enantiotopic arms, as well as to control the diastereoselectivity to be 
anti- in the customary zig-zag conformation. 
 
In contrast to substrate A, the synthesis of bis-aldehyde B was pursued with more promising 
results. The overall achievement is shown in Scheme 2.27. 
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Scheme 2.27: Reagents and Conditions: (i) a) NaH (2.5 eq), THF, 45 min, 0 °C to RT, b) 
allyl bromide (2 eq), 26 hrs, 70 °C; (ii) LiCl (2.2 eq), DMSO (with a little H2O), 21 hrs, 180 °C; 
(iii) LiAlH4 (1.6 eq), THF, 4 hrs, 0 °C to RT; (iv) a) NaH (1.2 eq), THF, 1.25 hrs, 0 °C to RT, 
b) BnBr (1.5 eq), TBAI (10 mol%), 18 hrs, RT; (v) a) O3, MeOH, 2 hrs, -78 °C to 0 °C, b) 
PPh3 (2.2 eq), 2 hrs, 0 °C to RT, c) Tosic acid (20 mol%), 18 hrs, RT. 
 
Thus, diethyl malonate was diallylated with an excess of allyl bromide in the presence of 
NaH as base (2.5 eq) and after the reaction work-up, the crude product was reduced via the 
Krapcho decarboxylation. The suggested mechanism for the decarboxylation is shown in 
Scheme 2.28.  
 
 
Scheme 2.28: The suggested mechanism for the Krapcho decarboxylation. 
 
Column chromatography gave the desired diallyl ester 36 in a 56% yield (over the two 
steps). For this known compound, the 1H NMR resonances (Figure 2.5) agreed with the 
literature.234 The most significant resonances were the downfield vinyl resonances and the 
ethyl triplet and quartet resonances (which are characteristically quite deshielded by the 
ester functionality). 
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Figure 2.5: The 1H NMR spectrum (CDCl3, 300 MHz) of 36. 
 
Ester 36 then underwent reduction with LiAlH4 to give alcohol 37 in excellent yield (82%) 
following column chromatography. Thereafter, 37 was protected with benzyl bromide using 
sodium hydride as base to give 38 in 77% yield. This is also a known compound with its 1H 
NMR resonances (Figure 2.6) agreeing with the literature.235 The aromatic and methylene 
resonances of the added benzyl group were most significant in confirming the structure of 
38. 
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Figure 2.6: The 1H NMR spectrum (CDCl3, 300 MHz) of 38. 
 
Product 38 was then subjected to a double ozonolysis in an attempt to produce the bis-enal, 
using PPh3 as the reducing agent. However, even though reaction TLCs were initially 
promising, the 1H NMR spectrum of the product after column chromatography did not show 
the expected resonances. Indeed, TLCs of the columned product showed streaks of a 
second, more polar product (or a mixture of products). This suggested that bis-aldehyde 39 
was prone to self-condensation (due to enolisation-type reactions) when adsorbed onto the 
relatively acidic and hygroscopic silica gel. Although other purification methods could have 
been explored, this was taken as a warning of the final product being unstable and difficult to 
handle. Therefore, it was decided to isolate the final symmetrical substrate as a bis-acetal - a 
masked aldehyde, which was expected to be far more stable and not prone to self-
condensation. This was achieved via a one-pot tandem ozonolysis / acetalisation procedure. 
The mechanism of this transformation is shown in Scheme 2.29, involving a 1,3-
cycloaddition to the double bond to form a molozonide, followed by a retro-1,3-cycloaddition 
(regioselectivity unknown) to a Criegee intermediate (an aldehyde and an aldehyde oxide). 
Because methanol is present, the carbonyl oxide is intercepted to form a hemi-acetal 
hydroperoxide. Thereafter, triphenylphosphine reduces this to a second molecule of 
aldehyde. On addition of the p-tosic acid the aldehydes are converted into their acetals, 
forming bis-acetal 40 ultimately, Scheme 2.29. 
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Scheme 2.29: The mechanism for the tandem ozonolysis / acetalisation step. 
 
The one-pot tandem ozonolysis/acetalisation gave the desired bis-acetal 40 in 68% yield as 
an oil. Since this was a new compound, its structure was elucidated using a range of 
analytical techniques (infrared spectroscopy and high-resolution mass spectrometry) in 
addition to 1H NMR and 13C NMR spectroscopy. The 1H NMR and 13C NMR spectra of 40 
are shown in Figure 2.7. The 1H spectrum showed the benzyl, methoxy (diastereotopic) and 
H-4 resonances in their expected places and with the correct integration. 
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Figure 2.7: The 1H NMR (CDCl3, 300 MHz) and 13C NMR (CDCl3, 75.5 MHz) spectra of bis-
acetal 40. 
 
The relative ease of this synthesis encouraged focus to be directed solely to the α-amination 
of bis-acetal substrates. Furthermore, a deeper search into the literature revealed that the 
conditions for an organocatalysed α-amination of an acetal had never been reported. In fact, 
outside of our work, the only other use of acetals to generate an enamine intermediate in 
organocatalysis reactions was Koley and co-worker’s organocatalysed Mannich cyclisation 
(Scheme 2.30) involving a hemiaminal as an N-acyliminium ion precursor being intercepted 
by an acetal-derived enamine (this was published in September 2014, 8 months after the 
publication of our work). Thus a model study was undertaken in order to develop optimal 
conditions for the α-amination of an acetal for taking forward into desymmetrisation. The 
next Chapter describes the results of this study. 
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Scheme 2.30: The use of an acetal in an organocatalysed Mannich reaction. 
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Chapter 3: The Acetal Model Study 
 
As discussed in the previous Chapter, the objective of the PhD developed into establishing 
optimal conditions for the usage of acetals as masked carbonyl equivalents in the 
organocatalysed enantioselective α-amination reaction, Scheme 3.1. The methodology 
intended was new although ketals had been shown to undergo non-stereoselective, Lewis-
acid catalysed α-amination to form α-hydrazino ketals.236  
 
Scheme 3.1: The envisioned acetal α-amination. 
 
3.1 Mechanistic Considerations – Finding an Appropriate Acid 
From the outset the mechanistic challenges involved in developing such a reaction were 
clear. As shown in Scheme 3.2, first was the need to use Lewis or Bronsted catalysis237–242 
in order to generate an oxocarbenium ion243,244 that could react with the organocatalyst to 
generate the key enamine intermediate. Additionally, water would need to be added to 
ensure catalyst turnover. However the presence of both these necessary components 
suggested the possibility of product racemization via acid-catalysed enol formation. Also, the 
enamine could in principle be generated directly from the oxocarbenium ion or from the 
aldehyde following complete hydrolysis of the oxocarbenium ion. Since the organocatalyst 
was more nucleophilic than water it was hoped that the first pathway would apply since this 
seemed likely to ensure a greater chance of chemoselectivity as well as retain one of the 
acetal groupings in the bis-acetal desymmetrisation.  
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Scheme 3.2: The suggested pathway for acetal α-amination. 
 
The initial pilot study was conducted on 1,1-dimethoxydecane (DMD) in order to avoid 
volatility issues with lower molecular weight substrates. The reaction conditions were chosen 
to be similar to those of List’s initial reaction67 using an excess of acetal (1.5 equivalents), 
DBAD (or DIAD) as the limiting reagent and 10 mol% of L-Proline at room temperature. 
However, whereas he had used acetonitrile, in our case acetic acid was added as both 
solvent and as a weak Bronsted acid catalyst (pKa = 4.8, 1 ml = 10.2 equivalents).245 
Moreover, at least one equivalent of water was included to ensure catalyst turnover (see 
Scheme 3.2), which subsequently was studied as a reaction parameter. When one 
equivalent of water was used (Table 3.1, entry 5), following borohydride reduction of the 
primary product to minimise racemization, hydrazino alcohol 41 was obtained after 2 days as 
an amorphous white solid, following column chromatography in 37% yield and 12% ee. Thus 
this initial result showed that the acetal was 45 hours slower and far less stereoselective 
than the List protocol with aldehydes. Importantly however, no hydrazino alcohol was 
observed in the absence of proline. Figure 3.1 shows the 1H NMR spectrum of 41. Except for 
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the H-10 upfield triplet, all of the other resonances occurred as unresolved peaks. This was 
attributed to the presence of a population of conformers involving the hydrazide functionality 
that slowly equilibrated on the NMR timescale together with s-cis and s-trans conformers 
around the N-CO bond involving the tertiary nitrogen of the hydrazide (similar spectra are 
observed for all compounds in List’s and other similar work). Nonetheless, the expected 
resonances were observed in the downfield aliphatic and aromatic regions as assigned in 
Figure 3.1. Owing to deshielding by adjacent heteroatoms, H-1 and H-2 appeared as 
multiplets in the same region as the OH resonance. The benzyl methylene resonances 
appeared as a multiplet in the 5.00 - 5.50 ppm range due to deshielding from the carbamate 
oxygen. Finally, the NH resonance appeared as a broad singlet very close to the benzyl 
aromatic multiplets. These diagnostic signals (H-1, H-2, OH, Bn and NH) were used to 
elucidate the structures of similar molecules synthesised later in the acetal model study. In 
view of the difficulties with the 1H NMR assignments just mentioned and also since this was 
a new compound, additional analysis techniques were used in order to confirm the structure 
(13C NMR, infrared spectroscopy and high-resolution mass spectrometry) 13C NMR 
spectroscopy was particularly useful in assigning the C-1, C-2, benzyl resonances in the 55-
70 ppm region as well as the two carbonyl resonances in the 150–160 ppm region, which 
were common to all hydrazino alcohols in this model study. 
 
 
Figure 3.1: The 1H NMR spectrum (CDCl3, 300 MHz) of 41. 
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With the correct product in hand, the reaction model study was conducted at room 
temperature in acetic acid varying the water content and aminating agent (DBAD or DIAD). 
The results are shown in Table 3.1.  
 
 
Entry 
Substrate 
(1.5eq) 
Electrophile 
(1 eq)  
Proline 
(mol %) Acid (eq) 
H2O 
(eq) Time  
Temp 
(°C) 
Yield 
(%) ee (%) 
1 DMD DIAD 10 AcOH (10.2) 1 5.5 d RT 69 2 
2 DMD DIAD 10 AcOH (10.2) 5 3 d RT 84 30 
3 DMD DIAD 10 AcOH (10.2) 10 2 d RT 80 42 
4 Decanal DIAD 10 AcOH (10.2) 10 24 hrs RT 84 46 
5 DMD DBAD 10 AcOH (10.2) 1 2 d RT 37 12 
6 DMD  DBAD 10 AcOH (10.2) 5 40 hrs RT 37 36 
7 DMD DBAD 10 AcOH (10.2) 10 16 hrs RT 38 42 
8 Decanal DBAD 10 AcOH (10.2) 10 2.5 hrs RT 41 54 
 
Table 3.1: The Initial acetal experiments with acetic acid. 
 
The results indicated that DBAD reacted about twice as fast as DIAD, likely for steric 
reasons, but gave about half the yield suggesting that it was less stable in the medium 
compared to DIAD. In each reaction the aminating agent was used as limiting, and reactions 
were run to complete conversion of the aminating agent by TLC. Similarly, the rate of each 
reaction in both series increased with increasing water content as did the ee. The reaction 
ees were determined by chiral HPLC (Chiralpak AD or OD columns) with a UV-detector. 
Thus the DBAD products proved more convenient because they contained a UV-active 
chromophore, whereas the DIAD-derived hydrazino alcohols needed to be benzoylated prior 
to HPLC analysis. Nevertheless, both aminating agents gave similar ee’s under identical 
conditions, with a maximum of 42% in both cases (entries 3 and 7); see Figure 3.2 for the 
HPLC chromatograms of entries 7 and 8. As a control, both the DIAD and DBAD reactions 
were carried out using decanal at 10 equivalents of water (the amount of water which gave 
the fastest reaction and the highest ee). Interestingly, the aldehyde reacted much faster (two 
times for DIAD and about six for DBAD) but ees were comparable (entries 3/4 and 7/8) to 
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those for the acetal. This supported the view from the literature243 that the rate-limiting step 
for the acetal is the formation of the oxocarbenium ion, since thereafter the steps are virtually 
identical for each substrate. Moreover, an HPLC chromatogram of the decanal product 
shown in Figure 3.2 revealed the same sense of stereogenicity in the product (known to be 
R- for aldehydes), which indicated that they operate via the same enamine as expected, with 
possibly a similar transition-state model. Despite its lower yields, DBAD was picked as the 
aminating agent of choice for further studies in view of its considerably faster reaction times 
and its operational simplicity due to UV-activity from the benzyl groups for ee evaluation via 
HPLC. 
 
 
*n-hexane:i-propanol = 97:3, flow rate = 1 ml/min, λ = 258 nm 
 
 
 
Figure 3.2: The HPLC chromatogram of entries 7 and 8. 
Entry 7, ee = 42% 
Entry 8, ee = 54% 
Racemic 
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The acetic acid results were encouraging but the ees were too low, and this was attributed to 
acid-catalysed enolisation post-amination leading to a degree of racemization. However, the 
low ee was also thought to be associated with long reaction times, which in turn were 
determined by the acid strength and water content. It was thus decided to carry out a study 
varying the strength of the acid in which TFA, p-tosic acid (p-TSA), MBA (monobromoacetic 
acid) and MCA (monoochloroacetic acid) were chosen as acids. Perhaps one of these acids 
(with the optimal amount of water) would give the desired ee improvement by minimising the 
reaction time and post-catalytic-cycle racemization. Blackmond had already shown that α-
amination reaction rates could be increased by the addition of a protic additive (such as 
AcOH or methanol) in which246 a level of 1% of acid (v/v) was found to be effective in their 
study – this translated to 2.6 equivalents (in 1 ml of solvent) of the stronger acid TFA (pKa = 
-0.28). DCM (a very common solvent in organocatalysis)66,247 was chosen as the reaction 
solvent at the same concentration as in the acetic acid study (1 ml, 0.5 M). Table 3.2 shows 
initial results focusing on TFA.  
 
Entry 
Electrophile 
(1 eq)  
Proline 
(mol %) Acid (eq) 
H2O 
(eq) 
Solvent 
(0.5 M) Time  
Temp 
(°C) 
Yield 
(%) 
ee 
(%) 
1 DBAD - TFA (2.6) 1 DCM 2 d RT 11 0 
2 DBAD 10 TFA (2.6)  1 DCM 24 hrs RT 22 74 
3 DBAD 10 TFA (2.6)  10 DCM 30 hrs RT 14 16 
4 DIAD 20 TFA (2.6)  1 DCM 6 d RT 28 26 
5 DBAD 20 TFA (2.6)  1 DCM 70 hrs 4 30 80 
6 DBAD 20 p-TSA (0.2)  1 DCM 9 d 4  20 76 
7 DBAD 20 MBA (2.6)  1 DCM 3 d 4 50 66 
8 DBAD 20 MCA (2.6)  1 DCM 3 d 4 48 72 
 
Table 3.2: Selected results from the comparison of different acids for the acetal α-amination. 
 
Entry 1 shows the blank reaction (no proline) for TFA at RT with 1 equivalent of water where 
disappointingly a product, albeit only a small amount (11%), was obtained in the absence of 
the organocatalyst. This implied that with TFA the substrate was completely hydrolysing to 
decanal, which then aminated via an enol nucleophile (or vinyl ether) from acid-catalysed 
enolisation. Naturally, in the absence of a chiral catalyst, this reaction gave 0% ee. However, 
in the presence of proline at 10 mol% (entry 2), also with one equivalent of water, the TFA 
reaction gave an impressive 74% ee (see Figure 3.3 for the HPLC chromatogram) in an 
improved 22% yield in half the time compared to the blank. Thus reaction time as determined 
by water content and acid strength seemed to be the important parameter to follow. An 
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attempt to improve the yield by increasing the water equivalents to 10 only resulted in a 
decrease in both yield and ee (entry 3), presumably because of an increased ionicity of the 
medium for promoting racemization via enol formation. The time factor was then confirmed 
by using DIAD (we knew reactions with this were slower) as the aminating agent (entry 4), 
which even at 20 mol% of catalyst and still with 1 equivalent of water resulted in a much 
longer reaction time (6 days) and a drastic decrease in ee to 26%. Returning to DBAD (at 20 
mol% of catalyst) and trying to improve on the 74% ee result in entry 2 led to choosing a 
decrease in reaction temperature (to 4 °C), which as expected retarded the reaction to 6 
days for full conversion, but pleasingly increased the ee to 80% as well as the yield from 
22% (entry 2) to 30% (entry 5), It was clear that DBAD was fairly unstable in the acid 
medium and with this in mind it was decided to test other (weaker) acids with different pKas 
(entries 6-8) including: p-toluenesulfonic acid (pKa = -1.34), MBA (pKa = 2.89) and MCA 
(pKa = 2.86). Similar to TFA, the even more acidic toluenesulfonic acid gave a high 80% ee 
although still at low yield. Only 0.2 equivalents of this acid were added as higher equivalents 
led to no reaction due to DBAD decomposition. Conversely, the weaker acids MBA and MCA 
gave an improved yield while still retaining a decent ee so in the next stage of optimisation 
MCA was chosen over MBA on the basis of results (entries 7/8) and chemical corrosiveness. 
 
 
*Chiralpak AD column, 3% i-Pr in n-hexane, 258 nm and 1 ml/min 
 
Figure 3.3: The HPLC chromatogram of entry 2. 
 
3.2 Optimisation Using MCA 
With the appropriate acid (MCA) and aminating agent (DBAD) chosen, the reaction 
conditions were further studied to optimise reaction time, yield and ee. Of particular interest 
was the influence of the amount of MCA on reaction rate and hence yield and ee. Significant 
results are shown in Table 3.3. 
 
 
Ee = 74% 
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Entry 
DMD 
(eq) 
DBAD 
 (eq) 
Cat  
(mol %) 
DCM 
(M) 
H2O 
(eq) MCA (eq) Time  
Temp 
(°C) 
Yield 
(%) ee (%) 
1 1.5 1 20 0.5 1 2.6 3 d 4 48 72 
2 1 4 20 0.5 1 4 18 d 4 83 32 
3 1 4 20 0.5 1 4 2 d 4 35 68 
4 1 4 20 0.5 1 10.4 49 hrs 4 81 74 
5 1 4 20 0.5 5 10.4 41 hrs 4 78 78 
6 1 4 20 0.1 5 10.4 5 d 4 72 84 
7 1 4 20 0.1 5 
10.4 + TFA 
(0.1 eq) 4 d 4 61 86 
 
Table 3.3: The MCA optimisation study. 
 
With entry 1 representing the baseline case from before using 2.6 equivalents of MCA, 20 
mol% of L-proline and 1 equivalent of water at RT, it was decided to increase the equivalents 
of DBAD (in view of its instability) and make the acetal (DMD) limiting. This (entry 2) resulted 
in the hoped for yield improvement to a high 83%, though significantly, with a much lower ee 
(32%), probably as a result of the much longer reaction time (18 days for full starting material 
conversion). Evidence for the latter (entry 3) came from stopping this reaction much earlier 
(at 2 days), which as expected gave a much lower yield (35%) but with a much higher ee of 
68%. Thus previous speculation about time-dependent acid-catalysed racemization was 
more or less confirmed. We were intrigued by the drop in rate on increasing the DBAD 
equivalents and then we realised that the high ee in entry 1 had been achieved with a ratio of 
DBAD:MCA equal to 1:2.6. Applying this ratio (as 4:10.4, entry 4) with the 4 equivalents of 
DBAD gratifyingly lowered the time from 18 days to 49 hours with a pleasing increase in yield 
to 81%, and importantly, an increase in ee to 74%. This suggested that the reaction requires 
a protonated transition-state in order to maximise stereocontrol. This will be discussed later 
in Section 3.4. Increasing the water to 5 equivalents (entry 5) marginally improved both time 
(41 hrs) and ee (78%), while diluting the solution (entry 6) from 0.5 M to List’s original 
reaction concentration of 0.1 M slowed the reaction down to 5 days but improved the ee 
further to 84% without compromising yield to any great extent (72%). This increased reaction 
time was somewhat reduced to 4 days by the addition of a catalytic amount of TFA (0.1 
equivalents) which also resulted in an increased ee (86%), though at lower yield (61%), 
(entry 7). The HPLC chromatogram of this reaction is shown in Figure 3.4. 
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*Chiralpak AD column, 3% i-Pr in n-hexane, 258 nm and 1 ml/min  
 
Figure 3.4: The HPLC chromatogram of Entry 7. 
 
From here, attention was turned to catalyst variation in which five organocatalysts were 
screened (Table 3.4): proline, the proline-tetrazole catalyst 13 (same numbering as in 
Chapter 1), Jørgensen’s diphenylsilyloxyprolinol 2, a new imidazolidinone primary amine 
catalyst (39) developed in our laboratories and McMillan’s first-generation imidazolidinone 
organocatalyst 1.  
 
N
H
COOH
N
H HN N
N
N
N
H
Ph
Ph
OTMS
N N
O
NH2
PhL-Proline 13 2 42
N
N
H
O
Me
Me
MePh
1
 
Cat 
DMD 
(eq) 
DBAD 
 (eq) 
Cat  
(mol %) 
DCM 
(M) 
H2O 
(eq) 
MCA 
(eq) Time  
Temp 
(°C) Yield (%) ee (%) 
Proline 1 4 20 0.5 5 10.4 2 d 4 78 78 
13 1 4 20 0.5 5 10.4 23 hrs 4 86 74 
2 1 4 20 0.5 5 10.4 5 d 4 to RT 20 36 
42 1 4 20 0.5 5 10.4 7 d 4 to RT 44 16 
1 1 4 20 0.5 5 10.4 >7 d 4 to RT trace - 
 
Table 3.4: The comparison of different organocatalysts. 
 
These catalysts were studied under the 0.5 M optimised conditions from entry 5 in Table 3.3. 
While the McMillan catalyst 1 was ineffective (trace amount of product after several days), 
and catalysts 2 and 42 returned a low ee (36% and 16 %, respectively) due to long reaction 
times, the tetrazole catalyst 13 promoted the fastest reaction (23 hours) and gave the 
highest yield (86%). Although the ee from 13 was slightly lower compared to that of using 
Ee = 86% 
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proline at 74%, its faster reaction time and higher yield were enough of an encouragement to 
continue using it in further optimisations. Overall, the results show that the usually high rate 
with aldehydes using all of these catalysts is reduced and is catalyst-dependent. Presumably 
this reflects that the addition step involving catalyst and the acetal-derived (alkylated) 
oxocarbenium ion (see the mechanism in Scheme 3.1) is now more responsive towards 
steric effects in the catalyst structure compared to the case for addition to the sterically less 
congested aldehyde. Figure 3.5 shows the chromatograms from chiral HPLC obtained using 
proline, 13 and 2. Importantly, Jørgensen’s catalyst 2 gave a major enantiomer of opposite 
configuration. This result is in accordance with the literature’s view on the transition-state of 
these aminations, and its mechanistic implications will be discussed further in Section 3.4. 
 
 
 
 
 
 
Figure 3.5: The HPLC chromatograms of products from proline, 13, and 2. 
 
L-Proline, ee = 78% 
 
Catalyst 2, ee = 36% 
Catalyst 13, Ee = 74% 
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Table 3.5 below shows the results from a direct comparison of proline with tetrazole catalyst 
13 using different amounts of DBAD in order to minimise cost and at the 2.6 ratio 
(DBAD:MCA), as well as varying the concentration as either 0.1 M or 0.5 M, while 
maintaining the water content at 5 equivalents, and the temperature at 4 °C. In entries 4 and 
5 a small amount of TFA was introduced.  
 
Entry Reaction Conditions 
L-Proline (20 mol %) 
 
Tetrazole Catalyst 13 (20 mol%) 
 
Time 
Yield 
(%) ee (%) Time 
Yield 
(%) ee (%) 
1 
DMD (1 eq), DBAD (4 
eq), MCA (10.4 eq), H2O 
(5 eq), DCM (0.5 M) 
41 hrs 78 78 23 hrs 86 74 
2 2 eq DBAD, 5.2 eq MCA 52 hrs 73 84 3 d 79 42 
3 
2 eq DBAD, 5.2 eq 
MCA, 0.1 M DCM 
5 d 72 84 5 d 70 56 
4 
2 eq DBAD, 5.2 eq 
MCA, 0.1 eq TFA, 0.1 M 
DCM 
4 d 61 86 17 hrs 83 90 
5 
2 eq DBAD, 5.2 eq 
MCA, 0.1 eq TFA, 0.5 M 
DCM  
 9hrs 79 90 
 
Table 3.5: A comparison of the proline results with those of catalyst 13. 
 
The results show that the tetrazole-catalysed reaction fared worse regarding ee when 
reducing the amount of DBAD with yields about the same (entries 1-3). However, pleasingly, 
with a small amount of TFA reaction rates improved to something experimentally attractive (< 
I day) with a concomitant increase of the ee up to 90%, which was only a few percent lower 
than the prototype reaction by List using the aldehyde. Hence, after many long months of 
arduous optimisation a set of experimental conditions in a multi-parameter reaction was 
arrived at in which a relatively low reaction time (for organocatalysis) was important to avoid 
racemization as was the acid strength of the medium and the ratio of acid:DBAD. By using a 
medium-strength acid at high concentration of reagent a high ee could be realised. The 
chromatogram in Figure 3.6 shows the 90% ee result from entry 5. 
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*Chiralpak AD column, 5% i-Pr in n-hexane, 258 nm and 1 ml/min 
 
Figure 3.6: The HPLC chromatogram of entry 5. 
 
The final step in the acetal reaction optimisation was a solvent study (Table 3.6). Using a 2 
equivalent excess of DBAD, 20 mol% of 13, 5.2 equivalents of MCA and 0.1 equivalents of 
TFA at a constant reaction temperature (4 °C) and time (9 hours), DCM (Entry 1) showed 
superiority in terms of yield and ee, with acetonitrile as close runner-up (entry 3). Chloroform, 
toluene and ethyl acetate also gave good ee’s, although in lower yields (18 – 66%).The 
Lewis basic solvents THF and DMSO gave no reaction product, suggesting that they 
interfere with the acid-base transformations and hydrogen bonding critical to the success of 
the reaction. 
 
Entry DMD DBAD 
13 
 (mol %) 
Solvent 
(0.5 M) H2O (eq) MCA (eq) Time  
Yield 
(%) ee (%) 
1 1 2 20 DCM 5 5.2 + TFA (0.1 eq) 9 hrs 79 90 
2 1 2 20 CHCl3 5 5.2 + TFA (0.1 eq) 9 hrs 66 86 
3 1 2 20 CH3CN 5 5.2 + TFA (0.1 eq) 9 hrs 75 90 
4 1 2 20 Toluene 5 5.2 + TFA (0.1 eq) 9 hrs 57 80 
5 1 2 20 EtOAc 5 5.2 + TFA (0.1 eq) 9 hrs 18 78 
6 1 2 20 THF 5 5.2 + TFA (0.1 eq) 9 hrs Trace (TLC) - 
7 1 2 20 DMSO 5 5.2 + TFA (0.1 eq) 9 hrs - - 
 
Table 3.6: The solvent study. 
 
Ee = 90% 
 96 
 
Thus this exhaustive optimisation study made it clear that enantioselective α-amination of 
acetals can successfully be achieved in high yields and ees, and in acceptable reaction 
times.  
 
3.3 Application to Different Acetal Substrates 
Regarding scope, Table 3.7 displays the results of applying the optimised conditions to a 
range of acetals. Changing the acetal from dimethoxy to diethoxy (entries 1 and 2) increased 
the reaction rate, presumably due to an increase in stability of the intermediate 
oxocarbenium ion as well as the greater basicity of the ethoxy group, making it a better 
leaving group.248 Importantly, in view of the faster reaction the yield rose to 93% reflecting 
the instability of DBAD in an acid medium over long periods. As with the model (entry 1) ee 
values were both very good (>85%). The highest ee of all was obtained with 
isovaleraldehyde diethylacetal, which gave an exceptional 94% ee (entry 3). Entry 4 reveals 
that quaternised stereocentres could also be accessed, albeit with a drop in ee to 56%. This 
nevertheless compares reasonably with other reports on the corresponding aldehyde170,249 
using proline-based catalysts at sub-stoichiometric amounts. Product 45 was isolated as an 
aldehyde without reduction to the hydrazino alcohol since the enolisable α-proton is absent 
in the aminated product. For ketals (entries 5-9), as expected, rates depended on the ketal 
OR-groups in the order cyclic > acyclic for the same OR-group and dimethoxy > dioxolane, 
which is in agreement with known hydrolysis rates248 and the stability of the intermediate 
oxocarbenium ion based on inductive and hyperconjugative effects. As indicated in Table 
3.7, in all ketal cases excess substrate was used (to 1 equiv of DBAD) to drive the reaction 
to completion as well as to avoid disubstitution. For slower reactions (entries 5 and 8) a large 
excess of ketal (20 equivalents) was used which also resulted in ee improvements (entries 6 
and 9). For ketals the α-aminated ketone was isolated without carbonyl reduction to avoid 
the introduction of an extra stereocentre into the product. This work was published in 
Tetrahedron Letters in 2014.250 
 
Entry Substrate Product 
Acetal 
(eq) 
DBAD 
(eq) 
Cat 
mol% 
DCM 
(M) 
H2O 
(eq) MCA (eq) Time 
T 
(°C) 
Yield 
(%) 
ee 
(%) 
1 
 
 
 
 
1 2 20 0.5 5 
5.2 + 
TFA  
(0.1 eq) 
9 hrs 4 79 90 
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Table 3.7: Different acetals and ketals. 
 
All of the above α-amination products (except 41, as discussed earlier) were known 
compounds whose 1H and 13C NMR resonances agreed with the literature.67,174,180,251 Figure 
3.7 shows the 1H NMR spectrum of 43, entry 2. The diagnostic downfield H-1, H-2, OH and 
Bn methylene resonances were in the expected 3.00–5.50 ppm region. As expected, the 
resonances were not very well resolved due to conformational interconversion. Furthermore, 
the upfield CH3 doublet (H-3), confirmed the presence of the propyl chain.  
 
2 
 
 
HO
N
N
H
Cbz
Cbz
43
 
1 2 20 0.5 5 
5.2 + 
TFA  
(0.1 eq) 
4 hrs 4 93 86 
3 
 
 
 
1 2 20 0.5 5 
5.2 + 
TFA  
(0.1 eq) 
9 hrs 4 73 94 
4 
 
 
1 4 20 0.5 5 
10.4 + 
TFA  
(0.1 eq) 
3 d 4 51 66 
5 
 
 
5 1 20 0.5 5 
5.2 + 
TFA  
(0.1 eq) 
5 d RT 22 82 
6 20 1 20 1 5 
10.4 + 
TFA  
(0.1 eq) 
2 d 4 33 86 
7 
 
O
N
Cbz
NH
Cbz
47
 
5 1 20 0.5 5 
5.2 + 
TFA  
(0.1 eq) 
9 hrs 4 71 62  
8 
 
 
5 1 20 0.5 5 
5.2 + 
TFA  
(0.1 eq) 
8 d 4 61 40 
9 20 1 20 0.5 5 
10.4 + 
TFA  
(0.1 eq) 
2 d 4 66 64 
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Figure 3.7: The 1H NMR spectrum (CDCl3, 300 MHz) of 43. 
 
Both 43 and 44 were synthesised as crystalline solids in which it was observed that repeated 
recrystallisations (DCM / hexane mixtures) resulted in enantioenrichment. In fact, in the case 
of compound 44 (HPLC chromatograms shown in Figure 3.8), the already excellent 94% ee 
was improved to >99%. This demonstrates how the organocatalysed α-amination reaction 
can result in optically pure chiral building blocks. 
 
 
 
 
Ee = 94%  
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*Chiralpak AD column, 10% i-Pr in n-hexane, 258 nm and 1 ml/min 
 
Figure 3.8: The HPLC chromatograms of 44 before and after recrystallisation. 
 
The 1H NMR spectrum of quaternary product 45 is displayed in Figure 3.9. In this case there 
is evidence of the product existing as a 3:1 mixture of rotamers. This is reflected in the NH 
and aldehyde protons each appearing as two resonances. The origin of the rotamers is the 
partial double bond created by nitrogen electron donation of the tertiary nitrogen into the 
carbonyl of the Cbz carbamate. This results in restricted rotation of the N-carbonyl bond.  
 
 
Figure 3.9: The 1H NMR spectrum (CDCl3, 300 MHz) of 45. 
 
 
Ee = >99% 
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For product 46 from the ketal of 2-butanone (entry 6), there was the possibility of obtaining 
two regioisomeric products depending on whether the amination occurred on C-2 or C-4 (see 
numbering in Figure 3.10). The racemic version of this reaction was carried out using the 
corresponding ketone, 2-butanone, under Jørgensen’s conditions66 with DL-Proline as the 
catalyst. As shown in the chromatogram in Figure 3.10, with Jørgensen’s reaction conditions 
the two regioisomers were seen as a 4:1 mixture (two enantiomer peak areas:regioismer 
peak area) with the desired C-2-aminated product (as a racemate) dominating, in 
accordance with intermediacy of the more stable enamine. However, in our ketal version of 
this reaction (with the corresponding ketal and tetrazole catalyst 13), the regioisomeric ratio 
was improved to an impressive 96:4. It is also worth mentioning that these two regioisomers 
can be distinguished by 1H and 13C NMR spectroscopy, but they cannot be separated by 
flash column chromatography.  
 
 
 
*Chiralpak OD column, 10% i-Pr in n-hexane, 258 nm and 1 ml/min 
 
 
 
Figure 3.10: The racemic and chiral HPLC chromatograms of 46. 
 
Figure 3.11 shows the 13C NMR spectrum of product 47 from cyclohexanone ketal. This 
product also appears as a mixture of rotamers which is suggested by the ketone carbonyl 
Minor Regioisomer 
Minor Regioisomer 
Racemic 
Ee = 86% 
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resonances appearing in duplicate. This conclusion is also supported by NH and H-1 
resonances in the 1H NMR spectrum each appearing in a 3:1 ratio. 
 
 
Figure 3.11: The 13C NMR spectrum (CDCl3, 75.5 MHz) of 47. 
 
3.4 Mechanistic Considerations and the Proposed Transition-State 
Before the acetal reaction mechanism and enantioselectivity is discussed, a brief discussion 
on the literature view of the α-amination mechanism is necessary. 
 
The aldehyde α-amination reaction was discovered simultaneously by List and 
Jørgensen,66,67,252 in which L-proline was used (Jorgensen and List)66,67 as well as a 
diarylprolinol catalyst 2 (Jorgensen only).252 Despite the same absolute (S)-configuration of 
prolinol catalyst 2 as that of proline, the reactions produced the same products with opposite 
enantioselectivity. This was probably the most important clue in uncovering the mechanism 
of asymmetric induction in the α-amination reaction. Thus researchers reasoned that these 
differences could be explained by two different transition-state models involving a single 
enamine configuration, Scheme 3.2. In this, proline is posited as operating through the 
activation of both the aldehyde (by forming a more nucleophilic enamine) and the 
electrophile (by hydrogen bonding) in which the enantioselectivity indicates the approach of 
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the electrophile (azodicarboxylate ester in this case) to be controlled by hydrogen bonding 
with the carboxyl group of the catalyst, resulting in re-face attack of the (E, s-trans)-enamine 
leading to the (R)-enantiomer.173 This transition-state model is referred to as the Houk-List 
model and involves a favourable six-membered transition-state.199 On the other hand, 
Jørgensen’s diarylprolinol catalyst resulted in high enantioselectivity despite the absence of 
functional groups that could participate in hydrogen bonding with the aminating agent. It was 
therefore reasoned that the enantioselectivity observed originated from the same enamine 
as that of proline (E, s-trans-) but now via introduction of steric bias onto one of the two 
enamine faces by the large diphenylsilyloxy substituent at the chiral centre This results in 
electrophile approach anti to this group, i.e. onto the si-face of the enamine, which explains 
the formation of the observed (S)-enantiomer, Scheme 3.3.40,172,200  
 
 
Scheme 3.3: The two catalyst-dependent transition-state models for the aminocatalysed α-
amination reaction.172 
 
Seebach and Eschenmoser have proposed a different model for depicting the 
stereochemical outcome using proline (Scheme 3.4). 253,254 Their model invokes anti-attack 
by the electrophile on the (E,s-cis)-enamine involving the intermediacy of an oxazolidinone. 
Seebach particularly suggested anti-addition to the syn-enamine rotamer, which leads 
directly to the exo-isomer of the product oxazolidinone, which later hydrolyses to the 
aldehyde with catalyst turnover.255 The Seebach-Eschenmoser hypothesis is consistent with 
the observed stereochemical outcome (R-), yet also accommodates Blackmond’s 
observation that the stereoselectivity can be reversed to afford predominantly (S-) in the 
presence of a base such as DBU.255 Interesting experimental evidence (such as NMR, IR 
and kinetic measurements) support the presence of the oxazolidinone intermediate. 
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However, ESI-MS, NMR spectroscopy and crystal structures of enamine intermediates by 
the List group have led them to present structural characterisations of a series of proline 
enamines. This provides substantial motivation for accepting their enamine mechanism in 
proline catalysis involving the s-trans rotamer.200,254 
 
 
Scheme 3.4: The Seebach-Eschenmoser transition-state model.255  
 
In accordance with the Houk-List hydrogen-bond-assisted model, Düthaler has proposed a 
chair conformation for L-proline-catalysed enamine reactions of ketones and aldehydes. In 
this model a six-membered chair is formed comprising the enamine double bond and 
nitrogen atom, the H of the proline carboxyl group and the two nitrogens of the diazo group, 
which is held together by hydrogen bonding (Figure 3.12).176 
 
 
Figure 3.12: The Düthaler proposed chair-conformation transition-state. 
 
Blackmond has also demonstrated that protic additives such as AcOH and MeOH increase 
the rate of the α-amination reaction (a point mentioned in Section 3.1), as well as the α-
aminoxylation, but not the aldol reaction.246 Additionally, kinetic studies based on these 
observations led her to the conclusion that the rate-determining step in the case of the 
amination reaction is enamine formation. As mentioned previously another Blackmond study 
revealed that the proline-catalysed amination reaction shows an inversion in the 
enantioselectivity when bases, such as DBU, are added to the reaction mixture.255 The 
authors suggested two explanations for this observation: 1) the proline carboxylate (along 
with its counter-cation) acts as a shielding group as with the TMS-protected diarylprolinol-
catalysts or; 2) the proline carboxylate assists the nucleophilic attack in accordance with the 
Seebach-Eschenmoser oxazolidinone model,253 although in this case to account for the 
observed stereochemistry, the resulting oxazolidinone would have to be formed through a 
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stable stereoelectronically favoured (E, s-trans)-enamine and the determining factor would 
no longer be the stability of the oxazolidinone products, as originally suggested by Seebach 
et al. Advanced kinetic studies of the α-amination reaction have also led Blackmond et al. to 
propose an autoinductive reaction mechanism where the product species accelerates the 
reaction.256,257 The hydrogen-bonded adduct of proline and the amination product was 
isolated and found to be more reactive than proline itself. Their experimental observation 
was therefore attributed to a specific hydrogen bonding interaction of the product aldehyde 
with proline in which the proline conformation is such that the nitrogen atom lone pair 
electrons are exposed, thus increasing its reactivity. The presence of the hydrogen-bonded 
adduct also increases the amount of proline (often insoluble in organic solvents) in solution, 
which in turn also increases the reaction rate.256,258 Thus, the reaction product has a role in 
increasing the concentration of active catalyst species (and therefore rate). Furthermore, 
proline can be channelled into the cycle in three different ways: as pure solid proline; as 
proline in solution; or in the form of an enamine (or oxazolidinone) produced by its reaction 
with the aldehyde starting material. Lastly, Blackmond and co-workers also suggest a 
transition-state similar to the Houk-List model even though they don’t reject the participation 
of an oxazolidinone in the catalytic cycle. This catalytic cycle may therefore be the best 
current explanation of all of the existing evidence mentioned earlier, based on both 
oxazolidinone and enamine species being detected in the α-amination reaction. Scheme 3.5 
illustrates the more complex catalytic cycle proposed by the Blackmond team involving 
autoinduction and an oxazolidinone. 
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Scheme 3.5: The catalytic cycle proposed by Blackmond. 
 
As far as the mechanism in our study is concerned, first of all the absolute configuration of 
the acetal products had to be determined. The HPLC traces comparing the acetal / proline 
product with that using Jørgensen’s catalyst as shown in Figure 3.5 earlier strongly indicated 
the R-configuration for proline. This was corroborated by measuring the optical rotation ([α]D) 
for product 43 (Table 3.7) from propionaldehyde diethyl acetal, which was established as -
22.6, comparing in sign with the literature value for the (R)-product of -32.0.174 These results 
indicate that the reaction proceeds via an assisted transition-state according to the Houk-List 
model, assuming, as is reasonable, that the acetal reaction proceeds through the same (E, 
s-trans)-enamine intermediate as that of the aldehyde form of the reaction. However, this still 
leaves the intriguing question as to why the ratio of MCA: DBAD needed to be greater than 2 
in order to secure a high product ee. Our rationale is that in this case the carboxyl group of 
the enamine intermediate is heavily H-bonded to a hydronium ion / water conglomerate, the 
concentration of hydronium ion as a powerful H-bond donor depending on the strength of 
acid. Such H-bonding is a sterically more severe environment than that in List and 
Jørgensen’s case pertaining to the reaction of aldehydes, which involves the production of 
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only one mol. of water per mol. of substrate from the condensation reaction to generate the 
enamine, and in which there is no acid. Indeed, in their model it is assumed that this water 
plays no important role in the assisted transition-state involving direct hydrogen bonding 
between the proline carboxyl group and one of the diazo nitrogens. In the acetal reaction, at 
high acid concentrations assistance might be promoted in two possible ways. Either 
protonation of the DBAD occurs, rendering it an excellent hydrogen bond donor to the 
carboxyl group carbonyl oxygen, or high hydronium ion concentration around the carboxyl 
group promotes general acid catalysis towards the electrophile. In either case, direct 
hydrogen bonding between the carboxyl OH and the DBAD as in the Houk-List model is not 
considered to be operating in view of the fluctuation in ee’s as a function of acid 
concentration (observed in Table 3.3). Reducing the acid strength (e.g. to AcOH) shifts the 
assisted model to a steric one leading to an increase in the (S)-enantiomer. Importantly, 
leaving the tetrazole 13-catalysed reaction for 48h, only marginally reduced the ee (90 to 
84%), indicating that racemization wasn’t a major event within this timeframe. Presumably 
the tetrazole catalyst promotes the fastest reaction because of the superior H-bonding 
acceptor attributes of the aza-amidine functionality. Scheme 3.6 below illustrates the 
proposed transition-state. 
 
Scheme 3.6: A comparison of our proposed transition-state with the Houk-List model. 
 
In answering the question of enamine formation regarding whether it proceeds from the 
aldehyde (from hydrolysis) or via the oxocarbenium ion, control experiments were 
conducted. Firstly, reacting the acetal with 10.4 equivalents of MCA and 5 equivalents of 
water (as in the optimised reaction) for 48 hours did not lead to acetal hydrolysis as judged 
by TLC. Secondly, unreacted DMD acetal could be recovered (as it is in excess) by column 
chromatography after the reaction, although trace amounts of decanol, formed by reduction 
of unreacted aldehyde originating form complete hydrolysis, was visible on TLC. Thus it was 
concluded that the enamine is mainly generated directly from the oxocarbenium ion of the 
acetal and not via hydrolysis to the aldehyde first.  
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3.5 Bis-Acetal Model Study 
Another demonstration of the scope of the acetal α-amination reaction came in the chemo-
differentiation of a bis-acetal, 1,1,6,6-tetramethoxy hexane (TMH), as a prototype for the 
desymmetrisation discussed in Chapter 2. This furnished the same product in comparable ee 
to that reported by Greck et al.,187 when they used L-proline on the corresponding half 
acetal/aldehyde substrate obtained from a Wittig sequence. In their case alcohol 48 was 
then transformed into (R)-proline.  
 
OMe
MeO
OMe
OMe
N
H HN N
N
N
O
H
N
NH
O
BnO
OBnO
DBAD / Acid /
H2O / DCM
OMe
OMe NaBH4
EtOH
HO
N
NH
O
BnO
OBnO
OMe
OMe
48
Tetramethoxy Hexane (TMH)
 
Entry 
TMH 
(eq) 
DBAD 
(eq) 
Cat 
(mol %) DCM (M) 
H2O 
(eq) MCA (eq) Time 
Temp 
(°C) 
Yield 
(%) ee (%) 
1 5 1 Proline (20) 0.1 5 
2.6 + TFA (0.1 
eq) 5 d 4 70 84 
2 5 1 13 (20) 0.1 5 2.6 + TFA (0.1 
eq) 2 d 4 78 66 
3 5 1 13 (20) 0.1 5 
5.2 + TFA (0.1 
eq) 22 hrs 4 78 90 
4 5 1 13 (20) 0.5 5 
5.2 + TFA (0.1 
eq) 6.5 hrs 4 70 88 
 
Table 3.8: Bis-acetal optimisation. 
 
In an initial trial reaction, applying the optimised acetal conditions and using TMH as the 
limiting reagent resulted in a low yield (22%) and a diamination product in 18% yield. 
However, as shown in entry 1 of Table 3.8, using an excess (5 equivalents) of the substrate 
resulted in a good yield and ee of the mono-aminated product 48, with proline as the 
catalyst. However, maintaining the DBAD:MCA ratio of 1:2.6 compromised the catalyst 13 ee 
result (entry 2) to give only 66% ee. Thus it was necessary to increase the ratio of MCA to 
DBAD to 5.2 to account for the increased basicity of the additional acetal grouping on the 
TMH substrate. This improved the reaction rate (22 hours) and ee to 90%, entry 3. Finally, 
concentrating the medium to 0.5 M gave an even faster reaction (6.5 hours) whilst 
maintaining a high yield (70%) and ee (88%), entry 4. Figure 3.13 shows the 1H NMR 
spectrum of 48. The important methoxy and H-6 resonances are visible as well as the 
characteristic α-hydrazino alcohol resonances. The 1H NMR and 13C NMR data of this known 
compound agreed with the literature.187 It was also established that this product had the 
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same stereogenicity as that of the corresponding aldehyde reaction by Greck ([α]D20 +5.2, lit 
+3.8). 
 
 
Figure 3.13: The 1H NMR spectrum (CDCl3, 300 MHz) of 48. 
 
This result opens up the possibility of desymmetrising prochiral bis-acetals into useful 
functionalised homochiral synthons in a rapid and benign manner, as discussed in Chapter 
2. 
 
3.6 Application to Other Masked Carbonyl Functionalities 
Finally, in view of an obvious application to carbohydrate α-amination, it was then decided to 
study the enantioselective α-amination of α-lactols containing masked aldehyde functionality. 
Thus lactol 49 as well as its relatives 3,4-dihydro-2H-pyran (DHP) and 2-
methoxytetrahydropyran (OMe-THP) were studied. The suggested mechanism for these 
transformations is shown in Scheme 3.7. Most important is the fact that, through acid-
catalysed hydrolysis equilibria, all three masked carbonyls lead to the same product 50. 
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Scheme 3.7: The suggested mechanism for cyclic masked carbonyl α-amination. 
 
Table 3.9 below shows the results of this final study.  
 
 
Entry 
Substrate 
(eq) 
DBAD 
(eq) 
Catalyst 
(mol %) Acid (eq) 
H2O  
(eq) 
CH3CN 
(M) Time 
Temp  
(°C) 
Yield 
(%) 
ee 
(%) dr 
1 Lactol (10) 1 Proline 
20 
- - 0.5 4.5 hrs RT 90 60 60:40 
2 Lactol (10) 1 Proline 
20 
MCA (0.1) 10 0.5 40 min RT 85 74 59:41 
3 Lactol (10) 1 13 20 
MCA (0.1) 
and TFA 
(0.1) 
10 0.5 9 hrs 0 80 93 61:39 
4 DHP (10) 1 Proline 
20 
TFA (0.2) 10 0.5 9 hrs RT 55 76 62:38 
5 
OMe-THP 
(10) 1 
Proline 
20 
1 M HCl 
(0.2) 10 0.5 3 d RT 28 74 
55:45 
65:35 
  
Table 3.9: Lactol-related masked carbonyls. 
 
As expected, in view of its ability to open directly to an aldehyde form, lactol 49 was quite 
reactive, forming the α-aminated product as a 3:2 ratio of diastereomers in high yield with 
proline as organocatalyst, within a few hours at room temperature and importantly without 
the need to include a Bronsted activator (entry 1). However, interestingly, the ee was quite 
low (60%), which was likely due to the free hydroxyl in the acyclic hydroxy-enamine 
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intermediate interfering with the hydrogen bond assisted transition-state. Introduction of 
MCA at low equivalents (0.1 eq, entry 2) and water (10 eq) to promote an even faster 
reaction and higher ee resulted in the desired reaction time (40 min) and ee improvement 
(74%), endorsing the idea of promoting transition-state assistance through a protonated 
environment. A combination of changing to the tetrazole catalyst, adding 0.1 equivalents of 
TFA and decreasing the temperature to 0 °C returned a much higher and pleasing ee of 
93% in high yield (entry 3). Both DHP and OMe-THP had slower rates since formation of the 
lactol intermediate (which is visible on TLC) was slower. Hence, more acidic conditions had 
to be employed (entries 4 and 5) which together with the longer reaction times resulted in 
lower yields due to decomposition of the limiting reagent (DBAD), and elimination of H2O 
from product 50 to form an aminated glycal, (this by-product was isolated via column 
chromatography and characterised by 1H NMR). Figure 3.14 below shows the racemic and 
chiral chromatograms of entry 3. HPLC data aided not only in determining the ee, but also in 
distinguishing between the two diastereomers, thereby determining the dr, which was always 
about 1:1 (since the diastereomers could equilibrate via the hemi-aminal).  
 
*Chiralpak AD column, 30% i-Pr in n-hexane, 258 nm and 0.9 ml/min 
 
 
Figure 3.14: The racemic and chiral HPLC chromatograms of entry 3. 
 
Diastereomer 1 
Diastereomer 2 
Diastereomer 2 
Diastereomer 1 
Ee = 93% 
Racemic 
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Figure 3.15 shows the 1H NMR and 13C NMR spectra of 50 as a mixture of diastereomers, 
which could not be separated by flash column chromatography. The H-2 and H-3 
resonances appear in the typical region, together with the deshielded H-6 resonances in the 
same downfield region. Notably, in the 13C NMR spectrum the hemiacetal C-2 and C-2’ 
resonances for the two diastereomers are deshielded by the two adjacent oxygens, resulting 
in a very downfield signal for an sp3 carbon to approximately 100 ppm. As this is a new 
compound, additional analysis techniques were used in order to confirm its structure 
(infrared spectroscopy and high-resolution mass spectrometry). Particularly helpful was the 
2-D HSQC NMR data which helped to confirm the NMR assignments and distinguish 
between the two diastereomers (50 and 50’).  
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OH'
H-3'
H-4', H-5'
N-H' H-6'
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Figure 3.15: The 1H NMR (CDCl3, 300 MHz) and 13C NMR (CDCl3, 75.5 MHz) spectra of the 
two diastereomers – 50 and 50’. 
 
In conclusion, conditions were successfully established for using acetals and associated 
masked functionalities as carbonyl equivalents in enantioselective α-amination reactions. 
 
However, the utility of the derived α-aminated products is only truly harnessed after cleavage 
of the hydrazine N-N bond. This results in chiral α−amino products, which are important 
building blocks for a variety of organic compounds. Although there are known methods for 
achieving this they are unchemoselective. Before discussion of efforts to apply the new 
acetal amination to desymmetrisation, the following Chapter discusses a new methodology 
that was developed for hydrazide N-N bond cleavage. 
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Chapter 4: Hydrazide N-N Bond Cleavage 
 
The traditional methods used to cleave the N-N bond in hydrazides derived from α-amination 
with Mitsunobu reagents involve classical reductive methods (Raney nickel,67 zinc / acetic 
acid,247 trifluoroacetic anhydride / samarium iodide185 and NaNO2 / HCl).249 Other reagents 
that are less commonly used include: Al amalgam,259 Li / NH3,260 B2H6,261 NiCl2262, 
polymethylhydrosiloxane,263 m-CPBA or magnesium monoperoxyphthalene.264 In general, 
these procedures involve harsh conditions and are not compatible with highly functionalised 
substrates containing, for instance, double bonds, triple bonds, benzyl ethers or acetals. 
Recently, following sporadic reports of eliminative N-N cleavage,265–269 Magnus reported N-N 
bond reductive cleavage of hydrazides with attached alkyl or aryl groups, as well as 
hydrazino dioxolanes derived from an achiral Lewis-acid catalysed α-amination reaction 
(mentioned in Chapter 3), via an E1CB protocol mechanism.236,270 Their method involved N-
alkylation of the secondary nitrogen of the hydrazide with ethyl (or methyl) bromoacetate 
followed by base-promoted elimination (NaH or Cs2CO3). The latter was postulated by 
Magnus to involve an E1CB mechanism involving the acidic methylene hydrogen of the 
newly introduced alkoxycarbonylmethylene group, and the two-step sequence could be 
carried out either sequentially (with purification of the N-alkylated intermediate) or as a one-
pot procedure, particularly when NaH was used (Scheme 4.1).  
 
Scheme 4.1: The recent Magnus methodology for hydrazide N-N bond reductive cleavage. 
 
It was envisaged that this would be an appropriate, benign procedure for the N-N bond 
cleavage of bis-acetal-derived products. However since this method had never been applied 
to α-hydrazino alcohols derived from the organocatalytic α-amination reaction, it was 
decided that a model study would be conducted first in order to test the applicability of this 
procedure, particularly in the context of acetal-containing substrates.  
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4.1 The Magnus Protocol Study  
The model substrate chosen was the α-hydrazino alcohol from decanal. However, from the 
outset it was noted that any attempt to cleave the N-N bond of this substrate using Magnus’ 
procedure would inevitably lead to base-catalysed cyclisation to the N-substituted 
oxazolidinone so the α−amination product was first converted to its oxazolidinone using 
NaOH. The procedure is shown below (Scheme 4.2) in which the overall sequence of three 
chemical steps could be realised in 86% overall yield and a 92% ee to afford oxazolidinone-
hydrazide product 51 in accordance with List and Jørgensen’s original findings. Decanal was 
chosen instead of its acetal form (from Chapter 3), since (for decanal and similar simple 
aldehydes) the classic List67 version of the amination was faster and operationally simpler 
than the current acetal protocol, while the conditions for the cyclisation were chosen from 
Jørgensen’s work on the α-amination of ketones.66  
 
O
H
O
O N NHCbz
51 86% yield
92% ee
(i), (ii)
7
8
 
Scheme 4.2: Oxazolidinone-hydrazide synthesis from decanal in a three-step, one-pot 
procedure. Reagents and Conditions: (i) a) decanal (1.5 eq), DBAD (1 eq), L-proline (10 
mol%), CH3CN, 0 °C to RT, 2 hrs, b) NaBH4 (1 eq), MeOH, 0 °C, 15 min; (ii) 1 M NaOH (3 
eq), RT, 2 hrs. 
 
The mechanism for this transformation is shown in Scheme 4.3. Regioselectivity is observed 
in the cyclisation in terms of kinetically favouring the 5-exo-trig product over the 6-exo-trig 
possibility in agreement with Baldwin’s rules. Chemoselectivity is also displayed in that the 
secondary nitrogen (NH) of the hydrazide doesn’t compete with the hydroxyl group as 
nucleophile in spite of its hydrogen being more acidic (due to resonance stabilisation of the 
N-anion), because of the unfavourable formation of a three-membered ring. 
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Scheme 4.3: A suggested mechanism for oxazolidinone formation. 
 
The 1H NMR and 13C NMR spectra of 51 are shown in Figure 4.1. The most important 
diagnostic 1H NMR signals, which were used in the characterisation of similar products in the 
study, were the H-4 and diastereotopic H-5 protons which came in the range of 3.50 – 4.50 
ppm in the chemical shift order H51 ≥ H4 ≥ H52 (the big chemical shift difference between the 
H5 protons being due to alkyl shielding); as well as the benzyl signals integrating for only 
one benzyl group. As in the hydrazino alcohol cases, the broad resonances suggested 
sluggish conformational interconversion on the NMR time-scale. The 13C NMR spectrum 
revealed a more marked difference between the C-5 and the less deshielded C-4 due to O 
being more electronegative and deshielding than N, while the oxazolidinone carbonyl 
resonance was in a similar range as the now single Cbz carbonyl resonance (150.0 – 160.0 
ppm). The 13C NMR spectrum also clearly showed all of the required singlets compared to 
the hydrazino alcohols in Chapter 3 where certain resonances were significantly relaxed and 
tied up with conformers. 
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Figure 4.1: The 1H NMR (CDCl3, 300 MHz) and 13C NMR (CDCl3, 75.5 MHz) spectra of 51. 
 
Before studying Magnus’ methodology in context it was decided to first apply other standard 
methodologies in which hydrogenolysis with Raney Ni gave an unimpressive yield of 53%, 
while the sequential one-pot Pd-C hydrogenolysis of the Cbz benzyl followed by Zn / acetic 
acid N-N reduction gave an even worse one of only 24% overall yield. This was despite the 
fact that both reactions showed a complete conversion of the starting material on TLC. We 
were also aware of the fact that such methods would have chemoselectivity issues with 
substrates containing unsaturated functional groups. Thus Magnus’ procedure using ethyl 
bromoacetate and NaH or Cs2CO3 appeared as very attractive by comparison. Table 4.1 
below shows the results of various attempts using the Magnus conditions varying the base 
and solvent. 
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Entry Procedure Base (2.5 eq) Alkylating agent (2eq) 
Solvent  
(0.25 M) Temp (°C) Time Yield 
1 
Magnus-1 
Cs2CO3 
Methyl 
bromoacetate 
CH3CN 80 >2 d - 
2 Cs2CO3 
Ethyl 
bromoacetate 
CH3CN 80 >2 d - 
3 
Magnus-2 
NaH 
Ethyl 
bromoacetate 
Diglyme 50 17 hrs 16% 
4 NaH 
Ethyl 
bromoacetate 
CH3CN 50-80 2 d - 
5 NaH 
Ethyl 
bromoacetate 
THF 50-80 2 d - 
6 NaH 
Ethyl 
bromoacetate 
DMF 50 24 hrs 46 
 
Table 4.1: Testing the original Magnus conditions. 
 
Magnus-1 refers to the use of methyl bromoacetate and Cs2CO3 in CH3CN as a one-pot 
procedure as described by Magnus,270 while Magnus-2 refers to his later usage of ethyl 
bromoacetate as the alkylating agent and NaH with diglyme as the solvent in a one-pot 
procedure.236 The results show that the Magnus-1 conditions were completely unsuccessful 
(entries 1 and 2). No conversion of starting material was observed on reaction TLCs even 
after prolonged heating for more than two days. By comparison, the Magnus-2 procedure did 
give a level of success in diglyme (Magnus’ solvent in his original publication), using sodium 
hydride as base giving a low isolated yield of 16% (full conversion of substrate) after heating 
at 50 °C for 17 hours (entry 3). However, this protocol involved a difficult isolation due to the 
tendency of diglyme to remain associated with the product in trace amounts even after water 
washings and column chromatography. Moreover, the excessively long reaction times at 50 
°C that were needed to achieve a full substrate conversion eventually led to alkylation of the 
cleaved product, as the bromoacetate alkylating agent was in excess. Owing to the 
heterogeneous nature of this reaction, it was then decided that other solvents should be 
tested in the hope of improving solubility and, hence, the reaction yield, but both THF and 
acetonitrile gave absolutely no starting material conversion (entries 4 and 5). However, DMF 
did afford a modest improvement as the best result (46% yield) and made for an easier 
purification compared to that from the diglyme reaction. This highlighted the solvent 
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dependency of the Magnus reaction. It was therefore speculated that the Magnus protocol 
failed due to steric and stereoelectronic factors introduced by having the oxazolidinone ring, 
compared to Magnus’ alkyl and aryl substrates in an open hydrazide system. In the hope of 
addressing these issues it was decided to try another readily available ester-based alkylating 
agent in the form of diethyl bromomalonate. The expectation here was that both steps would 
be accelerated, the alkylation step because of the enhanced electrophilicity and the E1cB 
step because of enhanced acidity based on comparing malonate against acetate in the 
respective steps. Table 4.2 below shows the initial results using diethyl bromomalonate and 
varying the base from NaH to Cs2CO3. 
 
 
Entry 
Diethyl 
bromomalonate 
(eq) 
Base (eq) 
Solvent 
(0.25 
M) 
Time  
Temp 
(°C) 
Yield 
(%) 
1 2 NaH (3) THF  24 hrs 50 48 
2 2 Cs2CO3 (2.5) CH3CN  2 d RT 64 
3 2 Cs2CO3 (2.5) CH3CN  4 hrs 50 64 
4 5 Cs2CO3 (2.5) CH3CN  5 hrs 50 66 
5 2 Cs2CO3 (5) CH3CN  5 hrs 50 68 
6 5 Cs2CO3 (5) CH3CN  5 hrs 50 80 
 
Table 4.2: Initial optimisation study for N-N bond cleavage using diethyl bromomalonate. 
 
Entry 1 shows that NaH (3 equivalents added to ensure complete starting material 
conversion) in THF gave only a moderate 48% yield, despite complete hydrazide 
consumption. Attempts to improve this by lowering the temperature (longer reaction time), 
and changing the reaction solvent (to DMF or acetonitrile) led to even lower yields (29% and 
0%, respectively). However, it was good to see that the bromomalonate system was 
compatible with a more volatile organic solvent other than DMF or diglyme. Cs2CO3 was 
then tested under a range of different conditions. With 2 equivalents of bromomalonate and 
2.5 equivalents of base at room temperature and 50 °C the same 64% yield could be 
achieved (entries 2 and 3), although the reaction time was far longer at room temperature. 
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Besides the eliminated imine (see Scheme 4.1), another important reaction by-product was 
the malonate dimer (Figure 4.2) which was characterised by 1H NMR spectroscopy, and it 
was thought that its formation was contributing to the moderate yields. 
 
 
Figure 4.2: The diethyl bromomalonate dimer. 
 
Secondary alkylation of product 52 was not observed in this case, e.g. extending the time for 
the 4 hr reaction in entry 3 to 20 hours at a higher 80 °C did not result in a yield decline 
(although refluxing at 80 °C for longer than two days did result in a yield depreciation). 
Reaction TLCs revealed that some of the cleaved product was formed within a few minutes, 
while the alkylated intermediate was never observed. These observations together with the 
long reaction times indicated that the alkylation step was rate-determining (k1), with a fast 
elimination step (k2). These conclusions supported our idea of malonate being a better E1CB 
partner than the acetate. Attempts to improve the moderate yields were made by increasing 
the equivalents of bromomalonate to 5 equivalents (to compensate for reagent loss due to 
dimerisation), while keeping the base at 2.5 equivalents but this led to an increase in product 
yield of only 2% (entry 4). Similarly, increasing the equivalents of only the base to 5 while 
keeping the reagent at 2 equivalents also only led to a modest 4% yield improvement (entry 
5). However, increasing both the bromomalonate and base equivalents to 5 (entry 6) gave 
the best result, a high 80 % yield. In view of excessive cost it was decided to continue the 
study with conditions from entry 2 using room temperature with 2 equivalents of reagent and 
2.5 of base. Nevertheless it was pleasing to see that reactions could be carried out in 
acetonitrile making product isolation much easier than before with the Magnus-2 original 
procedure.  
 
It was also appropriate to determine whether the identity of the aminating agent had any 
effect on the reaction. Thus oxazolidinone-hydrazides 53 and 54 were synthesised from 
DIAD and di-tert-butyl azodicarboxylate (DTBAD) reagents, respectively. However yields 
were much lower (60% and 13% respectively) for formation of the cyclic hydrazides 
compared to the yield for DBAD (Scheme 4.4). Furthermore, while the cleavage reaction 
worked in moderate yield for the DIAD case (up to 60% with conditions (iv) in Scheme 4.4), 
the reaction failed completely in the DTBAD case, again vindicating our notion that steric 
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effects do come into play. Thus it was concluded that DBAD was the best aminating reagent 
for our strategy. 
 
 
 
Scheme 4.4: Reagents and Conditions: (i) a) decanal (1.5 eq), DIAD (1 eq), L-proline (10 
mol%), CH3CN, 0 °C to RT, 2 hrs, b) NaBH4 (1 eq), MeOH, 0 °C, 15 min; (ii) 1 M NaOH (3 
eq), RT, 2 hrs; (iii) oxazolidinone (1 eq), Cs2CO3 (2.5 eq), diethyl bromomalonate (2 eq), 
CH3CN, 80 °C, 24 hrs; (iv) oxazolidinone (1 eq), Cs2CO3 (5 eq), diethyl bromomalonate (5 
eq), CH3CN, 80 °C, 6 hrs (v) a) decanal (1.5 eq), DTBAD (1 eq), L-proline (10 mol%), 
CH3CN, 0 °C to RT, 3 hrs, b) NaBH4 (1 eq), MeOH, 0 °C, 15 min; (vi) 1 M NaOH (3 eq), 60 
°C, 24 hrs. 
 
Although oxazolidinone-hydrazides 53 and 54 weren’t pursued any further, their structures 
were confirmed using 1H and 13C NMR spectroscopy. Figure 4.3 below shows the 1H NMR 
spectrum for 53 derived from DIAD. This showed similar characteristics to those in the 
spectrum for the equivalent DBAD-derived 51 with the key difference being that benzyl 
resonances were replaced by iso-propyl resonances. Again, rotamers could be observed 
(NH resonance). 
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Figure 4.3: The 1H NMR spectrum (CDCl3, 300 MHz) of 53. 
 
4.2 The Scope of the Bromomalonate Reaction 
Chiral 2-oxazolidinones have the advantage of being important chemical building blocks 
(e.g. for the synthesis of natural products186 and antibiotics) and reagents (e.g. as chiral 
auxiliaries – Evans’ auxiliary).271 Thus, the scope of the bromomalonate methodology was 
tested using a range of oxazolidinone-hydrazides varying the C-4 substituents, chosen to 
address aspects of chemoselectivity (Table 4.3). Substrates 55 to 62 were prepared using 
the three-step sequence used to synthesise 51, which successfully yielded high yields (80-
91%) - this included the functionalised oxazolidinone-hydrazides (58 to 62) containing OBn, 
propargyl ether, aromatic, heteroaromatic or a quaternary C-4 moiety. It is also worth noting 
that oxazolidinone-hydrazide 63 (a prototype for the desymmetrisation of a bis-acetal) was 
obtained via cyclisation of α-hydrazino alcohol 48 (synthesised from the acetal methodology 
described in Chapter 3) to give the acetal-containing oxazolidinone-hydrazide in a slightly 
lower yield (72%). The ees were determined by chiral HPLC. As expected for the simple 
aldehyde cases 55 to 57 based on published cases by List and Jørgensen the ees were high 
(>90%). The more funtionalised oxazolidinone-hydrazides also gave very high ees with the 
exception of 62 (46%) due to the low enantioselectivity of the proline-catalysed α-amination 
of branched aldehydes (as mentioned in Chapter 3). Unfortunately the enantiomers of the 
bis-acetal-derived 63 were not separable by all three of the chiral columns we had available 
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(Chiralpak AD, OD and IC) even after trying several iso-propyl / n-hexane mobile phase 
mixtures. Therefore its ee was inferred from hydrazino alcohol 48 (90% ee). 
 
 
Entry Starting Material Product Yield ee 
1 
 
 
92 90 
2 
 
 
88 90 
3 
 
 
91 91 
4 
 
 
89 93 
5 
 
 
86 92 
6 
 
 
87 90 
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7 
 
 
91 86 
8 
 
 
87 94 
9 
O
H
  
80a 46 
10 
 
 
72 90b 
            
a5 eq of aldehyde used to improve reaction rate and conversion  
                   bnferred from 48. 
Table 4.3: Asymmetric synthesis of oxazolidinone-hydrazides from the corresponding 
aldehydes. 
 
All of the new compounds were fully characterised by NMR spectroscopy, infrared 
spectroscopy and high-resolution mass spectrometry, the latter in view of them being oils. 
The 1H NMR spectrum of 63 (the desymmetrisation prototype) is shown in Figure 4.4. It 
clearly shows the acetal-associated resonances – two diastereotopic methoxy singlets as 
well as a downfield H-4’ triplet. The oxazolidinone resonances appear as multiplets in the 
expected chemical shift order H51 > H4 = H52. 
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Figure 4.4: The 1H NMR spectrum (CDCl3, 300 MHz) of 63. 
 
The Cs2CO3 / bromomalonate strategy was then tested on the wide range of oxazolidinone-
hydrazides using the aforementioned conditions. The results are shown in Table 4.4. In 
general, the reaction was conducted at room temperature; however, the temperature was 
increased to 50 °C for lower yielding or slower-converting cases (entries 7 and 14). The 
switch to room temperature was made in order to discourage side-reactions, including the 
formation of a malonate dimer and the possibility of alkylating the cleaved product. 
 
 
Entry Product 
Diethyl 
bromomalonate(eq)  
Cs2CO3 
(eq) 
Temp 
(°C) 
Time 
(hrs) Yield 
1 
 
2 2.5 RT 48 64 
2 2 2.5 50 4 64 
3 5 5 50 5 80 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5
f1 (ppm)
CDCl3
Ar
N-H
Bn
H-5
H-4'
H-4, H-5
2 x OMe
H-1
H-1', H-3'
H-2'
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4 
 
2 2.5 RT 20 88 
5 
 
2 2.5 RT 20 96 
6 
 
2 2.5 RT 48 
63 
(58% 
conv) 
7 2 2.5 50 48 
65 
(58% 
conv) 
8 
 
2 2.5 RT 5 84 
9 
 
2 2.5 RT 4 81 
10 
 
2 2.5 RT 3 82 
11 
 
2 2.5 RT 2 90 
12 
 
2 2.5 RT 48 - 
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13 
 
 
2 2.5 RT 48 
57 
(89% 
conv) 
14 2 2.5 50 48 59 
  
Table 4.4: N-N Cleavage using bromomalonate with caesium carbonate as base. 
 
Generally the cleaved products were obtained in very high yields (80 – 96%) following 
column chromatography, which was higher than that for the model case (52, 64%). Reaction 
times were also faster than that of the model (as low as two hours for 70, entry 11), and 
notably improved with polarity in the C-4 substituent (67 - 70). Oxazolidinones 66 and 72 
were obtained in only moderate yields (63% and 57%, respectively) and for some reason 
that couldn’t be ascertained struggled to go to full conversion even at 50 °C (entries 6/7 and 
13/14). Entry 12 shows how the quaternary case failed to give a reaction product (71). 
Indeed, even though reaction TLCs showed some (though not complete) conversion of the 
starting material, what was believed to be product 71 co-eluted with reaction by-products 
(which were not quite visible on TLCs) during column chromatographic purification. 
Nevertheless this Table clearly shows that our methodology can successfully be applied to a 
wide range of azatertiary substrates at room temperature, and without the need for a large 
excess of malonate or base (2 and 2.5 equivalents, respectively) for high yields. 
 
In view of the high cost of Cs2CO3, K2CO3 was also tested as a cheaper alternative. Table 
4.5 shows the results of this study. 
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Entry Product 
Diethyl 
Bromomalonate 
(eq)  
K2CO3 
(eq) 
Temp 
(°C) 
Time 
(hrs) Yield 
1 
 
2 2.5 RT 23 90 
2 
 
2 2.5 RT 48 61 
3 2 2.5 50 40 30 
4 
 
2 2.5 RT 48 62 
5 2 2.5 50 40 42 
6 
 
2 2.5 RT 48 
76 
(85% 
conv) 
7 2 2.5 50 48 
68 
(59% 
conv) 
8 
 
2 2.5 RT 24 82 
9 
 
2 2.5 RT 24 80 
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10 
 
2 2.5 RT 20 84 
11 
 
2 2.5 RT 24 75 
12 
 
2 2.5 RT 48 
86 
(70% 
conv) 
 
Table 4.5: Potassium carbonate study. 
 
Here reactions needed longer times, and yields were generally a little lower except for the 
model 52 (entry 1) which went from 64 to 90%. Starting material conversion and yields were 
also improved for 66 (76%, entry 6) and 72 (86%, entry 12) compared to using Cs2CO3. 
Products 64 and 65 were obtained in significantly lower yield (61% and 62%, respectively) 
than when using Cs2CO3, and increasing the reaction temperature to 50 °C led to a 
substantial drop in yield for both products (entries 3 and 5). However, the results of this 
study showed that both Cs2CO3 and K2CO3 are suitable bases for this reaction although 
reactions with them are substrate-dependent. Moreover, apart from a few cases, room 
temperature was far superior to 50 °C for this modified-strategy giving very high yields. 
Finally, the chemoselectivity profile was attractive in that many of the functional groups 
certainly wouldn’t have survived Raney-Nickel conditions. 
 
Another aspect to note was that the cleaved oxazolidinones gave much better resolved 1H 
NMR spectra due to the absence of conformers and rotamers associated with the Cbz-
hydrazide. This is exemplified by the 1H NMR spectrum for 72 shown in Figure 4.5 in which 
resonances are pleasingly resolved.  
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Figure 4.5: The 1H NMR spectrum (CDCl3, 300 MHz) of 72. 
 
In order to test the solvent dependency observed in Magnus’ original protocols (Table 4.2), a 
solvent study was conducted using potassium carbonate as base. The results are shown in 
Table 4.6 below using oxazolidinone-hydrazide 51 as the substrate. As seen in entry 1 
acetonitrile was the best solvent, giving a 90% yield. DMF (entry 3) did not perform as well 
as it did under Magnus-2 conditions, only returning a 30% yield. Toluene gave a moderate 
44% yield (entry 3) and methanol (entry 4) gave no reaction due to destruction of the 
bromomalonate as seen on reaction TLCs (the starting material was recovered and analysed 
by 1H NMR to confirm this conclusion). Reaction times were also considerably longer with 
solvents other than acetonitrile. 
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Entry 
Hydrizide 
(eq) 
Diethyl 
bromomalonate 
(eq) 
K2CO3 (eq) 
Solvent 
(ml) 
Time 
(hrs)  
Temp 
(°C) 
Yield 
(%) 
1 1 2.5 2 CH3CN 23 RT 90 
2 1 2.5 2 DMF 72 RT 30 
3 1 2.5 2 Toluene 72 RT 44 
4 1 2.5 2 Methanol 43 RT 0 
 
Table 4.6: Solvent study. 
 
Mechanistic considerations suggest that our modified Magnus methodology follows the 
same E1cB pathway (Scheme 4.5). As discussed earlier, the TLC results indicate that the 
rate-determining step is the SN2 alkylation step. This suggests that the improved results 
compared to using Magnus’ conditions are due to rate improvements in the alkylation and 
elimination steps as mentioned previously due to the superior characteristics of 
bromomalonate compared to bromoacetate. We also wondered whether our conditions for 
the reaction owed their success to having a cyclic template as the leaving group in the E1cB 
step. To address this possibility, the hydroxyl group of hydrazino alcohol 41 (synthesised 
from decanal) was TBDPS-protected and the product was reacted under our new conditions. 
However, no reaction occurred with either K2CO3 or Cs2CO3 as base, with only starting 
material (which was isolated from the reaction mixture and whose structure was confirmed 
by NMR spectroscopy) visible on TLC together with the bromomalonate and its dimer. These 
results suggest that our conditions do profit from something in the cyclic template, possibly 
to do with pre-organisation (stereoelectronics) in the elimination. However it doesn’t explain 
why Magnus’ conditions were pretty ineffective in our (cyclic) system. 
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Scheme 4.5: Likely E1cB mechanism for this modified Magnus strategy. 
 
Since no racemisation is possible during the N-N bond cleavage procedure due to low 
likelihood of carbanion formation at the chiral centre, the ees of the cleaved products were 
expected to remain unchanged from their original values (Table 4.1). However, chiral HPLC 
was once again utilised in order to confirm this. Owing to the absence of a UV-active 
chromophore in their structures, products 52, 64, 65 and 66 were Cbz-derivatised in 
reasonable yields (72-80%) to give UV-active products for HPLC analysis (Scheme 4.6). 
Unfortunately the Cbz protection of 68 and the acetal 72 couldn’t be performed because the 
substrates decomposed, even though they had been stored at -22 °C. 
 
Scheme 4.6: The Cbz-derivatisation of cleaved products. 
 
All these derivatives were new compounds and thus their structures were elucidated using 
the full gamut of 1H NMR, 13C NMR and infrared spectroscopies in addition to high-resolution 
mass spectrometry. As an example, Figure 4.6 depicts the 1H NMR spectrum of 74. As 
expected, the downfield NH resonance was replaced by benzyl resonances in the aliphatic 
and aromatic regions. 
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Figure 4.6: The 1H NMR spectrum (CDCl3, 300 MHz) of 74. 
 
The HPLC data from these compounds confirmed that the N-N bond cleavage step had not 
led to racemisation at C-4. Figure 4.7 compares HPLC chromatograms for the decanal-
derived oxazolidinone hydrazide 52 and its N-N cleaved and Cbz-protected analogue 73, 
which show a consistently high enantiomeric ratio of 95:5 for 52 and 92:8 for 73 (the slight 
differences in er for this and all other cases are a result of how well the chiral columns were 
able to separate the enantiomers). 
 
 
Chiralpak OD 10% i-Pr in n-Hexane, 258 nm and 0.3ml/min 
 
1.52.02.53.03.54.04.55.05.56.06.57.07.5
ppm
CDCl3
Ar
Bn
H-5, H-4
H-5
H-6
 
 
 
Oxazolidinone 52 
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Chiralpak OD 10% i-Pr in n-Hexane, 258 nm and 0.3ml/min 
  
Figure 4.7: A comparison of the HPLC chromatograms of product 52 and 73 showing a 
consistent enantiomeric ratio between the two products. 
 
Figure 4.8 shows the HPLC determined ees of the range of cleaved oxazolidinones 
produced.  
O
O NCbz
73 83% ee
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O
O NCbz
74 95% ee
O
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O NH
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N
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Figure 4.8: The ees of the final oxazolidinone products. 
 
In conclusion, a modified Magnus protocol was developed for the N-N bond cleavage of 
enantioenriched oxazolidinone-hydrazides. Its successful application to the acetal-containing 
oxazolidinone-hydrazide 63 opened up the way forward for bis-acetal desymmetrisation 
transformations. However, the decomposition of the cleaved oxazolidinone containing the 
acetal in the chain (72) was worrying and we hoped that this wouldn’t be a general trend for 
other bis-acetal hydrazide-cleaved products. 
  
Cbz-protected 73 
 134 
 
Chapter 5: The Desymmetrisation 
With new acetal α-amination and N-N bond cleavage methodologies developed and 
optimised, it was time to apply them to the desymmetrisation of bis-acetals.  
 
5.1 Synthesis of the Symmetrical Substrates 
Following the work presented in Chapter 2, a range of symmetrical, prochiral bis-acetal 
substrates needed to be synthesised. Thus three appropriate pathways were envisioned: 1) 
a divergent malonate-based strategy; 2) a divergent sulfone-based strategy; and 3) a far 
shorter 3-cyclopentene-based strategy. The chief goal was to develop a representative 
library of substrates containing a prochiral centre varying the A-value of the central 
substituent. 
 
5.1.1 The Divergent Malonate Strategy 
Allyl ester 36, whose synthesis was described in Chapter 2 using a malonate diallylation / 
decarboxylation sequence, was converted into bis-acetal ester 77 en route to the final benzyl 
ether derivative (Chapter 2), and this bisacetal ester 77 was identified as the starting 
material for two other derivatives, 79 and 80, varying the prochiral groups (Scheme 5.1). 
 
 
Scheme 5.1: Reagents and Conditions: (i) a) NaH (2.5 eq), THF, 45 min, 0 °C to RT, b) allyl 
bromide (2 eq), 26 hrs, reflux; (ii) LiCl (2.2 eq), DMSO (with a little H2O), 21 hrs, 180 °C; (iii) 
a) O3, MeOH, 30 min, -78 °C to 0 °C, b) PPh3 (2.2 eq), 2 hrs, 0 °C to RT, c) p-TSA (20 
mol%), 18 hrs, reflux.  
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Thus, through the tandem ozonolysis / acetalisation procedure described in Chapter 2, bis-
acetal 77 was synthesised from 36 over three steps and in a modest 37% yield after column 
chromatography. This lower yield was attributed to the fact that complete conversion of the 
bis-aldehyde (as judged by TLC) required refluxing for 26 hours. This in turn led to additional 
by-products related to the acetalisation intermediates. Figure 5.1 below shows the 1H NMR 
spectrum of bis-acetal 77, which displayed characteristic acetal-related resonances (two 
methoxy singlets and an H-4 triplet) as well as a set of ethyl ester resonances (an upfield 
triplet and downfield quartet). In this case the symmetrical H-3 protons of the chain resolved 
into a doublet of doublet of doublets (ddd) due to geminal coupling between the two 
diastereotopic H-3 protons (J = 13.7 Hz), coupling with H-2 (J = 7.5 Hz) and coupling with H-
4 (J = 5.3 Hz). This new compound was characterised with the use of 1H, 13C NMR and 
infrared spectroscopies as well as high-resolution mass spectrometry.  
 
 
Figure 5.1: The 1H NMR spectrum (CDCl3, 300 MHz) of 77. 
 
Bis-acetal 77 was then used to attempt the preparation of the other two targets 79 and 80. 
The first one, amine 79, protected as a Boc carbamate, was envisaged as being accessible 
via transposition of the ester group to an amine using the well-known Curtius rearrangement 
via an acyl azide. To this end, 77 was hydrolysed with KOH under ethanol reflux for 2 hours, 
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to give acid 78 as a crude product. The success of this transformation was judged by TLC 
analysis which showed the complete conversion of 77 to a more polar product that streaked 
on the TLC plate. This was expected because of greater hydrogen bonding interactions of 
the more polar carboxylic acid with the silica stationary phase. A Curtius rearrangement of 
78 was then attempted. This involved reaction with diphenylphosphoryl azide (DPPA) and 
triethylamine (one equivalent each) in order to generate an acyl azide. After four hours of 
refluxing in toluene, reaction TLCs showed complete conversion of the acid to two non-polar 
products, one of which appeared as a major spot hypothesised to be the rearranged 
isocyanate. Addition of four equivalents of butanol to the reaction in the hope of effecting an 
addition to the said isocyanate to furnish the corresponding Boc-carbamate followed by a 
further heating of 18 hours unfortunately gave a very complicated TLC reaction profile with 
no real major product. Scheme 5.2 summarises the chemistry. At this point an alternative 
target was pursued.   
 
 
Scheme 5.2: The attempted Curtius rearrangement. 
 
For the second derivative 80, the idea was to α-alkylate ester 77 to generate a quaternary 
centre at the prochiral carbon. To this end, 77 was treated with KHMDS at -78 °C in order to 
generate the ester enolate, always keeping the temperature low to avoid side-reactions 
(such as elimination to the ketene). The reaction was then warmed up after addition of 
benzyl bromide (intended to provide some bulk at the prochiral centre and as a reactive SN2 
electrophile). However, no conversion of starting material was observed by TLC. Thinking 
that the problem was in the deprotonation step, the enolate generation was allowed to warm 
to room temperature before cooling and adding the electrophile. The solution was then 
allowed to warm to RT after adding the electrophile as before, but still no product was 
produced after 24 hours, with only starting material and benzyl bromide showing on TLC. 
The starting material was isolated after the reaction work-up and analysed by 1H NMR 
spectroscopy to confirm this conclusion. In retrospect, alkylation with a smaller electrophile 
should have been carried out, but this route was also not pursued any further. Scheme 5.3 
summarises the relevant chemistry. 
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Scheme 5.3: The attempted alkylation of 77. 
 
Bis-acetal 77 was nevertheless successfully transformed via reduction and subsequent 
benzylation as described previously to produce 40 bearing a benzyloxymethyl substituent in 
a 46% yield over two steps, following column chromatography (Scheme 5.4). The product 
gave satisfactory spectroscopic and analytical (HRMS) data. 
 
 
Scheme 5.4: Reagents and Conditions: (i) LiAlH4 (1.6 eq), THF, 4 hrs, 0 °C to RT; (ii) a) 
NaH (1.2 eq), THF, 1.25 hrs, 0 °C to RT, b) benzyl bromide (1.5 eq), TBAI (10 mol%), 18 
hrs, RT. 
 
5.1.2 The Divergent Sulfone Strategy 
In view of the problems just described in generating a range of derivatives bearing different 
substituents at the all-important central prochiral carbon, it was decided to invest time into an 
alternative alkylation strategy based on the α-carbanionic and reductive chemistry of 
sulfones. Thus, as shown in Scheme 5.5, using sulfone functionality as the pivot a divergent 
sequence was pursued involving thiophenol alkylation, oxidation, double allylation, reductive 
cleavage and ozonolysis / acetalisation. In such a way an R-group could be introduced at the 
prochiral carbon from an alkyl or benzyl halide, the latter providing a phenyl group at the said 
centre ultimately. This relatively straightforward 5-step procedure was cheap and relatively 
simple to carry out from readily available starting materials (thiophenol and alkyl- or benzyl 
halides). Three R-substituents were targeted as phenyl, methyl and t-butyl. Scheme 5.5 
summarises the overall sequence: 
 
Scheme 5.5: An overview of the sulfone synthetic strategy. 
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The full details are given in Scheme 5.6: 
 
Scheme 5.6: Reagents and Conditions: (i) Thiophenol (1 eq), K2CO3 (1.1 eq), RCH2X (X = 
Br or I, 1 eq), DMF, 18 hrs, RT (100 °C for R = t-Bu); (ii) sulfide (1 eq), m-CPBA (3.5 eq), 
DCM,18 hrs, 0 °C to RT (or CH3CN, 50 °C); (iii) a) sulfone (1 eq), n-BuLi (1.1 eq), THF, 30 
min, 0 °C to 66 °C, b) allyl bromide (1 eq), 1 hr, RT to 66 °C, c) n-BuLi (1.1 eq), 30 min, 0 °C 
to 66 °C, d) allyl bromide (1 eq), 1 hr, RT to reflux; (iv) diallyl sulfone (1 eq), Mg (36 eq), 
MeOH, 3 hrs, 50 °C; (v) O3, MeOH, 30 min, -78 °C to RT, b) PPh3 (2.2 eq), 2 hrs, 0 °C to RT, 
c) p-Tosic acid (20 mol%), 21 hrs, 65 °C. 
  
Thus, in the first step, thiophenol was alkylated with either an alkyl or benzyl halide in the 
presence of K2CO3 according to the Zhang procedure272 to generate derivatives 81-83. 
Reaction TLCs showed the tert-butyl alkylation to be particularly sluggish (due to steric 
hindrance), which required heating to 100 °C to achieve complete starting material 
conversion. The crude product in each case was then oxidised with an excess of m-CPBA. 
The reactions could be followed by TLC in which the non-polar sulfide converted first to a 
relatively more polar sulfoxide and then to the slightly less polar sulfone. In the case of the 
methyl and t-butyl products full conversion of the sulfoxide required overnight heating at 50 
°C in acetonitrile. Column chromatographic purification gave the desired sulfones in 
moderate to good yields, with the methyl sulfone 82 giving the highest yield (78% over two 
steps). The suggested mechanism for the oxidation is illustrated in Scheme 5.7. The 
nucleophilic thiol attacks the more electrophilic peracid oxygen, with the resonance-
stabilised carboxylate ion acting as the leaving group. Deprotonation of the 
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hydroxysulfonium cation yields the sulfoxide intermediate, which is followed by a second 
oxidation in a similar fashion.  
 
Scheme 5.7: The suggested mechanism for sulfide oxidation to a sulfone. 
 
Sulfones 81 and 82 are known compounds whose 1H NMR data agreed with the 
literature.273,274 Additional analysis techniques (13C NMR and infrared spectroscopy as well 
as high-resolution mass spectrometry) were utilised to elucidate the structure of 83 as a new 
compound. Figure 5.2 shows its 1H NMR and 13C NMR spectra, which revealed a singlet for 
the methylene hydrogens confirming a sulfone since for a sulfoxide an AB pair of doublets 
would have been expected due to a pair of diastereotopic methylene hydrogens as a result 
of chirality at sulfur. Similarly, a methylene carbon resonance at 67.7 ppm was consistent 
with the more electron-withdrawing sulfone functionality rather than sulfoxide. Finally, the 
tert-butyl group was clearly discernible in both sets of spectra. 
 140 
 
  
  
Figure 5.2: The 1H NMR (CDCl3, 300 MHz) and 13C NMR (CDCl3, 75.5 MHz) spectra of 83. 
 
 
S
O
O
83
 
 141 
 
Next in this synthetic strategy was the diallylation step. Initially, phenylated derivative 81 was 
chosen to take through. Refluxing 81 in THF with an excess of NaH and allyl bromide (3.5 
equivalents each, similar to the malonate diallylation in Scheme 5.1), unfortunately gave a 
very low product yield (25%) due to low starting material conversion. It was therefore 
postulated that the heterogeneity of the NaH medium was hampering the sulfone 
deprotonation, thus NaH was replaced by n-BuLi (1.4 M in toluene). This modification, 
however, didn’t result in any yield improvement either, and was rationalised as due to n-BuLi 
reacting with the allyl bromide in situ. In order to address this, it was decided to perform the 
deprotonation and allylation steps separately with a minimum amount of base and allyl 
bromide. This involved first adding one equivalent of n-BuLi at 0 °C and warming the 
reaction to 66 °C in THF for 30 minutes in order to achieve complete deprotonation of the 
first acidic proton, followed by addition of one equivalent of allyl bromide at room 
temperature and heating to 66 °C over an hour at which time complete conversion of the 
sulfone to a less polar product was observed by TLC. The second allylation was achieved in 
the same way, with the same temperatures and times, which resulted in diallylated product 
84 being isolated in an improved 56% yield following column chromatography. 
 
The formation of highly non-polar by-products as observed on reaction TLCs during both 
allylation steps suggests that high yields (>75%) here were unobtainable. Application of this 
sequential one-pot diallylation sequence to the methyl and t-butyl sulfones 82 and 83 
respectively resulted in yields of 35% for 85  and 65% for 86. A highly speculative 
explanation for the higher t-butyl yield is the greater inductive electron releasing effect of the 
t-butyl, which gives rise to a more reactive carbanion (higher energy HOMO for this soft 
nucleophile). All three allyl sulfones are unknown compounds and were thus fully 
characterised using 1H NMR, 13C NMR and infrared spectroscopy as well as high-resolution 
mass spectrometry. Figure 5.3 shows the 1H and 13C NMR spectra obtained for 85 bearing a 
methyl group at the prochiral carbon. The most interesting resonances of the 1H NMR 
spectrum are the doublet of doublet of triplets seen for the symmetrical and diastereotopic H-
3/5 nuclei. This complicated multiplicity can be explained by virtue of geminal coupling with 
the other H-3/5 proton (J = 14.4 Hz), vicinal coupling with the H-2/6 proton (J = 6.9 Hz) and 
allylic coupling with the two H-1/7 protons (J = 1.2 Hz). The mirror-plane symmetry of this 
compound resulted in a very simple 13C NMR spectrum, which displayed a deshielded 
quaternary C-4 at 65.2 ppm due to the sulfone inductive electron-withdrawing effect. 
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Figure 5.3: The 1H NMR (CDCl3, 300 MHz) and 13C NMR (CDCl3, 75.5 MHz) spectra of bis-
acetal 85. 
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The penultimate step of this strategy involved cleavage of the sulfonyl moiety via reductive 
desulfonylation (replacement of a carbon-sulfur bond with a carbon-hydrogen bond). This 
was done according to Tunge’s procedure275 with activated Grignard magnesium in 
methanol at 50 °C. The suggested mechanism for the reaction is shown in Scheme 5.8. 
Single-electron transfer from magnesium to one of the sulfone oxygens generates a radical 
anion, which cleaves with expulsion of a stabilised phenylsulfinate ion generating the alkyl 
radical of the organic chain. Further electron transfer to the chain radical followed by 
carbanion protonation (MeOH) generates the reduced product. Of importance was the 
regioselective fragmentation to afford the alkyl radical in preference to the aryl radical 
alternative, presumably because of the partial double-bond character of the S-aryl bond 
(hence stronger) due to resonance between the ring and the sulfonyl group. 
 
Scheme 5.8: The suggested mechanism for reductive desulfonylation. 
 
Simple purification by filtration over a pad of silica gel gave the phenyl product 87 in a good 
78% yield. The 1H NMR spectrum of 87, a known compound, agreed with the literature.276 As 
Figure 5.4 shows, the expected allyl and aryl multiplets were observed with the correct 
integration. 
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Figure 5.4: The 1H NMR spectrum (CDCl3, 300 MHz) of 87. 
 
Unfortunately the cleavage of 85 (R = Me) and 86 (R = t-butyl) to give products 88 and 89 
respectively gave less favourable results (8% and 18% yield, respectively). Both reactions 
did not give a clean reaction product and Figure 5.5 shows the tert-butyl case as an 
example. Reaction TLCs showed a number of very non-polar products which were difficult to 
separate from 89 (also a very nonpolar compound), even after column chromatography. The 
extra resonances in the downfield vinyl region suggest that the phenylsulfinic acid by-product 
of this reaction (Scheme 5.8) was promoting side-reactions such as allyl shifts. Thus an 
alternative sulfone cleavage method will need to be employed in the future in order to 
improve yields and purity for 88 and 89. 
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Figure 5.5: The 1H NMR spectrum (CDCl3, 300 MHz) of 89. 
 
In spite of these issues we were gratified to have access to phenyl diallyl intermediate 87 for 
taking through for evaluation of the desymmetrisation methodology. Tandem ozonolysis / 
acetalisation of 87 yielded bis-acetal 90 in a modest 39% yield following column 
chromatography. Figure 5.6 displays its 13C NMR spectrum, which was used, in addition to 
1H NMR and infrared spectroscopy together with high-resolution mass spectrometry, to 
characterise this new compound. The acetal methoxy and methine resonances as well as 
the downfield aromatic resonances provided diagnostic features in support of the assigned 
structure. 
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Figure 5.6: The 13C NMR spectrum (CDCl3, 75.5 MHz) of 90. 
 
5.1.3 The Cyclopentenyl Strategy 
This was the simplest strategy of all since it involved direct tandem ozonolysis / acetalisation 
of a commercially available symmetrical 4-substituted cyclopentene. However, there wasn’t 
a wide range of commercially available options, which were in any case expensive and in 
which 3-cyclopentenol turned out to be the cheapest one. The conversion of this to the 
desired bis-acetal 92 is shown in Scheme 5.9 below.  
 
 
 
Scheme 5.9: Reagents and Conditions: (i) a) NaH (1.2 eq), THF, 1.25 hrs, 0 °C to RT, b) 
benzyl bromide (1.5 eq), TBAI (10 mol%), 19 hrs, 66 °C; (ii) a) O3, MeOH, 30 min, -78 °C to 
0 °C, b) PPh3 (2.2 eq), 2 hrs, 0 °C to RT, c) p-Tosic acid (20 mol%), 43 hrs, 65 °C. 
 
Benzyl protection of 3-cyclopentenol with benzyl bromide was conducted to prevent the 
hydroxyl group from competing as the nucleophile later in the envisaged bis-acetal α-
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amination reaction. This benzylation reaction was conducted under the same conditions as 
in earlier reactions (e.g. Scheme 5.1) using a slight excess of NaH and benzyl bromide and 
a catalytic amount of TBAI to improve the electrophilicity of the benzyl bromide by converting 
it to benzyl iodide (C-I bond is longer and weaker). This gave 91 happily in quantitative yield. 
Figure 5.7 shows the 1H NMR spectrum obtained for 91, which agreed with the literature.277 
The most prominent resonances were the downfield H-1; benzyl methylene; and the vinyl H-
3/4 resonances. This spectrum also clearly reflects the mirror-plane symmetry of this 
compound.  
 
 
Figure 5.7: The 1H NMR spectrum (CDCl3, 300 MHz) of 91. 
 
Tandem ozonolysis / acetalisation of 91 gave bis-acetal 92 in 35% yield following column 
chromatography, a yield similar to most of the other bis-acetals. The 13C NMR spectrum of 
92, a new compound, is shown below in Figure 5.8. It clearly shows the acetal-related 
resonances (two methoxy resonances representing two sets of diastereotopic methoxy 
carbons, and the very downfield C-1/5 methine resonance) as well as OBn-related 
resonances in the aliphatic and aromatic regions. As expected, the central C-3 nucleus was 
deshielded by the adjacent oxygen and thus had a 71.4 ppm chemical shift. 
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Figure 5.8: The 13C NMR spectrum (CDCl3, 75.5 MHz) of 92. 
 
Thus, four symmetrical bis-acetals were synthesised using three different strategies. 
Scheme 5.10 shows these compounds in order of increasing steric bulk on the central 
carbon according to R group A-values. This range of substrates was thus seen as suitable 
for testing our desymmetrisation hypothesis. 
 
 
Scheme 5.10: The synthesised bis-acetals in order of increasing steric bulk on the central 
carbon. 
 
5.2 The Desymmetrisation Reaction 
With a small library of bis-acetals in hand, it was finally time to perform the desymmetrisation 
reaction (Scheme 5.11). The reaction was hoped to proceed in the same way as in the 
acetal model study where an enamine generated from the bis-acetal and organocatalyst 13 
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nucleophilically adds to DBAD to give the desymmetrised aminated product following 
enamine hydrolysis.  
Scheme 5.11: The bis-acetal desymmetrisation 
 
Once again, in developing a model to accommodate stereoselectivity aspects, for simplicity’s 
sake only one of the (equivalent) substrate forms (with the R1-group at the prochiral centre 
wedged) will be considered, in which the two enamines formed on the left or the right 
enantiotopic arms of the symmetrical substrate are illustrated (Scheme 5.12). The success 
of the 1,1,6,6-tetramethoxyhexane (TMH) amination in the model study confirmed that it was 
possible to generate a mono-enamine. Furthermore, the mechanistic discussions in Chapter 
3 showed that the mono-enamine here would likely have an E-s-trans geometry. The two 
enamines generated are diastereomers (shown in Scheme 5.12) and expected to be very 
similar in energy (but not equal), and as such they would both be present in approximately 
equal amounts.  Owing to the hydrogen bonding network on the enamine re-face (syn to the 
chiral centre), enamine addition to the electrophile would be favoured as syn. This leads to 
the conclusion that addition to the right-hand enantiotopic arm to give Y with anti- relative 
stereochemistry would be kinetically favoured over that involving the left to give X with syn- 
relative stereochemistry as a result of anticipated lower non-bonded interactions between 
the hydrogen-bonded electrophile and the R1-group at the prochiral centre. Thus the bis-
acetal desymmetrisation would be achieved in an enantioselective fashion regarding the 
discrimination of the enantiotopic arms, as well as with an anti-diastereoselectivity. A 
chemoselectivity was also anticipated (already shown in the model reaction with TMH) by 
using excess substrate in which α-amination was expected to occur on one acetal group 
whilst leaving the other intact. Thus a chemo-, and diastereoselective desymmetrisation to 
produce an enantioenriched product was hoped for. 
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Scheme 5.12: Kinetic evaluation of the stereoselectivity in the bis-acetal α-amination. 
 
In testing this hypothesis in the laboratory, the knowledge gained from the extensive model 
study in Chapter 3 was expected to help considerably. Bis-acetal 40 was the first substrate 
chosen as it was available in good amount and also had reasonable steric bulk to test out 
the model. In carrying out the desymmetrisation reaction (as shown in Scheme 5.13) a few 
challenges were anticipated such as difficulties in isolating the product as separate 
diastereomers, as well as obtaining good 1H and 13C NMR spectra in view of the greater 
conformational complexity in the desymmetrised products. Nevertheless, reaction conditions 
were chosen based on the optimised conditions from the tetramethoxyhexane (TMH) model 
study (Scheme 5.13). As with TMH a reasonably large excess of substrate was used (5 
equiv) to maximise mono-amination. The reaction was carried out in DCM (0.5 M) at 4 °C 
with tetrazole catalyst 13 (20 mol%), MCA and TFA (5.2 and 0.1 eq, respectively) and 5 
equivalents of water. Thus a high DBAD:acid ratio was maintained in order to ensure good 
“enantioselectivity. The amination was complete as judged by consumption of DBAD on TLC 
within 29 hrs. This was 22 hours longer than the corresponding TMH reaction, and attributed 
to the greater steric hindrance due to the substituent at the prochiral centre close by. 
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Following column chromatography hydrazino alcohol 93 was isolated in 35% yield as a 
mixture of diastereomers (although TLC analysis did suggest that separation of the 
diastereomers was possible by preparative TLC). Subsequent careful HPLC studies 
revealed a dr of about 3:2. This low yield (40% lower than the TMH reaction) was attributed 
to minor by-products associated with bis-acetal hydrolysis however, it was possible to 
recover about 50% of the excess bis-acetal starting material through column 
chromatography. 1H NMR analysis revealed that the hydrazino alcohol 93 (even after 
separation as a single diastereomer) gave a highly complex set of resonances due to 
hydrazide conformers, thus it was decided to characterise the desymmetrisation products as 
oxazolidinones, which was easily achieved at room temperature using NaOH in methanol, 
Scheme 5.13. Consequently, the 3-step sequence to oxazolidinone hydrazides was 
conducted in one pot (as in Chapter 4) in all future cases. 
 
 
Scheme 5.13: The desymmetrisation of bis-acetal 40. 
 
Through careful flash column chromatography and preparative TLC it was possible to 
separate the diastereomers of oxazolidinone 94. The 1H NMR spectrum of the major 
diastereomer of 94 is shown below in Figure 5.9. Similar to the oxazolidinones described in 
Chapter 4, the spectrum was far more resolved than that of alcohol 93 and the oxazolidinone 
resonances followed the chemical shift order H-51 > H-4 ≥ H-52. The H-4’ and the Cbz benzyl 
methylene resonances had a similar chemical shift, resulting in a complex 4.00 – 4.50 ppm 
region, although the AB system for the benzyl ether diastereotopic methylene protons could 
clearly be seen. Finally, the presence of only one acetal functionality was confirmed by two 
diastereotopic methoxy singlets (in very close proximity) integrating for 6H. In support of 
these assignments, the 13C NMR spectrum displayed the oxazolidinone ring resonances, 
which appeared in the expected chemical shift order C-5 > C-4. In the same region, the 
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benzyl ether and Cbz benzyl resonances were also visible. The presence of an acetal group 
was confirmed by the highly deshielded acetal carbon resonance (105 ppm), as well as the 
two methoxy resonances (which in this case overlapped). This new compound was 
characterised using 1H NMR, 13C NMR and infrared spectroscopies in addition to high-
resolution mass spectrometry as it was an oil. Furthermore the infrared spectrum was very 
helpful in confirming the presence of two carbonyl groups – C-2 and the Cbz carbonyl at 
1775 and 1716 cm-1 respectively. 
 
 
Figure 5.9: The 1H NMR spectrum (CDCl3, 300 MHz) of 94. 
 
The ees and drs were once again determined using chiral HPLC. Figure 5.10 shows the 
HPLC results obtained when using a Chiralpak AD column. The chromatogram of the major 
diastereomer for the racemic reaction (carried out with DL-Proline) is shown first. This was 
compared with the chromatogram of the same diastereomer from the chiral reaction and the 
ee was determined to be 76% (88:12) based on the peak area ratio between the two peaks. 
HPLC analysis of the minor diastereomer also gave the same ee value of 76%. This ee was 
good, but lower than that from the TMH model reaction (88% as 94:6) under the same 
conditions which was attributed to the longer reaction time. Nevertheless, the good ee 
demonstrated that the bisacetal desymmetrisation could in fact be achieved with a fair 
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degree of enantioselectively. We expected the diastereomeric mixture of 94 to separate into 
four distinct peaks (representing the major and minor enantiomers from each diastereomer 
according to the 2n stereogenicity rule). Unfortunately the AD column did not give good 
separation of the diastereomeric mix (Figure 5.10, third chromatogram). However, the 
Chiralpak OD column was more effective at separating the diastereomers (although the 
minor enantiomers of each diastereomer co-eluted, see later in Figure 5.11). Thus the dr 
was determined as 60:40 and happily, the ee values were consistent with those given by the 
AD column. This was certainly a lower dr than we had hoped given our desymmetrisation 
hypothesis thus an optimisation study was embarked on to try to improve both yield and 
diastereoselectivity. 
 
 
* Chiralpak AD column, 10% i-Pr in n-hexane, 258 nm and 0.5 ml/min 
 
 
 
* Chiralpak AD column, 10% i-Pr in n-hexane, 258 nm and 0.4 ml/min 
Figure 5.10: The racemic and chiral HPLC chromatograms of 94 given by the AD column. 
Major Diastereomer 
Racemic 
 
Two enantiomers of the major Diastereomer with 
(S)-catalyst 
76% ee 
Diastereomeric Mixture with (S)-catalyst 
76% ee  
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In order to try to improve the modest yield and diastereoselectivity, the reaction conditions 
were revisited. Table 5.1 below shows the results obtained for oxazolidinone 94 in the brief 
optimisation study conducted. From the exhaustive studies presented in Chapter 3 it was 
known that the DBAD, acid and water equivalents were at optimal levels in order to ensure 
high enantioselectivity. Therefore, solvent amount (concentration) and temperature were the 
only remaining parameters that could be manipulated whilst minimising chances of 
compromising the enantioselectivity. The temperature could be lowered (perhaps to -22 °C 
as in the aza-Michael model in Chapter 2), however this would have increased the reaction 
time significantly with the risk of product racemisation. Thus dilution was judged as the best 
option to focus on, hoping that the more dilute medium would decrease the bis-acetal by-
products and improve the reaction yield. Dilution had also been shown to improve 
enantioselectivity in Chapter 3 (Table 3.3). The results of this optimisation study are 
displayed in Table 5.1. 
 
Entry DCM (M) H2O (eq) MCA (eq) Time  
Temp 
(0C) 
Yield 
(%) ee (%) dr 
1 0.5 5 5.2 + 0.1 eq TFA 29 hrs 4 35 76 6:4  
2 0.1 5 5.2 + 0.1 eq TFA 3 d 4 40 78 6:4  
3 0.05 5 5.2 + 0.1 eq TFA 3 d 4 61 80  74:26  
 
Table 5.1: Desymmetrisation of bis-acetal 40. 
 
Entry 1 shows the baseline case with a 0.5 M concentration and 35% yield. Entries 2 and 3 
show the positive effect of diluting the medium to 0.1 and 0.05 M, respectively. As expected, 
this led to a lower rate (3 days for both reactions). The best results were obtained at a 0.05 
M concentration to give a 61% yield, 80% ee (for both separated diastereomers) and 7:3 dr. 
Figure 5.11 shows the HPLC chromatogram of a diastereomeric mixture from this 0.05 M 
reaction), using the Chiralpak OD column. With this data the enantioselectivity of the 
diastereomers could only be determined as an average based on the peak-area ratio 
between the sum of the major enantiomers and the minor enantiomer mixture [(A+C) : B]. 
This was calculated to be 90:10, to give an 80% ee. The dr was determined using the peak 
area ratio between the major enantiomer of each diastereomer (C : A) to give a dr of 74:26. 
Perhaps diluting the reaction even further would have yielded a better diastereoselectivity, 
however this would have slowed things down too much. The absolute configuration was not 
determined, but from the acetal model study results it was expected that the aminated centre 
would have an (R)- configuration. Therefore, an anti-diastereoselectivity would translate to 
an (S)- configuration in the major diastereomer at the prochiral centre C-3. 
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* Chiralpak OD column, 10% i-Pr in n-hexane, 258 nm and 0.4 ml/min 
 
Figure 5.11: The HPLC chromatogram of the diastereomeric mixture of 94 using the OD 
column. 
 
As further support of proof of concept, the desymmetrisation was also performed on bis-
acetal 90 bearing a phenyl group at the prochiral centre. Because phenyl has a higher A-
value than a benzyloxymethyl ether group, it was hoped this would improve the 
diastereoselectivity by ensuring better facial discrimination in the transition-state. As shown 
in Scheme 5.14, the reaction was first carried out according to the baseline conditions for 40 
with the concentrated 0.5 M medium. The amination step was complete after 31 hours as 
judged by TLC, and following NaBH4 reduction, NaOH cyclisation and column 
chromatography gave oxazolidinone 95 as a mixture of diastereomers in a good 70% yield. 
This higher yield (as well as the cleaner TLC reaction profile) suggested that this bis-acetal 
was more robust towards the acidic medium and thus less prone to side-reactions.  
OMe
MeO OMe
OMePh
(i) 13 (20 mol%) / DBAD (1 eq) / 
Acid (5.2 eq) / TFA (0.1 eq) H2O (5 eq) / DCM (0.5 M) / 4 °C / 31 h
(ii) NaBH4 (1 eq) / MeOH / 0 °C to 
RT / 30 min
(iii) NaOH (3 eq) / RT / 2 h90 5 equiv
O
O N NHCO2Bn
O
O
95
 
Scheme 5.14: The desymmetrisation of bis-acetal 90. 
 
Preparative TLC was used to separate the diastereomers of oxazolidinone 95, although this 
proved more difficult than for 94. Compound 95 was also a new compound, an oil, which 
was characterised using 1H NMR, 13C NMR and infrared spectroscopies together with high-
resolution mass spectrometry. Once again, the infrared spectrum was helpful in confirming 
the structure by showing two carbonyl resonances at 1778 and 1718 cm-1. Figure 5.12 
Major Enantiomer, 
Diastereomer 1  
Peak A Minor enantiomers, 
Diastereomers 1&2 
Peak B 
Major Enantiomer, 
Diastereomer 2  
Peak C 
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shows the 1H NMR and 13C NMR spectra of the major diastereomer of 95. Similar to the 1H 
NMR spectrum for 94, all the expected resonances were observed in which once again the 
oxazolidinone resonances appeared in the chemical shift order H-51 > H-4 > H-52 and in the 
same downfield region as the H-3’ triplet. Notably, H-1’ (H-2’ in 94) of the chain α-to the 
oxazolidinone ring was now more deshielded by the adjacent phenyl, appearing at 3.10 ppm 
compared to 2.26 ppm in 94 (Figure 5.9). Furthermore two separated diastereotopic 
methoxy singlets integrating for 6H could be readily observed. The oxazolidinone 13C 
resonances in the 13C NMR spectrum appeared in the chemical shift order C-5 > C-4 in the 
expected region. The two diastereotopic methoxy resonances, C-3’ (as expected at 102.7 
ppm) and aromatic resonances from the phenyl and benzyl functional groups were also 
observed. The deshielding of the phenyl group at C-1’ (benzylic) was confirmed in the 13C 
NMR spectrum by the higher chemical shift (44.8 ppm versus 31.2 ppm for C-2’ in 94). 
 
 
2.02.42.83.23.64.04.44.85.25.66.06.46.87.2
f1 (ppm)
CDCl3
Ar
Ar
N-H
Bn
DCM OMe
OMe
H-2'
H-2'
H-1'
H-5
H-4
H-5
H-3'
3.94.14.34.5
f1 (ppm)
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Figure 5.12: The 1H NMR (CDCl3, 300 MHz) and 13C NMR (CDCl3, 75.5 MHz) spectra of 95. 
 
In order to determine the ee and dr of this reaction, HPLC analysis of the diastereomeric 
mixture of 95 was carried out using the same Chiralpak OD column as for 94. Figure 5.13 
displays the HPLC chromatogram obtained, which illustrates how well the OD column 
separated the diastereomers of 95, with the four expected peaks appearing separately The 
enantioselectivity was determined by calculating the peak area ratio A : B giving 88 : 12 
(76% ee) which was consistent with the value obtained from the second diastereomer (D : 
C). This was a good result, consistent with that of 94 and showed that phenyl substitution did 
not compromise enantioselectivity (although it didn’t enhance it either). The 
diastereoselectivity was determined by calculating the ratio A : D which gave 68:32. This dr 
value was confirmed by calculating the ratio B : C, which gave a consistent value. This was 
only slightly better than the dr from 94 under the same reaction conditions. In other words, 
changing the benzyl ether to a more bulky phenyl substituent did not result in much of a 
diastereoselectivity improvement. Thus the next step was to see whether dilution of the 
reaction would improve the diastereoselectivity. 
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Chiralpak OD column, 10% i-Pr in n-hexane, 258 nm and 0.4 ml/min 
 
Figure 5.13: The HPLC chromatogram of the diastereomeric mixture of 95. 
 
As discussed, the 0.5 M medium gave 95 in a good yield, high ee and low dr (Table 5.2, 
entry 1). In an effort to improve the diastereoselectivity the reaction medium was diluted to 
0.1 M (entry 2). This dilution gave too long a reaction time - after 14 days approximately only 
a 50 % conversion (based on TLC) of 90 was achieved so no yield was ascertained. Thus 
the dr from the 0.5 M reaction suggests that the phenyl substituent exerted a modest steric 
influence in the stereoinduction step. 
 
Entry DCM (M) H2O (eq) MCA (eq) Time  
Temp 
(0C) 
Yield 
(%) ee (%) dr 
1 0.5 5 5.2 + 0.1 eq TFA 31 hrs 4 70 76 68:32  
2 0.1 5 5.2 + 0.1 eq TFA  14 d 4 
- 
(57% 
conv) 
- -
 
 
 
Table 5.2: Desymmetrisation of bis-acetal 90. 
 
In conclusion, this study has demonstrated a level of validity in a desymmetrisation 
hypothesis Enantioselective α-amination methodology has been applied in a chemoselective 
fashion to demonstrate desymmetrisation of a prochiral bis-acetal with  modest 
diastereoselectivity (3:1 at best). To gain a more sophisticated understanding of the interplay 
of the various conformations involved in the transition-state, particularly regarding the 
assumption that zig-zag conformations of the chain are the major ones influencing 
stereoselectivity ultimately, one would need to resort to doing some conformational energy 
calculations using molecular mechanics. However, assuming the zig-zag conformation to be 
the dominant conformer throughout, a simple model accounting for the interplay between 
Major Enantiomer, 
Diastereomer 1 
Peak A 
Minor Enantiomer, 
Diastereomer 1 
Peak B 
Minor Enantiomer, 
Diastereomer 2 
Peak C 
Major Enantiomer, 
Diastereomer 2 
Peak D 
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diastereo- and enantioselectivity features as observed in the work may be summarised in the 
following Scheme 5.15. Here syn-addition relative to the chiral directing group on the 
organocatalyst controls the enantioselectivity (major), while anti-addition with respect to the 
prochiral centre controls the diastereoselectivity, Further work would need to determine 
absolute configurations in order to validate the concept. 
 
  
Scheme 5.15: A model explaining the observed stereochemical outcome. 
 
5.3 Application of the N-N Bond Cleavage Methodology 
The N-N bond cleavage methodology developed in Chapter 4 was applied to both 
oxazolidinones 94 and 95 (isolated as a mixture of diastereomers). Since the model 
oxazolidinone 63 showed better results under the K2CO3 reaction conditions, this was the 
base chosen for this transformation (Scheme 5.16). Thus each of the oxazolidinone 
hydrazides was reacted with 2 equivalents of bromomalonate and 2.5 equivalents of K2CO3 
in acetonitrile at room temperature.  
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Scheme 5.16: N-N bond cleavage of the desymmetrisation products. 
 
Reaction TLCs showed very promising results in terms of complete starting material 
conversion (after 48 hrs) and formation of a more polar product, as expected from the model 
study. The products were isolated successfully by column chromatography as a mixture of 
diastereomers in both cases. However, in the process of drying the products in vacuo, a 
change in appearance was observed – clear, colourless oils turned greyish brown. This was 
seen as a sign of product decomposition and 1H NMR analysis of both products confirmed 
this suspicion. Figure 5.14 shows the 1H NMR spectrum of the product obtained after the N-
N bond cleavage of 95. The spectrum is far more complicated than expected: e.g. multiple 
methoxy-like and aromatic resonances were observed, a more upfield N-H resonance was 
not observed and the oxazolidinone H-5 resonances did not resolve to the expected dd and 
triplet. Thus this spectrum could not be used to confirm the success of the N-N cleavage 
reaction initially (from the crude). Similar oxazolidinone decomposition had been observed 
with the cleaved acetal model substrate 72, albeit at a slower rate since the cleaved product 
was stable long enough to be fully characterised (as discussed in Chapter 4). 
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Figure 5.14: The 1H NMR spectrum (CDCl3, 300 MHz) obtained after the N-N cleavage of 
95. 
 
This disappointing result suggested that the methyl acetal was not robust enough for the 
cleavage reaction, even though acetals are generally stable under basic conditions at room 
temperature. Future work therefore needs to focus on the synthesis of more robust bis-
acetals (e.g. ethyl acetals and dioxolanes, which were shown in the model study to undergo 
successful α-amination, Table 3.7, Chapter 3). 
 
In closing, the two cases shown of successful chemo- and stereoselective desymmetrisation 
of bis-acetals served as a proof of concept, which justifies the possibility of developing this 
strategy in the future.  
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Chapter 6:  Conclusions and Future Work 
6.1 Conclusions 
Scheme 6.1 illustrates a summary of the work achieved in this project. Novel methodologies 
and synthetic strategies were developed with the ultimate goal of achieving the asymmetric 
desymmetrisation of symmetrical prochiral bis-acetals via enantioselective α-amination. The 
final products were chiral oxazolidinones with two contiguous stereocentres. 
 
 
 
Scheme 6.1: An overview of work achieved in this project. 
 
6.2 Future Work 
Future work will focus on developing the desymmetrisation methodology by exploring other 
substrates varying the prochiral R group. As mentioned, a change from dimethoxy to 1,3-
dioxolane will be made for the acetals. Substrates will need to be prepared in quantity (e.g. 
by improving the yields of the sulfone strategy) so that the optimisation of reaction conditions 
can be pursued to maximise the yield, and the enantio- and diastereoselectivity. This will 
hopefully lead to a deeper understanding of the workings of the asymmetric induction step, 
through careful experimental work, notably regarding how the R-group at the prochiral centre 
influences the stereo-outcome. Finally, determination of the absolute configurations of the 
major diastereomer will also be addressed by preparing a crystalline derivative for an X-Ray 
determination so as to address ideas described herein. 
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6.2.1 Potential Application of Desymmetrised products 
On paper the desymmetrised oxazolidinones have a number of potential options for further 
transformation into useful chirons. Some possibilities are shown in the following synopsis:  
 
a) Proline mimics (Scheme 6.2):  
As discussed earlier, Greck has used the half acetal/aldehyde analogue of 1,1,6,6-
tetramethoxyhexane to synthesise D-proline.187 In a similar manner, the synthesis of 3-
substituted prolines from our desymmetrised hydrazino alcohols is envisioned. 
 
 
Scheme 6.2: Pyrrolidine amino acid synthesis. 
 
R = Ph, (the trans diastereomer of 3-phenyl proline), is a known compound278 with reported 
optical rotation values. Therefore this substrate is ideal for determining the absolute 
configuration of the desymmetrisation products, by comparing experimental and literature 
optical rotation values. 
 
b) Hexahydro-1H-pyrrolizidines (Scheme 6.3): 
Chiral pyrrolizidine derivatives constitute a class of heterocyclic compounds that serve as 
promising scaffolds for anticancer drugs.279 The conversion of our cleaved oxazolidinones to 
these valuable structural cores could in principle be achieved in four steps using mesylation 
and SN2 substitution steps. 
 
Scheme 6.3: Pyrrolizidine synthesis. 
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c) Lactol synthesis (Scheme 6.4): 
The three-step conversion of desymmetrised hydrazino alcohols into chiral aminolactols 
would give access to aminated sugar-like products:  
 
 
Scheme 6.4: Lactol synthesis. 
 
d) Pyridazine synthesis (Scheme 6.5): 
The synthesis of chiral hexahydropyridazines is also envisioned. In this case cyclisation is 
unambiguous in view of only one NH in the hydrazide leading to a 6-membered chiral di-
substituted pyridazine core. Other strategies, in principle, could be developed for chiral 2,3-
disubstituted pyrrolidines. 
 
 
Scheme 6.5: Pyridazine synthesis. 
 
In conclusion, a package of methodologies lies in wait for extending the organocatalysed 
enantioselective α-amination reaction of acetals, with an asymmetric desymmetrisation of a 
prochiral bis-acetal as the highlight. The study bodes well for expanding the work towards 
obtaining a range of functionalised chirons for application to synthesis.  
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Chapter 7: Experimental 
 
7.1 General Information 
Column chromatography was performed using silica-gel 60 (Merck 7734). Thin layer 
chromatography was carried out on aluminium-backed Merck silica-gel 60 F254 plates. 
Compounds were visualised on TLC by using one or more of the following revealing 
techniques: UV lamp, iodine vapour or spraying with a 2.5% solution of anisaldehyde in a 
mixture of sulfuric acid and ethanol (1:10 v/v). Nuclear Magnetic Resonance spectra were 
recorded on a Varian Mercury 300 MHz (75.5 MHz for 13C) or a Bruker 400 MHz (101 MHz 
for 13C) instrument and were carried out in chloroform-d. Chemical shifts (δ) were recorded 
relative to residual chloroform (δ 7.26 in 1H NMR and δ 77.0 in 13C NMR). All chemical shifts 
are reported in ppm. Infra-Red (IR) absorptions were measured on a Perkin Elmer Spectrum 
100 FT-IR Spectrometer. All mass spectra were recorded on a Waters Synapt G2 machine 
in ESI mode. Melting points were obtained using a Reichert-Jung Thermovar hot-stage 
microscope and are uncorrected. Elemental analyses were performed using a Fisons EA 
1108 CHNS elemental analyser. The enantiomeric excess (ee) of the products were 
determined by HPLC on an Agilent 1220 Series using a Diacel Chiracel OD (250 × 4.6 mm) 
or Chiralpak AD (250 × 4.6 mm) column. Optical rotations were obtained using a Perkin 
Elmer 343 polarimeter at λ = 589 nm and 20 °C. The concentration c refers to g/100ml. 
 
All solvents were freshly distilled. Dichloromethane was distilled from phosphorus pentoxide 
under nitrogen. Acetonitrile was distilled from calcium hydride under nitrogen. THF was 
distilled over sodium wire with benzophenone under nitrogen. All reagents were available by 
commercial sources (Sigma-Aldrich, Merck) and were used without further purification. 
Isovaleraldehyde diethyl acetal was synthesised from isovaleraldehyde and EtOH under p-
TSA catalysis, whilst butanone dimethyl ketal was synthesised using trimethyl 
orthoformate.280 Cyclohexanone ethylene ketal was synthesised by ketal exchange with 
ethylene glycol. Tetrahydro-2H-pyran-2-ol was synthesised from 3,4-dihydro-2H-pyran using 
Tamaru’s procedure.281 
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7.2 Experimental Section 
Ethyl 2-allylpent-4-enoate234 
 
In a solution of diethyl malonate (7.12 ml, 48.8 mmol, 1 equiv) in THF (250 ml), was added 
NaH (60% in mineral oil, 4.60 g, 115 mmol, 2.5 equiv) and the mixture cooled to 0 °C. Allyl 
bromide (8.00 ml, 92.4 mmol, 2 equiv) was then added and the reaction was warmed to 
reflux for 26 hours, until complete consumption of the diethyl malonate was observed on 
TLC. The reaction was then cooled to room temperature and quenched with saturated NH4Cl 
solution (80.0 ml) and extracted with EtOAc (3 x 80.0 ml). The organic layer was then dried 
with MgSO4 and the solvent was evaporated in vacuo. The crude product was judged pure 
enough to continue to the next step. 
To a solution of the crude α,α’-diallyl malonate in DMSO (82.0 ml) and H2O (1.00 ml) was 
added LiCl (4.30 g, 101 mml, 2.20 equiv). The reaction mixture was then heated to 180 °C 
for 21 hours. The reaction was then cooled to room temperature and quenched with brine 
(70.0 ml), extracted with EtOAc (3 x 100 ml) and washed with water (3 x 50.0 ml). The 
organic layer was dried with MgSO4 and the solvent was evaporated in vacuo. The crude 
residue was then purified by flash column chromatography (5% ethyl acetate / petroleum 
ether) to give 36 (4.31 g, 56% yield over two steps) as a yellowish oil.  
1H NMR (300 MHz, CDCl3) δ 5.82-5.66 (m, 2H, H-4), 5.12-4.99 (m, 4H, H-5), 4.11 (q, J = 7.7 
Hz, 2H, H-6), 2.50 (m, 1H, H-2), 2.30 (m, 4H, H-3), 1.24 (t, J = 7.7 Hz, 3H, H-7). 
 
2-Allylpent-4-en-1-ol235 
 
Product 36 (3.68 g, 21.9 mmol, 1 equiv) was dissolved in 35.0 ml THF and cooled to 0 °C. 
LiAlH4 (1.33 g, 35.0 mmol, 1.6 equiv) was then added and the reaction warmed to reflux for 
4 hours. The reaction mixture was then cooled to 0 °C and quenched with water (4.30 ml), 
25.0 ml of NaOH (10% solution) and stirred at room temperature for 20 minutes. The 
resultant suspension was filtered over Celite and washed with ether (100 ml). The filtrate 
was dried with MgSO4 and the solvent evaporated in vacuo. The crude residue was then 
purified by flash column chromatography (10% ethyl acetate / petroleum ether) to give 37 
(2.26 g, 82% yield) as a colourless oil. 
 167 
 
1H NMR (300 MHz, CDCl3) δ 5.88-5.74 (m, 2H, H-4), 5.05 (m, 4H, H-5), 3.57 (d, J = 3.3 Hz, 
2H, H-1), 2.10 (t, J = 6.9 Hz, 4H, H-3), 1.78-1.65 (m, 1H, H-2), 1.42 (s, 1H, OH). 
 
(((2-Allylpent-4-en-1-yl)oxy)methyl)benzene235 
 
To as solution of alcohol 37 (3.10 g, 24.6 mmol, 1 equiv) in THF (125 ml) was added NaH 
(60% in mineral oil, 1.20 g, 29.5 mmol, 1.2 equiv) at 0 °C and the reaction mixture was 
warmed to room temperature and stirred for a further 1.25 hours. Benzyl bromide (4.40 ml, 
36.8 mmol, 1.5 equiv) was added along with TBAI (907 mg, 2.45 mmol, 10 mol%) and the 
reaction mixture warmed to reflux for 18 hours. When complete consumption of 37 was 
observed on TLC the reaction was quenched with water (80.0 ml) and extracted with ethyl 
acetate (3 x 50.0 ml). The organic layers were dried with MgSO4 and the solvent evaporated 
in vacuo. The crude residue was then purified by flash column chromatography (2% ethyl 
acetate / petroleum ether) to give 38 (4.09 g, 77% yield) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ 7.23 (m, 5H, Ar), 5.78-5.62 (m, 2H, H-4), 5.01-4.86 (m, 4H, H-
5), 4.40 (s, 2H, Bn), 3.29 (d, J = 6.0 Hz, 2H, H-1), 2.14-1.98 (m, 4H, H-3), 1.78-1.69 (m, 1H, 
H-2). 
 
General procedure 1: bis-acetal synthesis via ozonolysis 
Into a solution of the diallyl substrate (10.0 mmol, 1 equiv) in methanol (50.0 ml) and DCM 
(10.0 ml) at -78 °C was bubbled O3 gas for 30 minutes (or until the solution turned blue). The 
reaction mixture was then flushed with O2 gas and warmed to 0 °C under an inert Ar 
atmosphere. PPh3 (5.77 g, 22.0 mmol, 2.2 equiv) was then added and the reaction mixture 
warmed to room temperature over 2 hours. p-TSA (360 mg, 1.90 mmol, 20 mol%) was 
added and the reaction mixture was stirred at room temperature (or refluxed, if necessary) 
until complete consumption of the dially intermediate was observed on TLC (minimum of 18 
hours). The reaction mixture was then quenched with saturated K2CO3 (25.0 ml) and 
extracted with ethyl acetate (4 x 50.0 ml). The organic layers were dried with MgSO4 and the 
solvent was evaporated in vacuo. The crude residue was then purified by flash column 
chromatography (5-10% ethyl acetate / petroleum ether) to yield the desired bisacetal. 
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((2-(2,2-Dimethoxyethyl)-4,4-dimethoxybutoxy)methyl)benzene 
OMe
MeO OMe
OMe
OBn
2
1
3
4
3
4
40
 
Synthesised using General procedure 1 from 38 to give the product 40 (2.02 g, 65 % yield) 
as a colourless oil. 
IR (CHCl3) νmax/cm-1 1265 (C-O), 1112 (C-O); 1H NMR (300 MHz, CDCl3) δ 7.30 (m, 5H, Ar), 
4.46 (s, 2H, Bn), 4.43 (t, J = 5.9 Hz, 2H, H-4), 3.37 (d, J = 5.1 Hz, 2H, H-1), 3.27 (s, 6H, 
2xOMe), 3.26 (s, 6H, 2xOMe), 1.89 (m, 1H, H-2), 1.75-1.55 (m, 4H, H-3); 13C NMR (101 
MHz, CDCl3) δ 138.6 (i-Ar), 128.2 (Ar), 127.5 (Ar), 127.4 (Ar), 103.1 (C-4), 72.9, 72.8, 52.7 
(OMe), 52.3 (OMe), 34.7 (C-3), 31.1 (C-2); HRMS (ESI): m/z 335.1838 [M + Na]+, 
C17H28O5Na requires 335.1834. 
 
General procedure 2: α-amination of acetals 
Dibenzyl azodicarboxylate (DBAD, 75.0 mg, 0.500 mmol, 2 equiv (1.00 mmol, 4 equiv for 
45)) was added to a mixture of acetal (0.250 mmol, 1 equiv), tetrazole catalyst (7.00 mg, 
0.050 mmol, 20 mol%) monochloroacetic acid (MCA, 123 mg, 1.30 mmol, 5.2 equiv (246 mg, 
2.60 mmol, 10.4 equiv for 45)), trifluoroacetic acid (TFA, 2.0 µl, 0.025 mmol, 0.1 equiv) and 
water (22.5 mg, 1.25 mmol, 5 equiv) in DCM (0.50 ml). The reaction mixture was kept at 4 
°C until complete consumption of the acetal was observed by TLC. On reaction completion, 
the reaction mixture was quenched with water (10.0 ml) and extracted with DCM (3 x 10 ml) 
and the organic extracts were washed with saturated NaHCO3 (10.0 ml) and brine (10.0 ml). 
The organic layers were then dried with MgSO4 and the solvent was evaporated in vacuo. 
To the resultant residue was added EtOH (3.0 ml) and NaBH4 (18.9 mg, 0.500 mmol, 2 
equiv) at 0 °C and the mixture was allowed to warm up over 15 minutes. The reaction was 
quenched with saturated NH4Cl (10.0 ml), extracted with DCM (3 x 10.0 ml) and the organic 
extracts were washed with brine (10.0 ml). The organic layer was dried with MgSO4 and the 
solvent was evaporated in vacuo. The crude residue was then purified by flash column 
chromatography (ethyl acetate / petroleum ether) to give the desired product. 
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(R)-Dibenzyl 1-(1-hydroxydecan-2-yl)hydrazine-1,2-dicarboxylate 
 
Synthesised from the corresponding acetal using General procedure 2 to give 41 (79% 
yield) as a white amorphous solid and a 3:1 mixture of rotamers.  
[α]D20 -6.0 (c = 0.4, CHCl3); IR (CHCl3) νmax/cm-1 1714 (C=O); 1H NMR (400 MHz, CDCl3) δ 
7.31 (m, 10H, Ar), 6.45 (br s, 1H, NH), 5.20 (m, 4H, 2xBn), 4.49-3.93 (m, 2H, H-2, OH), 3.44 
(3.55) (m, 2H, H-1), 1.23 (m, 14H, H-3-H-9), 0.88 (t, J = 6.9 Hz, 3H, H-10). 13C NMR (101 
MHz, CDCl3) δ 156.2 (C=O), 135.8 (i-Ar), 135.09 (i-Ar), 128.7 (Ar), 128.5 (Ar), 128.3 (Ar), 
127.9 (Ar), 69.6 (Bn), 62.2 (Bn), 61.1 (C-1), 60.0 (C-2), 31.8 (C-3), 29.4 (C-8), 29.2 (C-5), 
27.8 (C-6), 26.0 (C-7), 22.6 (C-4,C-9), 14.0 (C-10); HRMS (ESI): m/z 457.2703 [M + H]+, 
C26H37N2O5 requires 457.2702.  
The ee (90%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol = 95:5, flow rate = 0.5 ml/min, λ = 258 nm); τmajor = 41.40 min, τminor = 45.25 min. 
 
(R)-Dibenzyl 1-(1-hydroxypropan-2-yl)hydrazine-1,2-dicarboxylate174 
 
Synthesised from the corresponding acetal using General procedure 2 to give 43 (93% 
yield) as colourless crystals.  
[α]D20 -22.5 (c = 0.4, CHCl3), lit: [α]D20 -32.0 (c = 0.4, CHCl3);1H NMR (400 MHz, CDCl3) δ 
7.26 (m, 10H, Ar), 6.57 (m, 1H, NH), 5.23 (m, 4H, 2xBn), 4.64-3.79 (m, 2H, OH, H-2), 3.45 
(m, 2H, H-1), 1.01 (d, J = 6.1 Hz, 3H, H-3); 13C NMR (101 MHz, CDCl3) δ 156.1 (C=O), 135.8 
(i-Ar), 135.1 (i-Ar), 128.6 (Ar), 128.5 (Ar), 128.2 (Ar), 127.9 (Ar), 68.5 (Bn), 63.2 (Bn), 56.4 
(C-1), 55.4 (C-2), 13.7 (C-3). 
The ee (86%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol = 90:10, flow rate = 1 ml/min, λ = 258 nm); τmajor = 18.00 min, τminor = 19.66 min. 
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 (R)-Dibenzyl 1-(1-hydroxy-3-methylbutan-2-yl)hydrazine-1,2-dicarboxylate174,67 
 
Synthesised from the corresponding acetal using General procedure 2 to give 44 (73% 
yield) as colourless crystals.  
1H NMR (400 MHz, CDCl3) δ 7.32 (m, 10H, Ar), 6.48 (br s, 1H, NH), 5.21 (m, 4H, 2xBn), 
4.34-3.92 (m, 2H, OH, H-2), 3.73 (m, 1H, H-1), 3.46 (m, 1H, H-1), 1.62 (m, 1H, H-3), 0.88 
(m, 6H, H-4, H-5); 13C NMR (101 MHz, CDCl3) δ 157.4 (C=O), 135.8 (i-Ar), 135.1 (i-Ar), 
128.7 (Ar), 128.5 (Ar), 128.3 (Ar), 128.2 (Ar), 127.9 (Ar), 127.8 (Ar), 68.5 (Bn), 68.3 (C-1), 
67.2 (C-2), 60.4 (Bn), 27.5 (C-3), 20.1 (C-4/5), 19.4 (C-4/5). 
The ee (94%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol = 90:10, flow rate = 1 ml/min, λ = 258 nm); τmajor = 15.81 min, τminor = 23.26 min. 
 
 (R)-Dibenzyl 1-(1-oxo-2-phenylpropan-2-yl)hydrazine-1,2-dicarboxylate251 
 
Synthesised from the corresponding acetal using General procedure 2 to give 45 (51% 
yield) as a colourless oil and a 2:1 mixture of rotamers.  
1H NMR (400 MHz, CDCl3, minor rotamer cited in parentheses) δ 9.62 (9.69) (m, 1H, H-1), 
7.29 (m, 15H, Ar), 6.54 (6.33) (br s, 1H, NH), 5.09 (m, 4H, 2xBn), 1.83-1.56 (m, 3H, H-3); 13C 
NMR (101 MHz, CDCl3) δ 192.2 (194.1) (C-1), 156.3 (C=O), 156.2 (C=O), 135.3 (i-Ar), 135.1 
(i-Ar), 135.1 (i-Ar), 129.0 (Ar), 128.9 (Ar), 128.8 (Ar), 128.6 (Ar), 128.5 (Ar), 128.4 (Ar), 128.3 
(Ar), 128.2 (Ar), 126.8 (Ar), 73.4 (C-2), 68.9 (Bn), 68.0 (Bn), 17.6 (C-3). 
The ee (56%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol 88:12, flow rate = 1 ml/min, λ = 258 nm); τmajor = 69.56 min, τminor = 64.05 min. 
 
General procedure 3: α-amination of ketals (Compounds 46 & 47) 
DBAD (75.0 mg, 0.250 mmol, 1 equiv) was added to a mixture of ketal (5.00 mmol, 20 
equiv), tetrazole catalyst (7.00 mg, 0.05 mmol, 20 mol%), MCA (246 mg, 2.60 mmol), TFA 
(2.0 µl, 0.025 mmol, 0.1 equiv) and water (22.5 mg, 1.25 mmol, 5 equiv) in DCM (0.50 ml). 
The reaction mixture was kept at 4 °C until complete consumption of the DBAD was 
observed by TLC. On reaction completion, the reaction mixture was quenched with water 
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(10.0 ml) and extracted with DCM (3 x 10.0 ml) and the organic extracts were washed with 
saturated NaHCO3 (10.0 ml) and brine (10.0 ml). The organic layer was dried with MgSO4 
and the solvent was evaporated in vacuo. The crude residue was then purified by flash 
column chromatography (ethyl acetate / petroleum ether) to give the desired product. 
 
(R)-Dibenzyl 1-(3-oxobutan-2-yl)hydrazine-1,2-dicarboxylate / dibenzyl 1-(2-
oxobutyl)hydrazine-1,2-dicarboxylate174 
 
Synthesised from the corresponding acetal using General procedure 3 to give 46 (33% 
yield) as a white solid and a mixture of regioisomers (major : minor = 96:4), each of which 
existing as a 3:1 mixture or rotamers.  
For the major regioisomer (which corresponded to the reported literature data):174 1H NMR 
(400 MHz, CDCl3, minor rotamer cited in parentheses) δ 7.26 (m, 10H, Ar), 6.81 (6.59) (br s, 
1H, NH), 5.14 (m, 4H, 2xBn), 4.92 (4.67) (m, 1H, H-2), 2.18 (m, 3H, H-4), 1.43 (m, 3H, H-1); 
13C NMR (101 MHz, CDCl3) δ 207.1 (C-3), 156.2 (C=O), 135.7 (i-Ar), 135.5 (i-Ar), 128.6 (Ar), 
128.4 (Ar), 128.2 (Ar), 128.1 (Ar), 127.8 (Ar), 127.6 (Ar), 68.3 (C-2), 67.9 (Bn), 67.7 (Bn), 
26.5 (C-4), 13.1 (C-1).  
The ee (86%) was determined by chiral HPLC using a Chiralcel OD column (n-hexane:i-
propanol = 90:10, flow rate = 1 ml/min, λ = 258 nm); τmajor = 23.54 min; τminor = 19.52 min. 
 
 (R)-Dibenzyl 1-(2-oxocyclohexyl)hydrazine-1,2-dicarboxylate174,180 
 
Synthesised from the corresponding acetal using General procedure 3 to give 47 (71% 
yield) as a white solid and a 2:1 mixture of rotamers.  
1H NMR (400 MHz, CDCl3, minor rotamer cited in parentheses) δ 7.28 (m, 10H Ar), 6.86 
(6.60) (br s, 1H, NH), 5.15 (m, 4H, 2xBn), 4.92 (4.67) (m, 1H, H-1), 2.50-1.60 (m, 8H, H-3 - 
H-6); 13C NMR (101 MHz, CDCl3) δ 207.5 (207.0) (C-2), 156.3 (C=O), 156.1 (C=O), 135.7 (i-
Ar), 128.5 (Ar), 128.3 (Ar), 128.0 (Ar), 127.5 (Ar), 68.2 (Bn), 67.6 (Bn), 65.8 (C-1), 41.3 (C-
3), 30.7 (C-6), 26.7 (C-4), 24.3 (C-5).  
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The ee (64%) was determined by chiral HPLC using a Chiralcel OD column (n-hexane:i-
propanol = 90:10, flow rate = 0.9 ml/min, λ = 258 nm); τmajor = 24.55 min, τminor = 17.50 min. 
 
(R)-Dibenzyl 1-(1-hydroxydecan-2-yl)hydrazine-1,2-dicarboxylate187 
 
Dibenzyl azodicarboxylate (258 mg, 75.0 mg, 0.250 mmol, 1 equiv) was added to a mixture 
of 1,1,6,6-tetramethoxyhexane (1.25 mmol, 5 equiv), tetrazole catalyst (0.05 mmol, 20 
mol%), MCA (123 mg, 1.3 mmol, 5.2 equiv), TFA (2.0 µl, 0.025 mmol, 0.1 equiv) and water 
(22.5 mg, 1.25 mmol, 5 equiv) in DCM (2.50 ml). The reaction mixture was kept at 4 °C until 
complete consumption of the DBAD was observed by TLC. On reaction completion, the 
reaction mixture was quenched with water (10.0 ml) and extracted with DCM (3 x 10.0 ml) 
and the organic extracts were washed with saturated NaHCO3 (10.0 ml) and brine (10.0 ml). 
The organic layer was then dried with MgSO4 and the solvent was evaporated in vacuo. To 
the resultant residue was added EtOH (3 ml) and NaBH4 (18.9 mg, 0.5 mmol, 2 equiv) at 0 
°C and the mixture was allowed to warm up over 15 minutes. The reaction was quenched 
with saturated NH4Cl (10.0 ml), extracted with DCM (3 x 10.0 ml) and the organic extracts 
were washed with brine (10.0 ml). The organic layer was dried with MgSO4 and the solvent 
was evaporated in vacuo. The crude residue was then purified by flash column 
chromatography (30% ethyl acetate / petroleum ether) to give 90mg of 48 (78% yield) as a 
colourless solid.  
[α]D20 +5.2 (c = 1, MeOH), lit: [α]D25 +3.8 (c = 0.4, MeOH); 1H NMR (400 MHz, CDCl3) δ 7.26 
(m, 10H, Ar), 6.82 (m, 1H, NH), 5.19 (m, 4H, 2xBn), 4.52-4.01 (m, 3H, OH, H-2, H-6), 3.58-
3.35 (m, 2H, H-1), 3.26 (s, 3H, OMe), 3.25 (s, 3H, OMe), 1.92-1.20 (m, 6H, H-3-H-5); 13C 
NMR (101 MHz, CDCl3) δ 157.1 (C=O), 156.1 (C=O), 135.8 (i-Ar), 135.2 (i-Ar), 128.6 (Ar), 
128.5 (Ar), 128.5 (Ar), 128.2 (Ar), 127.9 (Ar), 127.8 (Ar), 104.2 (C-6), 68.4 (Bn), 62.2 (Bn), 
61.0 (C-1), 59.8 (C-2), 53.0 (OMe), 52.5 (OMe), 32.0 (C-3), 27.4 (C-5), 20.9 (C-4). 
The ee (90%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol = 90:10, flow rate = 0.5 ml/min, λ = 258 nm); τmajor = 47.28 min, τminor = 43.68 min. 
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Dibenzyl 1-((3R)-2-hydroxytetrahydro-2H-pyran-3-yl)hydrazine-1,2-dicarboxylate 
 
DBAD (75.0 mg, 0.25 mmol, 1 equiv) was added to a mixture of lactol 49 (255 mg, 2.50 
mmol, 10 equiv), tetrazole catalyst (7.00 mg, 0.05 mmol, 20 mol%) MCA (2.36 mg, 0.025 
mmol, 0.1 equiv), TFA (2.0 µl, 0.025 mmol, 0.1 equiv) and water (22.5 mg, 2.50 mmol, 5 
equiv) in CH3CN (0.50 ml). The reaction mixture was kept at 0 °C until complete 
consumption of the DBAD was observed by TLC. On reaction completion, the reaction 
mixture was quenched with water (10.0 ml) and extracted with DCM (3 x 10.0 ml) and the 
organic extracts were washed with saturated NaHCO3 (10.0 ml) and brine (10.0 ml). The 
organic layer was dried with MgSO4 and the solvent was evaporated in vacuo. The crude 
residue was purified by flash column chromatography (30% ethyl acetate / petroleum ether) 
to give 80mg (80% yield) of 50 as a white amorphous solid and a 6:4 mixture of 
diastereomers.  
[α]D20 +7.4 (c = 0.5, MeOH); IR (CHCl3) νmax/cm-1 1746 (C=O), 1688 (C=O); for the major 
diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.26 (m, 10H, Ar), 6.80 (br s, 1H, NH), 5.22 (m, 
4H, 2xBn), 4.57 (m, 1H, H-2), 3.96-3.83 (m, 3H, H-3, H-6), 3.14 (br s, 1H, OH), 2.01-1.56 (m, 
4H, H-4, H-5); 13C NMR (101 MHz, CDCl3) δ 156.2 (C=O), 155.8 (C=O), 135.6 (i-Ar), 135.3 
(i-Ar), 128.6 (Ar), 128.5 (Ar), 128.2 (Ar), 127.8 (Ar), 96.2 (C-2), 68.4 (Bn), 68.2 (Bn), 66.3 (C-
6), 60.7 (C-3), 26.0 (C-4), 25.2, (C-5); for the minor diastereomer: 1H NMR (400 MHz, 
CDCl3) δ 7.26 (m, 10H, Ar), 6.92 (br s, 1H, NH), 5.22 (m, 5H, 2xBn, H-2), 4.27 (m, 1H, H-3), 
3.40 (s, 1H, H-6), 3.53 (s, 1H, H-6), 3.14 (br s, 1H, OH), 2.01-1.56 (m, 4H, H-4, H-5); 13C 
NMR (101 MHz, CDCl3) δ 156.2 (C=O), 155.8 (C=O), 135.6 (i-Ar), 135.3 (i-Ar), 128.6 (Ar), 
128.5 (Ar), 128.2 (Ar), 127.8 (Ar), 91.9 (C-2), 68.4 (Bn), 68.2 (Bn), 59.0 (C-6), 56.0 (C-3), 
24.8 (C-5), 20.0 (C-4); HRMS (ESI): m/z 383.1613 [M – H2O + H]+, C21H23N2O5 requires 
383.1605; Analysis: found C 62.53%, H 6.10%, N 7.01%; C21H24N2O6 requires C 62.99%, H 
6.04%, N 7.00%.  
The ee (93%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol = 70:30, flow rate = 0.9 ml/min, λ = 258 nm); τmajor = 9.38 min, τminor = 22.72 min; 
τmajor = 11.05 min, τminor = 14.49 min. 
 
General Procedure 4: synthesis of oxazolidinones 
To a solution of the appropriate aldehyde (1.66 mmol, 1.5 equiv) and L-proline (13.0 mg, 
0.11 mmol, 10 mol%) in CH3CN (10 ml) at 0 °C was added dibenzyl azodicarboxylate (330 
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mg, 1.11 mmol, 1.0 equiv) and the reaction mixture was left to stir at 0 °C for 30 minutes and 
then warmed to room temperature until the complete consumption of DBAD (as determined 
by TLC). The reaction mixture was then cooled to 0 °C and diluted with methanol (20.0 ml) 
followed by addition of sodium borohydride (42 mg, 1.11 mmol, 1.0 equiv). After 15 minutes, 
1M NaOH (3.3 ml, 3.32 mmol, 3.0 equiv) was added and after an additional 2 hours the 
resulting mixture was quenched with NH4Cl (15.0 ml) and extracted with ethyl acetate (3 x 
30.0 ml). The combined organic layers were washed with brine (20.0 ml) and dried over 
MgSO4 and the solvent evaporated in vacuo. The crude residue was chromatographed on 
silica gel with an ethyl acetate / petroleum ether mixture to afford the oxazolidinone 
hydrazide. 
 
Benzyl (R)-(4-octyl-2-oxooxazolidin-3-yl)carbamate 
 
Synthesised from the corresponding aldehyde using General procedure 4 to give 51 (92% 
yield) as a colourless oil.  
[α]D20 -12.9 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 1740 (2 x C=O); 1H NMR (300 MHz, CDCl3) 
δ 7.29 (m, 5H, Ar), 6.68 (br s, 1H, N-H), 5.12 (s, 2H, Bn), 4.39 (m, 1H, H-5), 3.90 (m, 2H, H-
5, H-4), 1.73 (m, 1H, H-6), 1.44 (m, 1H, H-6), 1.19 (m, 12H, H-7-H-12), 0.81 (t, J = 6.0 Hz, 
3H, H-13); 13C NMR (101 MHz, CDCl3) δ 157.6 (C=O), 155.4 (C=O), 135.4 (i-Ar), 128.7 (Ar), 
128.6 (Ar), 128.3 (Ar), 68.2 (Bn), 67.8 (C-5), 56.9 (C-4), 31.9 (C-6), 31.8 (C-11), 29.6 (C-8), 
29.4 (C-9), 29.2 (C-10), 24.6 (C-7), 22.8 (C-12), 14.2 (C-13); HRMS (ESI): m/z 349.2131 [M 
+ H]+, C19H29N2O4 requires 349.2127.Chiralpak. 
The ee (90%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 1 ml/min, λ = 258 nm); τmajor = 23.60 min, τminor = 15.37 min. 
 
Benzyl (R)-(4-methyl-2-oxooxazolidin-3-yl)carbamate 
 
Synthesised from the corresponding aldehyde using General procedure 4 to give 55 (88% 
yield) as a white solid.  
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[α]D20 -12.7 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 1772 (C=O), 1704 (C=O); 1H NMR (400 
MHz, CDCl3) δ 7.34–7.22 (m, 5H, Ar), 6.73 (br s, 1H, N-H), 5.11 (s, 2H, Bn), 4.41 (t, J = 5.3 
Hz, 1H, H-5), 4.12–3.97 (m, 1H, H-4), 3.82 (t, J = 5.3 Hz, 1H, H-5), 1.21 (d, J = 6.0 Hz, 3H, 
H-6); 13C NMR (101 MHz, CDCl3) δ 155.6 (C=O), 154.2 (C=O), 135.4 (i-Ar), 128.8 (Ar), 
128.6 (Ar), 128.4 (Ar), 68.9 (Bn), 68.3 (C-5), 53.0 (C-4), 17.0 (C-6); HRMS (ESI): m/z 
251.1036 [M + H]+, C12H15N2O4 requires 251.1032.  
The ee (90%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 1 ml/min, λ = 258 nm); τmajor = 31.62 min, τminor = 23.81 min. 
 
Benzyl (R)-(4-isopropyl-2-oxooxazolidin-3-yl)carbamate 
 
Synthesised from the corresponding aldehyde using General procedure 4 to give 56 (91% 
yield) as a colourless oil.  
[α]D20 -12.5 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 1764 (C=O), 1726 (C=O); 1H NMR (300 
MHz, CDCl3) δ 7.31–7.23 (m, 5H, Ar), 6.96 (br s, 1H, N-H), 5.09 (s, 2H, Bn), 4.28 (m, 1H, H-
5), 4.09–3.80 (m, 1H, H-5, H-4), 2.03–1.85 (m, 1H, H-6), 0.91 (m, 6H, H-7); 13C NMR (101 
MHz, CDCl3) δ 156.1 (C=O), 155.1 (C=O), 135.3 (i-Ar), 128.6 (Ar), 128.5 (Ar), 128.2 (Ar), 
68.1 (Bn), 64.1 (C-5), 60.9 (C-4), 28.5 (C-6), 17.8 (C-7), 15.9 (C-7); HRMS (ESI): m/z 
279.1345 [M + H]+, C14H19N2O4 requires 279.1345. 
The ee (91%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 1 ml/min, λ = 258 nm); τmajor = 23.60 min, τminor = 15.37 min. 
 
Benzyl (R)-(2-oxo-4-pentyloxazolidin-3-yl)carbamate 
 
Synthesised from the corresponding aldehyde using General procedure 4 to give 57 (89% 
yield) as a colourless oil.  
[α]D20 -12.8 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 3285 (N-H), 1770 (C=O), 1722 (C=O); 1H 
NMR (400 MHz, CDCl3) δ 7.33–7.22 (m, 5H, Ar), 6.74 (br s, 1H, N-H), 5.10 (d, J = 2.0 Hz, 
2H, Bn), 4.38 (m, 1H, H-5), 4.00–3.83 (m, 2H, H-5, H-4), 1.76–1.36 (m, 2H, H-6), 1.29–1.14 
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(m, 6H, H-7-H-9), 0.91 (t, J = 6.8 Hz, 3H, H-10); 13C NMR (101 MHz, CDCl3) δ 159.2 (C-2), 
155.4 (C=O), 136.2 (i-Ar), 128.9 (Ar), 128.8 (Ar), 127.7 (Ar), 68.3 (Bn) 66.5 (C-5), 54.6 (C-4), 
33.3 (C-6), 31.7 (C-8), 26.1 (C-7), 22.8 (C-9), 14.3 (C-10); HRMS (ESI): m/z 307.1657 [M + 
H]+, C16H23N2O4 requires 307.1658. 
The ee (93%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 1 ml/min, λ = 258 nm); τmajor = 26.03 min, τminor = 17.21 min. 
 
Benzyl (R)-(4-(2-(benzyloxy)ethyl)-2-oxooxazolidin-3-yl)carbamate 
 
Synthesised from the corresponding aldehyde using General procedure 4 to give 58 (86 % 
yield) as a colourless oil.  
[α]D20 -8.0 (c = 1.0, CHCl3); IR (CHCl3) νmax/cm-1 1774 (C=O), 1730 (C=O), 1221 (C-O); 1H 
NMR (400 MHz, CDCl3) δ 7.40-7.28 (m, 10H, Ar), 6.94 (br s, 1H, NH), 5.19 (s, 2H, Bn), 4.51 
(m, 1H, H-5), 4.45 (s, 2H, Bn), 4.12 (m, 2H, H-4, H-5), 3.50 (m, 2H, H-2’), 1.96 (m, 2H, H-1’); 
13C NMR (101 MHz, CDCl3) δ 157.3 (C=O), 155.3 (C=O), 137.6 (i-Ar), 135.4 (i-Ar), 128.6 
(Ar), 128.5 (Ar), 128.4 (Ar), 128.2 (Ar), 127.9 (Ar), 127.7 (Ar), 73.5 (Bn), 68.0 (Bn), 68.0 (C-
5), 66.3 (C-2’), 56.1 (C-4), 31.9 (C-1’); HRMS (ESI): m/z 371.1601 [M + H]+, C20H23N2O5 
requires 371.1607. 
The ee (92%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol 50:50, flow rate = 1 ml/min, λ = 258 nm); τmajor = 25.92 min, τminor = 10.15 min. 
 
Benzyl (R)-(2-oxo-4-(2-(prop-2-yn-1-yloxy)ethyl)oxazolidin-3-yl)carbamate 
 
Synthesised from the corresponding aldehyde using General procedure 4 to give 59 (87 % 
yield) as a yellow oil.  
[α]D20 -12.9 (c = 1.0, CHCl3); IR (CHCl3) νmax/cm-1 1771 (C=O), 1726 (C=O), 1222 (C-O); 1H 
NMR (400 MHz, CDCl3) δ 7.36 (m, 5H, Ar), 6.80 (br s, 1H, NH), 5.18 (s, 2H, Bn), 4.55 (m, 
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1H, H-5), 4.09 (d, J = 2.4 Hz, 2H, H-1’’), 4.08 (m, 2H, H-4, H-5), 3.66 (m, 1H, H-2’), 3.56 (m, 
1H, H-2’), 2.42 (t, J = 2.4 Hz, 1H, H-3’’), 1.99 (m, 2H, H-1’); 13C NMR (101 MHz, CDCl3) δ 
157.2 (C=O), 155.3 (C=O), 135.3 (i-Ar), 128.7 (Ar), 128.5 (Ar), 128.3 (Ar), 79.1 (C-2’’), 74.9 
(C-3’’), 68.2 (Bn), 68.0 (C-5), 66.0 (C-2’), 58.4 (C-1’’), 56.1 (C-4), 31.7 (C-1’); HRMS (ESI): 
m/z 319.1281 [M + H]+, C16H19N2O5 requires 319.1294.  
The ee (90%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol 50:50, flow rate = 0.5 ml/min, λ = 258 nm); τmajor = 16.53 min, τminor = 15.64 min. 
 
Benzyl (R)-(4-benzyl-2-oxooxazolidin-3-yl)carbamate 
 
Synthesised from the corresponding aldehyde using General procedure 4 to give 60 (91 % 
yield) as a colourless oil.  
[α]D20 -19.5 (c = 1.0, DCM); IR (CHCl3) νmax/cm-1 1774 (C=O), 1728 (C=O), 1217 (C-O); 1H 
NMR (400 MHz, CDCl3) δ 7.53 (br s, 1H, NH), 7.31 (m, 8H, Ar), 7.15 (m, 2H, Ar), 5.13 (s, 
2H, Bn), 4.28 (m, 2H, H-4, H-5), 4.03 (m, 1H, H-5), 3.15 (dd, J = 10.2, 3.3 Hz, 1H, H-6), 2.81 
(m, 1H, H-6); 13C NMR (101 MHz, CDCl3) δ 157.3 (C=O), 155.3 (C=O), 135.3 (i-Ar), 135.3 (i-
Ar), 128.8 (Ar), 128.7 (Ar), 128.4 (Ar), 128.2 (Ar), 128.0 (Ar), 127.0 (Ar), 67.8 (Bn), 67.0 (C-
5), 57.6 (C-4), 37.6 (C-6); HRMS (ESI): m/z 327.1338 [M + H]+, C18H19N2O4 requires 
327.1345 
The ee (86%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol 50:50, flow rate = 0.5 ml/min, λ = 258 nm); τmajor = 17.10 min, τminor = 15.69 min. 
 
Benzyl (R)-(2-oxo-4-(pyridin-3-ylmethyl)oxazolidin-3-yl)carbamate 
 
Synthesised from the corresponding aldehyde using General procedure 4 to give 61 (87 % 
yield) as a colourless oil.  
[α]D20 -12.8 (c = 1.0, MeOH); IR (CHCl3) νmax/cm-1 1777 (C=O), 1718 (C=O), 1215 (C-O); 1H 
NMR (400 MHz, CDCl3) δ 8.47 (d, J = 3.3 Hz, 1H, H-6’), 8.41 (s, 1H, H-2’), 8.34 (br s, 1H, 
NH), 7.49 (m, 1H, H-4’), 7.31 (m, 5H, Ar), 7.19 (dd, J = 5.7, 3.3 Hz, 1H, H-5’), 5.12 (s, 2H, 
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Bn), 4.33 (m, 2H, H-5, H-4), 3.97 (m, 1H, H-5), 3.03 (dd, J = 10.5, 3.2 Hz, 1H, H-6), 2.87 (m, 
1H, H-6); 13C NMR (101 MHz, CDCl3) δ 157.1 (C=O), 155.6 (C=O), 149.8 (Ar), 148.1 (Ar), 
136.9 (Ar), 135.4 (Ar), 131.2 (i-Ar), 128.5 (Ar), 128.4 (Ar), 128.1 (Ar), 123.7 (Ar), 67.9 (Bn), 
66.5 (C-5), 57.1 (C-4), 34.8 (C-6); HRMS (ESI): m/z 328.1298 [M + H]+, C17H18N3O4 requires 
328.1297. 
The ee (94%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol 60:40, flow rate = 1 ml/min, λ = 258 nm); τmajor = 17.86 min, τminor = 8.95 min. 
 
Benzyl (R)-(4-methyl-2-oxo-4-phenyloxazolidin-3-yl)carbamate249 
 
Synthesised from the corresponding aldehyde using General procedure 4 (with the 
modification of using 5 eq of aldehyde) to give 62 (80 % yield) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ 7.39-7.31 (m, 10H, Ar), 6.69 (br s, 1H, NH), 5.13 (s, 2H, Bn), 
4.37 (d, J = 8.8 Hz, 1H, H-5), 4.34 (d, J = 8.8 Hz, 1H, H-5), 1.79 (br s, 3H, Me). 
The ee (46%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol 88:12, flow rate = 1 ml/min, λ = 258 nm); τmajor = 57.65 min, τminor = 62.26 min. 
 
Benzyl (R)-(4-(4,4-dimethoxybutyl)-2-oxooxazolidin-3-yl)carbamate 
 
To a solution of hydrazine alcohol 48 (780 mg, 1.69 mmol, 1 equiv) in MeOH (15.0 ml) was 
added NaOH (5.10 ml, 1M, 5.10 mmol, 3 equiv) and the reaction was stirred for 1 hour at 
room temperature, when complete consumption of the hydrazine was observed on TLC. The 
reaction was quenched with saturated NH4Cl solution (20.0 ml) and extracted with ethyl 
acetate (3 x 20.0 ml). The organic layers were dried with MgSO4 and the solvent evaporated 
in vacuo. The crude residue was then purified by flash column chromatography (40% ethyl 
acetate / petroleum ether) to give 63 (430 mg, 72% yield) as a colourless gum. 
[α]D20 -12.2 (c = 0.5, DCM); IR (CHCl3) νmax/cm-1 1780 (C=O), 1740 (C=O), 1236 (C-O), 1125 
(C-O); 1H NMR (300 MHz, CDCl3) δ 7.35 (m, 5H, Ar), 7.19 (br s, 1H, NH), 5.22 (s, 2H, Bn), 
4.45 (m, 1H, H-5), 4.33 (t, J = 5.4 Hz, 1H, H-4'), 3.96 (m, 2H, H-4, H-5), 3.30 (s, 6H, 2xOMe), 
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1.78 (m, 1H, H-1’), 1.59 (m, 3H, H-1’, H-3’) 1.34 (m, 2H, H-2’); 13C NMR (101 MHz, CDCl3) δ 
157.3 (C=O), 155.3 (C=O), 135.3 (i-Ar), 128.5 (Ar), 128.4 (Ar), 128.1 (Ar), 104.1 (C-4'), 67.9, 
(Bn), 67.4 (C-5), 56.6 (C-4), 52.9 (OMe), 52.9 (OMe), 32.2 (C-1'), 31.3 (C-3'), 19.3 (C-2'); 
HRMS (ESI): m/z 375.1529 [M + Na]+, C17H24N2O6Na requires 375.1532. 
 
General Procedure 5: N-N bond cleavage 
To a solution of the oxazolidinone hydrazide (0.26 mmol, 1.0 equiv) in dry CH3CN (1.00 ml) 
at room temperature under nitrogen, was added a base (K2CO3 or Cs2CO3, 0.65 mmol, 2.5 
equiv) followed by addition of diethyl bromomalonate (0.09 ml, 0.52 mmol, 2.0 eq). The 
reaction mixture was left to stir at 20 °C until the starting material was consumed before 
being quenched with ammonium chloride (5.00 ml) and extracted with ethyl acetate (3 x 10.0 
ml). The combined organic layers were dried over MgSO4 and the solvent evaporated in 
vacuo. The crude residue was chromatographed on silica gel with an ethyl acetace / 
petroleum ether mixture to afford the cleaved product. 
 
(R)-4-Octyloxazolidin-2-one 
 
Synthesised using General procedure 5 with oxazolidinone 51 and K2CO3 to give 52 (90% 
yield) as a colourless oil. 
[α]D20 +29.0 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 1746 (C=O), 1239 (C-O); 1H NMR (400 
MHz, CDCl3) δ 5.75 (br s, 1H, N-H), 4.41 (t, J = 5.3 Hz, 1H, H-5), 3.94 (dd, J = 6.2, 5.3 Hz, 
1H, H-5), 3.77 (m, 1H, H-4), 1.70–1.39 (m, 2H, H-6), 1.30–1.12 (m, 12H, H-7-H-12), 0.81 (t, 
J = 6.0 Hz, 3H, H-13); 13C NMR (101 MHz, CDCl3) δ 160.2 (C=O), 70.5 (C-5), 67.9 (C-4), 
35.4 (C-6), 31.9 (C-11), 29.5 (C-8), 29.5 (C-9), 29.3 (C-10), 25.6 (C-7), 22.7 (C-12), 14.2 (C-
13); HRMS (ESI): m/z 200.1652 [M + H]+, C11H22NO2 requires 200.1651. 
 
 
 
 
 
 
(R)-4-Methyloxazolidin-2-one 
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Synthesised using General procedure 5 with oxazolidinone 55 and Cs2CO3 to give 64 (88% 
yield) as a white solid. 
[α]D20 +22.3 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 1721 (C=O), 1238 (C-O); 1H NMR (300 
MHz, CDCl3) δ 6.47 (br s, 1H, N-H), 4.42 (t, J = 7.9 Hz, 1H, H-5), 3.95 (m, 1H, H-4), 3.87 
(dd, J = 7.9, 6.3 Hz, 1H, H-5), 1.22 (d, J = 6.0 Hz, 3H, H-6); 13C NMR (101 MHz, CDCl3) δ 
160.2 (C=O), 71.7 (C-5), 48.3 (C-4), 20.7 (C-6); HRMS (ESI): m/z 102.0541 [M + H]+, 
C4H8NO2 requires 102.0555. 
 
(R)-4-Isopropyloxazolidin-2-one 
 
Synthesised using General procedure 5 with oxazolidinone 56 and Cs2CO3 to give 65 (96% 
yield) as a colourless oil. 
[α]D20 +22.3 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 1728 (C=O), 1224 (C-O); 1H NMR (300 
MHz, CDCl3) δ 6.88 (br s, 1H, N-H), 4.36 (t, J = 6.0 Hz, 1H, H-5), 4.03 (dd, J = 6.0, 5.0, 1H, 
H-5), 3.54 (m, 1H, H-4), 1.65 (oct, J = 6.7 Hz, 1H, H-6), 0.88 (d, J = 6.9 Hz, 3H, H-7), 0.93 
(d, J = 6.6 Hz, 3H, H-7); 13C NMR (101 MHz, CDCl3) δ 160.6 (C=O), 68.6 (C-5), 58.4 (C-4), 
32.7 (C-6), 17.9 (C-7), 17.6 (C-7); HRMS (ESI): m/z 130.0873 [M + H]+, C6H12NO2 requires 
130.0868. 
 
(R)-4-Pentyloxazolidin-2-one 
 
Synthesised using General procedure 5 with oxazolidinone 57 and K2CO3 to give 66 (76% 
corrected yield based on a 85% conversion of 57) as a colourless oil. 
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[α]D20 +25.1 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 1742 (C=O), 1233 (C-O); 1H NMR (300 
MHz, CDCl3) δ 6.26 (br s, 1H, N-H), 4.41 (t, J = 6.3 Hz, 1H, H-5), 3.94 (dd, J = 6.3, 4.8 Hz, 
1H, H-5), 3.78 (m, 1H, H-4), 1.50 (m, 2H, H-6), 1.34–1.14 (m, 6H, H-7-H-9), 0.82 (t, J = 5.8 
Hz, 3H, H-10); 13C NMR (101 MHz, CDCl3) δ 160.1 (C=O), 70.5 (C-5), 52.8 (C-4), 35.4 (C-6), 
31.6 (C-8), 25.0 (C-7), 22.5 (C-9), 14.0 (C-10); HRMS (ESI): m/z 158.1183 [M + H]+, 
C8H16NO2 requires 158.1181. 
 
(R)-4-(2-(Benzyloxy)ethyl)oxazolidin-2-one 
 
Synthesised using General procedure 5 with oxazolidinone 58 and Cs2CO3 to give 67 (84% 
yield) as a colourless oil. 
[α]D20 +22.0 (c = 1.0, CHCl3); IR (CHCl3) νmax/cm-1 1738 (C=O), 1243 (C-O); 1H NMR (400 
MHz, CDCl3) δ 7.40-7.28 (m, 5H, Ar), 6.33 (br s, 1H, NH), 4.50 (s, 2H, Bn), 4.46 (dd, J = 7.8, 
5.7 Hz, 1H, H-5), 4.03 (m, 2H, H-4, H-5), 3.58 (t, J = 5.7 Hz, 2H, H-2’), 1.87 (m, 2H, H-1’); 
13C NMR (101 MHz, CDCl3) δ 137.7 (C=O), 129.8 (i-Ar), 128.6 (Ar), 128.0 (Ar), 127.7 (Ar), 
73.5 (Bn), 70.4 (C-5), 67.6 (C-2’), 52.0 (C-4), 35.1 (C-1’); HRMS (ESI): m/z 222.1119 [M + 
H]+, C12H16NO3 requires 222.1130. 
The ee (88%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol 70:30, flow rate = 1 ml/min, λ = 258 nm); τmajor = 8.62 min, τminor = 9.71 min. 
 
(R)-4-(2-(Prop-2-yn-1-yloxy)ethyl)oxazolidin-2-one 
 
Synthesised using General procedure 5 with oxazolidinone 59 and Cs2CO3 to give 68 (81% 
yield) as a colourless oil. 
 [α]D20 +21.3 (c = 1.0, DCM); IR (CHCl3) νmax/cm-1 1733 (C=O), 1243 (C-O); 1H NMR (400 
MHz, CDCl3) δ 6.30 (br s, 1H, NH), 4.50 (m, 1H, H-5), 4.14 (d, J = 2.4 Hz, 2H, H-1’’), 4.03 
(m, 2H, H-4, H-5), 3.63 (t, J = 5.7 Hz, 2H, H-2’), 2.46 (t, J = 2.4 Hz, 1H, H-3’’), 1.85 (m, 2H, 
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H-1’); 13C NMR (101 MHz, CDCl3) δ 159.7 (C=O), 79.3 (C-2’’), 74.9 (C-3’’), 70.4 (C-5), 67.1 
(C-2’), 58.4 (C-1’’), 51.6 (C-4), 34.9 (C-1’); HRMS (ESI): m/z 170.0809 [M + H]+, C8H12NO3 
requires 170.0817. 
 
 (R)-4-Benzyloxazolidin-2-one 
 
Synthesised using General procedure 5 with oxazolidinone 60 and K2CO3 to give 69 (84% 
yield) as a colourless oil. 
 [α]D20 +51.4 (c = 1.0, DCM); IR (CHCl3) νmax/cm-1 1738 (C=O), 1246 (C-O); 1H NMR (400 
MHz, CDCl3) δ 7.35 (m, 2H, Ar), 7.28 (m, 1H, Ar), 7.20 (m, 2H, Ar), 6.08 (br s, 1H, NH), 4.43 
(t, J = 5.7 Hz, 1H, H-5), 4.11 (m, 2H, H-4, H-5), 2.93 (dd, J = 10.2, 4.8 Hz, 1H, H-6), 2.86 
(dd, J = 10.2, 4.8 Hz, 1H, H-6); 13C NMR (101 MHz, CDCl3) δ 159.6 (C=O), 135.9 (i-Ar), 
129.0 (Ar), 128.9 (Ar), 127.1 (Ar), 69.5 (C-5), 53.7 (C-4), 41.3 (C-6); HRMS (ESI): m/z 
178.0864 [M + H]+, C10H12NO2 requires 178.0868. 
The ee (84%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol 50:50, flow rate = 1 ml/min, λ = 258 nm); τmajor = 6.71 min, τminor = 6.04 min. 
 
(R)-4-(Pyridin-3-ylmethyl)oxazolidin-2-one 
 
Synthesised using General procedure 5 with oxazolidinone 61 and Cs2CO3 to give 70 (90% 
yield) as a colourless oil. 
 [α]D20 +18.5 (c = 1.0, MeOH); IR (CHCl3) νmax/cm-1 1771 (C=O), 1726 (C=O), 1222 (C-O); 1H 
NMR (400 MHz, CDCl3) δ 8.51 (s, 1H, H-2’), 8.45 (d, J = 3.5 Hz, 1H, H-6’), 7.70 (m, 1H, H-
4’), 7.30 (dd, J = 6.0, 3.5 Hz, 1H, H-5’), 6.79 (br s, 1H, NH), 4.42 (t, J = 6.3 Hz, 1H, H-5), 
4.23 (m, 1H, H-4), 4.10 (dd, J = 6.3, 4.2 Hz, 1H, H-5), 2.96 (d, J = 4.5 Hz, 2H, H-6); 13C NMR 
(101 MHz, CDCl3) δ 159.7 (C=O), 151.6 (Ar), 149.1 (Ar), 137.8 (Ar), 133.6 (i-Ar), 124.5 (Ar), 
69.8 (C-5), 53.9 (C-4), 39.0 (C-6); HRMS (ESI): m/z 179.0819 [M + H]+, C9H11N2O2 requires 
179.0821. 
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The ee (92%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol 60:40, flow rate = 1 ml/min, λ = 258 nm); τmajor = 14.92 min, τminor = 13.44 min. 
 
(R)-4-(4,4-Dimethoxybutyl)oxazolidin-2-one 
 
Synthesised using General procedure 5 with oxazolidinone 63 and K2CO3 to give 72 ( 86% 
corrected yield based on a 70% conversion of 63) as a colourless oil. 
[α]D20 -27.1 (c = 0.5, DCM); IR (CHCl3) νmax/cm-1 1748 (C=O), 1263 (C-O); 1H NMR (300 
MHz, CDCl3) δ 6.36 (br s, 1H, NH), 4.45 (t, J = 8.3 Hz, 1H, H-5), 4.33 (t, J = 5.4 Hz, 1H, H-
4’), 3.99 (dd, J = 8.3, 6.0 Hz, 1H, H-5), 3.84 (m, 1H, H-4), 3.30 (s, 3H, OMe), 3.29 (s, 3H, 
OMe), 1.58 (m, 4H, H-1’, H-3'), 1.37 (m, 2H, H-2'); 13C NMR (101 MHz, CDCl3) δ 157.0 
(C=O), 104.2 (C-4’), 80.6 (C-5), 68.8 (C-4), 55.2 (OMe), 50.0 (OMe), 30.3 (C-1’), 29.4 (C-3’), 
17.5 (C-2'); HRMS (ESI): m/z 226.1052 [M + Na]+, C9H17NO4Na requires 226.1055. 
 
General Procedure 6: Cbz-derivatisation of oxazolidinones 
To a solution of oxazolidinone (4.00 mmol, 1.0 equiv) in THF (10.0 ml) at 0 °C, was added 
NaH (60% in mineral oil, 120 mg, 3.00 mmol, 1.5 equiv) and the reaction was stirred for  
15 min at 0 °C. A solution of benzyl chloroformate (0.30 ml, 2.00 mmol, 1.0 equiv) in THF 
(10.0 ml) was then added dropwise and the reaction mixture was stirred for 3 hrs at room 
temperature before being quenched with NH4Cl (10.0 ml) and extracted with EtOAc (3 x 20.0 
ml). The combined organic layers were dried over MgSO4 and the solvent evaporated in 
vacuo. The crude residue was chromatographed on silica gel with ethyl acetate / petroleum 
ether mixtures. 
 
Benzyl (R)-4-octyl-2-oxooxazolidine-3-carboxylate 
 
Synthesised from 52 using General procedure 6 to give 73 (88% yield) as a white solid.  
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[α]D20 -7.0 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 1792 (C=O), 1725 (C=O); 1H NMR (300 
MHz, CDCl3) δ 7.37–7.19 (m, 5H, Ar), 4.58 (s, 2H, Bn), 4.20 (m, 2H, H-5, H-4), 3.95 (m, 1H, 
H-5), 2.01–1.53 (m, 2H, H-6), 1.19 (m, 12H, H-7–H-12), 0.80 (t, J = 6.0 Hz, 3H, H-13); 13C 
NMR (101 MHz, CDCl3) δ 151.8 (C=O), 151.6 (C=O), 135.6 (i-Ar), 128.9 (Ar), 128.7 (Ar), 
128.5 (Ar), 69.6 (C-5), 66.5 (Bn), 50.9 (C-4), 35.4 (C-6), 31.5 (C-11), 29.6 (C-8), 29.6 (C-9), 
29.3 (C-10), 24.6 (C-7), 22.5 (C-12), 14.3 (C-13); HRMS (ESI): m/z 356.1831 [M+Na]+, 
C19H27NNaO4 requires 356.1838. 
The ee (83%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 0.3 ml/min, λ = 258 nm); τmajor = 15.07 min, τminor = 14.25 min. 
 
Benzyl (R)-4-methyl-2-oxooxazolidine-3-carboxylate 
 
Synthesised from 64 using General procedure 6 to give 74 (88% yield) as a white solid.  
[α]D20 -9.0 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 1735 (C=O), 1718 (C=O), 1251 (C-O); 1H 
NMR (300 MHz, CDCl3) δ 7.38–7.21 (m, 5H, Ar), 5.23 (s, 2H, Bn), 4.32 (m, 2H, H-5, H-4), 
3.85 (m, 1H, H-5), 1.34 (d, J = 6.0 Hz, 3H, H-6); 13C NMR (101 MHz, CDCl3) δ 151.8 (C=O), 
150.8 (C=O), 135.0 (i-Ar), 128.7 (Ar), 128.6 (Ar), 128.2 (Ar), 68.6 (Bn), 68.6 (C-5), 51.3 (C-
4), 19.6 (C-6); HRMS (ESI): m/z 251.1036 [M + H]+, C12H15N2O4 requires 251.1032. 
The ee (96%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 0.5 ml/min, λ = 258 nm); τmajor = 31.62 min, τminor = 23.81 min. 
 
Benzyl (R)-4-isopropyl-2-oxooxazolidine-3-carboxylate 
 
Synthesised from 65 using General procedure 6 to give 75 (88% yield) as a white solid.  
[α]D20 -8.0 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 1800 (C=O), 1714 (C=O); 1H NMR (300 
MHz, CDCl3) δ 7.41–7.22 (m, 5H, Ar), 5.25 (s, 2H, Bn), 4.15 (m, 3H, H-5, H-4), 2.33–2.21 
(m, 1H, H-6), 0.91 (d, J = 4.5 Hz, 3H, H-7), 0.84 (d, J = 6.6 Hz, 3H, H-7); 13C NMR (101 
MHz, CDCl3) δ 155.8 (C=O), 155.1 (C=O), 136.1 (i-Ar), 128.7 (Ar), 128.6 (Ar), 128.2 (Ar), 
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67.1 (Bn), 65.2 (C-4), 60.7 (C-5), 28.5 (C-6), 17.2 (C-7), 16.9 (C-7); HRMS (ESI): m/z 
286.1048 [M+Na]+, C14H17NNaO4 requires 286.1055. 
The ee (92%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol = 90:10, flow rate = 0.5 ml/min, λ = 258 nm); τmajor = 26.70 min, τminor = 29.63 min. 
 
Benzyl (R)-2-oxo-4-pentyloxazolidine-3-carboxylate 
 
Synthesised from 66 using General procedure 6 to give 76 (88% yield) as a white solid.  
[α]D20 -9.0 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 1737 (C=O), 1726 (C=O), 1251 (C-O); 1H 
NMR (300 MHz, CDCl3) δ 7.39–7.22 (m, 5H, Ar), 5.25 (s, 2H, Bn) 5.20 (m, 2H, H-5, H-4), 
4.02 (t, J = 6.0 Hz, 1H, H-5), 2.32 (m, 2H, H-6), 1.98 (m, 6H, H-7-H-9), 0.91 (t, J = 6.2 Hz, 
3H, H-10); 13C NMR (101 MHz, CDCl3) δ 152.8 (C=O), 151.7 (C=O), 135.5 (i-Ar), 128.7 (Ar), 
128.7 (Ar), 128.5 (Ar), 69.5 (C-5), 66.2 (Bn), 51.8 (C-4), 35.6 (C-6), 31.8 (C-8), 23.0 (C-7), 
22.4 (C-9), 14.0 (C-10); HRMS (ESI): m/z 292.1537 [M + H]+, C16H22NO4 requires 292.1549.  
The ee (88%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 0.3 ml/min, λ = 258 nm); τmajor = 41.29 min, τminor = 44.52 min. 
 
Ethyl 2-(2,2-dimethoxyethyl)-4,4-dimethoxybutanoate 
 
 
Synthesised from 36 using General procedure 1 on a 5.6 mmol scale, to give 77 (950 mg, 
64 % yield) as a colourless oil. 
IR (CHCl3) νmax/cm-1 1727 (C=O), 1265 (C-O), 1124 (C-O), 1093 (C-O); 1H NMR (300 MHz, 
CDCl3) δ 4.46 (t, J = 5.4 Hz, 2H, H-4), 4.20 (q, J = 7.2 Hz, 2H, H-5), 3.37 (s, 6H, 2xOMe), 
3.36 (s, 6H, 2xOMe), 2.65 (m, 1H, H-2), 2.04 (ddd, J = 13.7, 7.5, 5.4 Hz, 2H, H-3), 1.80 (ddd, 
J = 13.7, 7.5, 5.4 Hz, 2H, H-3), 1.37 (t, J = 7.2 Hz, 3H, H-6); 13C NMR (101 MHz, CDCl3) δ 
175.3 (C-1), 103.0 (C-4), 60.3 (C-5), 53.2 (OMe), 53.0 (OMe), 37.7 (C-2), 35.4 (C-3), 14.2 
(C-6); HRMS (ESI): m/z 287.1476 [M + Na]+, C12H24O6Na requires 287.1471. 
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(Benzylsulfonyl)benzene273 
 
To a mixture of thiophenol (3.31 g, 30.0 mmol, 1 equiv) and K2CO3 (4.56 g, 30.0 mmol, 1.1 
equiv) in DMF (25.0 ml) was added benzyl bromide (5.13 g, 30.0 mmol, 1 equiv). The 
reaction mixture was then stirred at room temperature for 18 hours, after which it was 
quenched with water (30.0 ml), extracted with ethyl acetate (3 x 50.0 ml) and washed with 
brine (3 x 50.0 ml). The organic layer was then dried with MgSO4 and the solvent was 
evaporated in vacuo. The crude sulfide product was judged pure enough to continue to the 
next step. 
To a solution of the crude sulfide in DCM (150 ml) was added m-CPBA (18.1 g, 105 mmol, 
3.5 equiv) at 0 °C. The reaction mixture was warmed to room temperature and stirred for a 
further 18 hrs. The reaction was then quenched with saturated NaHCO3 (150 ml) and stirred 
for 2 hours. The reaction mixture was extracted with DCM (3 x 50.0 ml) the organic layer 
dried with MgSO4 and the solvent evaporated in vacuo. The crude residue was then purified 
by flash column chromatography (20% ethyl acetate / petroleum ether) to give 81 (4.60 g, 
66% yield over two steps) as a white solid. 
1H NMR (300 MHz, CDCl3) δ 7.70-7.59 (m, 3H, Ar), 7.43-7.35 (m, 2H, Ar), 7.24-7.12 (m, 3H, 
Ar), 7.09-7.08 (m, 2H, Ar), 4.33 (s, 2H, CH2). 
 
(Ethylsulfonyl)benzene274 
 
To a mixture of thiophenol (3.31 g, 30.0 mmol, 1 equiv) and K2CO3 (4.56 g, 30.0 mmol, 1.1 
equiv) in DMF (25.0 ml) was added iodoethane (4.71 g, 30.2 mmol, 1 equiv). The reaction 
mixture was then stirred at room temperature for 18 hours, after which it was quenched with 
water (30.0 ml), extracted with ethyl acetate (3 x 50.0 ml) and washed with brine (3 x 50.0 
ml). The organic layer was then dried with MgSO4 and the solvent was evaporated in vacuo. 
The crude sulfide product was judged pure enough to continue to the next step. 
To a solution of the crude sulfide in CH3CN (150 ml) was added m-CPBA (18.1 g, 105 mmol, 
3.5 equiv) at 0 °C. The reaction mixture was warmed to 50 °C and stirred for a further 18 hrs. 
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The reaction was then cooled to room temperature, quenched with saturated NaHCO3 (150 
ml) and stirred for 2 hours. The reaction mixture was extracted with DCM (3 x 50.0 ml), the 
organic layer dried with MgSO4 and the solvent evaporated in vacuo. The crude residue was 
then purified by flash column chromatography (20% ethyl acetate / petroleum ether) to give 
82 (4.00 g, 78% yield over two steps) as a white solid. 
1H NMR (300 MHz, CDCl3) δ 7.88 (m, 2H, Ar), 7.65-7.49 (m, 3H, Ar), 3.10 (q, J = 5.4 Hz, 2H, 
CH2) 1.24 (t, J = 5.4 Hz, 3H, CH3). 
 
((4-Methylhe(Neopentylsulfonyl)benzene 
 
To a mixture of thiophenol (6.62 g, 60.0 mmol, 1 equiv) and K2CO3 (9.12 g, 60.0 mmol, 1.1 
equiv) in DMF (50.0 ml) was added neopentyl bromide (5.13 g, 60.0 mmol, 1 equiv). The 
reaction mixture was warmed to 100 °C and then stirred for 18 hours, after which water (60.0 
ml) was added and the organic material extracted into ethyl acetate (3 x 100 ml), and 
washed with brine (3 x 50.0 ml). The organic layer was then dried with MgSO4 and the 
solvent evaporated in vacuo. The crude sulfide product was judged pure enough (by TLC) to 
continue to the next step. 
To a solution of the crude sulfide in CH3CN (150 ml) was added m-CPBA (20.7 g, 120 mmol, 
3.5 equiv) at 0 °C. The reaction mixture was warmed to 50 °C and stirred for a further 18 hrs. 
The reaction was then cooled to room temperature, quenched with saturated NaHCO3 (150 
ml) and stirred for 2 hours. The reaction mixture was then extracted with ethyl acetate (3 x 
100 ml), the organic layer dried with MgSO4 and the solvent evaporated in vacuo. The crude 
residue was then purified by flash column chromatography (20% ethyl acetate / petroleum 
ether) to give 83 (5.70 g, 45% yield over two steps) as colourless crystals. 
M.p. 34-36 °C (from DCM / n-Hexane); IR (CHCl3) νmax/cm-1 1314 (S=O), 1307 (S=O), 1151 
(S=O); 1H NMR (300 MHz, CDCl3) δ 7.90 (m, 2H, Ar), 7.64-7.48 (m, 3H, Ar), 3.02 (s, 2H, 
CH2), 1.17 (s, 9H, t-Bu); 13C NMR (101 MHz, CDCl3) δ 142.0 (i-Ar), 133.3 (Ar), 129.2 (Ar), 
127.5 (Ar), 67.7 (CH2), 32.5 (t-Bu), 29.8 (CH3); HRMS (ESI): m/z 213.0953 [M + H]+, 
C11H17O2S requires 213.0949. 
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((4-Phenylhepta-1,6-dien-4-yl)sulfonyl)benzene 
 
To a solution of sulfone 81 (2.33 g, 10.0 mmol, 1 equiv) in THF (30.0 ml) at 0 °C was added 
n-BuLi (7.90 ml, 1.4 M, 11.0 mmol, 1.1 equiv) in a dropwise fashion. The reaction mixture 
was then warmed to reflux for 30 minutes. Allyl bromide (0.870 ml, 10.0 mmol, 1 equiv) was 
then added at room temperature, after which the reaction mixture was heated to reflux for a 
further hour after which consumption of the starting material was observed on TLC. The 
reaction mixture was then cooled to 0 °C and a further aliquot of n-BuLi (7.90 ml, 1.4 M, 11.0 
mmol, 1.1 equiv) was added in a dropwise fashion. The reaction mixture was then warmed 
to reflux for 30 minutes. Allyl bromide (0.870 ml, 10.0 mmol, 1 equiv) was then added at 
room temperature, after which the reaction mixture was heated to reflux for a further hour 
after which consumption of the monoallyl intermediate was observed on TLC. The reaction 
mixture was then quenched with saturated NH4Cl solution (20.0 ml) and extracted with ethyl 
acetate (3 x 20.0 ml). The organic layer was dried with MgSO4 and the solvent evaporated in 
vacuo. The crude residue was then purified by flash column chromatography (5% ethyl 
acetate / petroleum ether) to give 84 (1.75 g, 56% yield) as colourless crystals. 
M.p. 88-91 °C (from DCM / n-Hexane); IR (CHCl3) νmax/cm-1 1305 (S=O), 1295 (S=O), 1148 
(S=O); 1H NMR (300 MHz, CDCl3) δ 7.58-7.52 (m, 2H, Ar), 7.36-7.25 (m, 8H, Ar), 6.02-5.84 
(m, 2H, H-2/6), 5.29-5.14 (m, 4H, H-1/7), 3.35 (ddt, J = 15.0, 6.6, 1.9 Hz, 2H, H-3/5), 3.09 
(ddt, J = 15.0, 6.6, 1.9 Hz, 2H, H-3/5); 13C NMR (101 MHz, CDCl3) δ 135.3 (i-Ar), 134.6 (i-
Ar), 133.3, 132.0, 130.2, 129.6, 128.6, 128.1, 127.8, 119.4 (C-1/7), 70.7 (C-4), 35.1 (C-3/5); 
HRMS (ESI): m/z 305.1071 [M + Na]+, C19H20O2NaS requires 305.1082. 
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((4-Methylhepta-1,6-dien-4-yl)sulfonyl)benzene 
 
To a solution of sulfone 82 (2.00 g, 11.8 mmol, 1 equiv) in THF (40.0 ml) at 0 °C was added 
n-BuLi (9.20 ml, 1.4 M, 12.9 mmol, 1.1 equiv) in a dropwise fashion. The reaction mixture 
was then warmed to reflux for 30 minutes. Allyl bromide (1.02 ml, 11.75 mmol, 1 equiv) was 
then added at room temperature, after which the reaction mixture was heated to reflux for a 
further hour after which consumption of the starting material was observed on TLC. The 
reaction mixture was then cooled to 0 °C and a further aliquot of n-BuLi (9.20 ml, 1.4 M, 12.9 
mmol, 1.1 equiv) was added in a dropwise fashion. The reaction mixture was then warmed 
to reflux for 30 minutes. Allyl bromide (1.02 ml, 11.75 mmol, 1 equiv) was then added at 
room temperature, after which the reaction mixture was heated to reflux for a further hour 
after which consumption of the monoallyl intermediate was observed on TLC. The reaction 
mixture was quenched with saturated NH4Cl solution (20.0 ml) and extracted with ethyl 
acetate (3 x 20.0 ml). The organic layer was dried with MgSO4 and the solvent evaporated in 
vacuo. The crude residue was then purified by flash column chromatography (5% ethyl 
acetate / petroleum ether) to give 85 (1.02 g, 35% yield) as colourless crystals. 
M.p. 43-46 °C (from DCM / n-Hexane); IR (CHCl3) νmax/cm-1 1302 (S=O), 1293 (S=O), 1146 
(S=O); 1H NMR (300 MHz, CDCl3) δ 7.89 (m, 2H, Ar), 7.70-7.53 (m, 3H, Ar), 5.98-5.84 (m, 
2H, H-2/6), 5.16-5.01 (m, 4H, H-1/7), 2.54 (ddt, J = 14.4, 6.9, 1.2 Hz, 2H, H-3/5), 2.41 (ddt, J 
= 14.4, 6.9, 1.2 Hz, 2H, H-3/5), 1.25 (s, 3H, Me); 13C NMR (101 MHz, CDCl3) δ 135.8 (i-Ar), 
133.6, 132.1, 130.4, 128.7, 119.4 (C-1/7), 65.2 (C-4), 38.0 (C-3/5), 19.5 (Me); HRMS (ESI): 
m/z 251.1098 [M + H]+, C14H19O2S requires 251.1106; Analysis: found C 66.45%, H 7.53%, 
S 11.98%; C21H24N2O6 requires C 67.17%, H 7.25%, N 12.81%. 
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((4-(tert-Butyl)hepta-1,6-dien-4-yl)sulfonyl)benzene 
 
To a solution of sulfone 83 (4.25 g, 20.0 mmol, 1 equiv) and THF (60.0 ml) at 0 °C was 
added n-BuLi (15.7 ml, 1.4 M, 22.0 mmol, 1.1 equiv) in a dropwise fashion. The reaction 
mixture was then warmed to reflux for 30 minutes. Allyl bromide (1.73 ml, 20.0 mmol, 1 
equiv) was then added at room temperature, after which the reaction mixture was heated to 
reflux for a further hour after which consumption of the starting material was observed on 
TLC. The reaction mixture was then cooled to 0 °C and a further aliquot of n-BuLi (15.7 ml, 
1.4 M, 22.0 mmol, 1.1 equiv) was added in a dropwise fashion. The reaction mixture was 
then warmed to reflux for 30 minutes. Allyl iodide (1.83 ml, 20.0 mmol, 1 equiv) was then 
added at room temperature, after which the reaction mixture was heated to reflux for a 
further hour after which consumption of the monoallyl intermediate was observed on TLC. 
The reaction mixture was quenched with saturated NH4Cl solution (40.0 ml) and extracted 
with ethyl acetate (3 x 40.0 ml). The organic layer was dried with MgSO4 and the solvent 
was evaporated in vacuo. The crude residue was then purified by flash column 
chromatography (5% ethyl acetate / petroleum ether) to give 86 (3.75 g, 64% yield) as 
yellowish crystals. 
M.p. 68-70 °C (from DCM / n-Hexane); IR (CHCl3) IR (CHCl3) νmax/cm-1 1301 (S=O), 1286 
(S=O), 1134 (S=O); 1H NMR (300 MHz, CDCl3) δ 7.96 (m, 2H, Ar), 7.70-7.55 (m, 3H, Ar), 
6.11-5.97 (m, 2H, H-2/6), 5.15-5.06 (m, 4H, H-1/7), 2.72 (ddt, J = 15.6, 6.9, 1.5 Hz, 2H, H-
3/5), 2.59 (ddt, J = 15.6, 6.9, 1.5 Hz, 2H, H-3/5), 1.34 (s, 9H, t-Bu); 13C NMR (101 MHz, 
CDCl3) δ 139.7 (i-Ar), 134.4, 133.3, 130.6, 128.7, 118.2 (C-1/7), 75.5 (C-4), 39.4 (t-Bu), 38.0 
(C-3/5), 28.8 (CH3); HRMS (ESI): m/z 315.1071 [M + Na]+, C17H24O2NaS requires 315.1380. 
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Hepta-1,6-dien-4-ylbenzene276 
 
Sulfone 84 (2.50 g, 8.00 mmol, 1 equiv) was dissolved in dry MeOH (80.0 ml). Grignard 
magnesium (7.00 g, 288 mmol, 36 equiv) was added and the reaction was warmed to 50 °C 
and stirred for 3 hours, whilst carefully monitoring the exothermic reaction. When complete 
consumption of the sulfone was observed on TLC the reaction was quenched with 2 M HCl 
(150 ml) at 0 °C and allowed to warm up to room temperature. The reaction mixture was 
then extracted with ethyl acetate (3 x 50.0 ml) and washed with NaHCO3 (100 ml) and finally 
with brine (100 ml). The organic layer was dried with MgSO4 and the solvent evaporated in 
vacuo. The crude residue was then purified by filtering over a pad of silica (2% ethyl acetate 
/ petroleum ether) to give 87 (1.07 g, 78% yield) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ 7.28-7.07 (m, 5H, (Ar), 5.71-5.53 (m, 2H, H-2/6), 4.90 (m, 4H, 
H-1/7), 2.63 (m, 1H, H-4), 2.43-2.25 (m, 4H, H-3/5). 
 
4-Methylhepta-1,6-diene282 
 
Sulfone 85 (1.20 g, 4.79 mmol, 1 equiv) was dissolved in dry MeOH (50.0 ml). Grignard 
magnesium (4.31 g, 177 mmol, 37 equiv) was added and the reaction was warmed to 50 °C 
and stirred for 3 hours, whilst carefully monitoring the exothermic reaction. When complete 
consumption of the sulfone was observed on TLC the reaction was quenched with 2 M HCl 
(200 ml) at 0 °C and allowed to warm up to room temperature. The reaction mixture was 
then extracted with ethyl acetate (3 x 30.0 ml) and washed with NaHCO3 (50.0 ml), and 
finally with brine (50.0 ml). The organic layer was dried with MgSO4 and the solvent 
evaporated in vacuo. The crude residue was then purified by filtering over a pad of silica (2% 
ethyl acetate / petroleum ether) to give 88 (40.0 mg, 8% yield) as a volatile colourless oil. 
1H NMR (300 MHz, CDCl3) δ 6.01-5.82 (m, 2H, H-2/6), 5.07-4.97 (m, 4H, H-1/7), 2.19 (m, 
4H, H-3/5), 1.97 (m, 1H, H-4), 0.89 (m, 3H, Me); 13C NMR (101 MHz, CDCl3) δ 137.2 (C-2/6), 
116.4 (C-1/7), 42.4 (C-4), 40.9 (C-3/5), 20.9 (Me). 
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(1,1,5,5-Tetramethoxypentan-3-yl)benzene 
 
Synthesised from 87 using General procedure 1 on a 5.10 mmol scale to give 90 (540 mg, 
39 % yield) as a colourless oil. 
IR (CHCl3) νmax/cm-1 1265 (C-O), 1124 (C-O); 1H NMR (300 MHz, CDCl3) δ 7.35 (m, 2H, Ar), 
7.22 (m, 3H, Ar), 4.09 (dd, J = 7.7, 4.2 Hz, 2H, H-1/5), 3.29 (s, 6H, 2xOMe), 3.22 (s, 6H, 
2xOMe), 2.88 (m, 1H, H-3), 2.01 (ddd, J = 14.1, 7.7, 5.4 Hz, 2H, H-2/4), 1.84 (ddd, J = 14.1, 
9.9, 4.2 Hz, 2H, H-2/4); 13C NMR (101 MHz, CDCl3) δ 144.1 (i-Ar), 128.3 (Ar), 127.6 (Ar), 
126.0 (Ar), 102.6 (C-1/5), 52.6 (OMe), 52.5 (OMe), 39.4 (C-2/4), 37.6 (C-3); HRMS (ESI): 
m/z 291.1567 [M + Na]+, C15H24O4Na requires 291.1572.  
 
 
 ((Cyclopent-3-en-1-yloxy)methyl)benzene283 
 
To a solution of cyclopent-3-en-1-ol (750 mg, 8.90 mmol, 1 equiv) in THF (50.0 ml) was 
added NaH (60% in mineral oil, 429 mg, 10.7 mmol, 1.2 equiv) at 0 °C and the reaction 
mixture was warmed to room temperature and stirred for a further 1 hour. Benzyl bromide 
(1.40 ml, 11.9 mmol, 1.5 equiv) was then added along with TBAI (329 mg, 0.890 mmol, 10 
mol%) and the reaction mixture was warmed to reflux for 19 hours. When complete 
consumption of the alcohol was observed on TLC the reaction was quenched with water 
(50.0 ml) and extracted with ethyl acetate (3 x 30.0 ml). The organic layers were dried with 
MgSO4 and the solvent was evaporated in vacuo. The crude residue was then purified by 
flash column chromatography (2% ethyl acetate / petroleum ether) to give 91 (1.55 g, 
quantitative yield) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ 7.25-7.17 (m, 5H, Ar), 5.60 (m, 2H, H-3/4), 4.40 (s, 2H, Bn), 
4.22 (m, 1H, H-1), 2.51 (m, 2H, H-2/5), 2.37 (m, 2H, H-2/5). 
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(((1,1,5,5-Tetramethoxypentan-3-yl)oxy)methyl)benzene 
 
Synthesised from 91 using General procedure 1 on a 5.74 mmol scale, to give 92 (800 mg, 
47% yield) as a colourless oil. 
IR (CHCl3) νmax/cm-1 1276 (C-O), 1121 (C-O); 1H NMR (300 MHz, CDCl3) δ 7.31-7.22 (m, 5H, 
Ar), 4.51 (dd, J = 6.6, 5.0, 2H, H-1/5), 4.49 (s, 2H, Bn) 3.65 (m, 1H, H-3), 3.28 (s, 6H, 
2xOMe), 3.26 (s, 6H, 2xOMe), 1.87 (ddd, J = 14.4, 7.2, 5.0 Hz, 2H, H-2/4), 1.79 (ddd, J = 
14.4, 6.6, 5.4 Hz, 2H, H-2/4); 13C NMR (101 MHz, CDCl3) δ 138.6 (i-Ar), 128.3 (Ar), 127.8 
(Ar), 127.5 (Ar), 102.0 (C-1/5), 72.8 (Bn), 71.4 (C-3), 52.9 (OMe), 52.6 (OMe), 37.9 (C-2/4); 
HRMS (ESI): m/z 321.1677 [M + Na]+, C16H26O5Na requires 321.1678. 
 
Benzyl (4-(1-(benzyloxy)-4,4-dimethoxybutan-2-yl)-2-oxooxazolidin-3-yl)carbamate
O
O N NHCO2Bn
O
O
O 1'
2' 3'
4'
45
21
3
94
 
Dibenzyl azodicarboxylate (150 mg, 0.50 mmol, 1 equiv) was added to a mixture of bis-
acetal 40 (700 mg, 2.24 mmol, 4.5 equiv), tetrazole catalyst (14 mg, 0.10 mmol, 20 mol%), 
MCA (246 mg, 2.60 mmol, 5.2 equiv), TFA (4.0 µl, 0.05 mmol, 0.1 equiv) and water (45 mg, 
2.50 mmol, 5 equiv) in DCM (10.0 ml). The reaction mixture was kept at 4 °C until complete 
consumption of the DBAD was observed by TLC. On reaction completion, the reaction 
mixture was quenched with water (10.0 ml) and extracted with DCM (3 x 10.0 ml) and the 
organic extracts were washed with saturated NaHCO3 (10.0 ml) and brine (10.0 ml). The 
organic layer was then dried with MgSO4 and the solvent was evaporated in vacuo. To the 
resultant residue was added MeOH (5.0 ml) and NaBH4 (18.9 mg, 0.5 mmol, 1 equiv) at 0 °C 
and the mixture was allowed to warm up to room temperature over 15 minutes. NaOH (1.50 
ml, 1M, 1.50 mmol, 3 equiv) was then added and the reaction was stirred for 2 hours at room 
temperature, when complete consumption of the hydrazine was observed on TLC. The 
reaction was quenched with saturated NH4Cl solution (10.0 ml) and extracted with ethyl 
acetate (3 x 10.0 ml). The organic layers were dried with MgSO4 and the solvent evaporated 
in vacuo. The crude residue was then purified by flash column chromatography (35% ethyl 
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acetate / petroleum ether) to give 94 (140 mg, 61% yield) as a colourless gummy oil and a 
mixture of diastereomers (dr = 74:26). 
For the major diastereomer (separated using preparative TLC): [α]D20 +3.17 (c = 0.6, DCM); 
IR (CHCl3) νmax/cm-1 1775 (C=O), 1716 (C=O), 1245 (C-O), 1207 (C-O); 1H NMR (400 MHz, 
CDCl3) δ 7.33 (m, 10H, Ar), 6.94 (br s, 1H, NH), 5.19 (s, 2H, Bn), 4.46 (m, 2H, Bn), 4.37 (m, 
2H, H-4’, H-5), 4.25 (m, 2H, H-4, H-5), 3.48 (m, 2H, H-1’), 3.30 (s, 3H, OMe), 3.30 (s, OMe), 
2.26 (m, 1H, H-2’), 1.60 (m, 2H, H-3’); 13C NMR (101 MHz, CDCl3) δ 157 (C=O), 157 (C=O), 
137.6 (i-Ar), 135.5 (i-Ar), 128.6 (Ar), 128.5 (Ar), 128.4 (Ar), 128.1 (Ar), 127.9 (Ar), 127.5 (Ar), 
104.5 (C-4’), 73.4 (Bn), 71.4 (Bn), 68.4 (C-1’), 66.6 (C-5), 55.6 (C-4), 50.8 (OMe), 50.8 
(OMe), 31.2 (C-2’), 30.4 (C-3’); HRMS (ESI): m/z 481.1946 [M + Na]+, C24H30N2O7Na 
requires 481.1942. 
The ee (80%) was determined by chiral HPLC using a Chiralpak AD column (n-hexane:i-
propanol = 90:10, flow rate = 0.5 ml/min, λ = 258 nm); τmajor = 57.15 min, τminor = 69.77 min. 
The dr (74:26) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 0.4 ml/min, λ = 258 nm); τmajor = 47.37 min, τminor = 39.23 min. 
 
Benzyl (4-(3,3-dimethoxy-1-phenylpropyl)-2-oxooxazolidin-3-yl)carbamate 
 
Dibenzyl azodicarboxylate (894 mg, 0.30 mmol, 1 equiv) was added to a mixture of bis-
acetal 90 (400 mg, 1.50 mmol, 5 equiv), tetrazole catalyst (8.0 mg, 0.06 mmol, 20 mol%), 
MCA (147 mg, 1.56 mmol, 5.2 equiv), TFA (2.3 µl, 0.025 mmol, 0.1 equiv) and water (27.0 
mg, 1.50 mmol, 5 equiv) in DCM (0.60 ml). The reaction mixture was kept at 4 °C until 
complete consumption of the DBAD was observed by TLC. On reaction completion, the 
reaction mixture was quenched with water (10.0 ml) and extracted with DCM (3 x 10.0 ml) 
and the organic extracts were washed with saturated NaHCO3 (10.0 ml) and brine (10.0 ml). 
The organic layer was then dried with MgSO4 and the solvent was evaporated in vacuo. To 
the resultant residue was added MeOH (3.0 ml) and NaBH4 (11.0 mg, 0.30 mmol, 1 equiv) at 
0 °C and the mixture was allowed to warm up over 15 minutes to room temperature. NaOH 
(0.9 ml, 1M, 0.90 mmol, 3 equiv) was then added and the reaction was stirred for 2 hours at 
room temperature, when complete consumption of the hydrazine was observed on TLC. The 
reaction was quenched with saturated NH4Cl solution (10.0 ml) and extracted with ethyl 
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acetate (3 x 10.0 ml). The organic layers were dried with MgSO4 and the solvent evaporated 
in vacuo. The crude residue was then purified by flash column chromatography (35% ethyl 
acetate / petroleum ether) to give 95 (87 mg, 70% yield) as a yellowish gummy oil and a 
mixture of diastereomers (dr = 68:22). 
For the major diastereomer (separated using preparative TLC): [α]D20 -18.0 (c = 0.25, DCM); 
IR (CHCl3) νmax/cm-1 1778 (C=O), 1718 (C=O), 1240 (C-O), 1212 (C-O); 1H NMR (400 MHz, 
CDCl3) δ 7.35 (m, 8H, Ar), 7.15 (m, 2H, Ar), 7.09 (m, 1H, N-H), 5.23 (s, 2H, Bn), 4.31 (m, 
1H, H-5), 4.16 (m, 1H, H-4), 4.05 (dd, J = 6.3, 2.4 Hz, 1H, H-5), 3.95 (t, J = 6.6 Hz, 1H, H-3’), 
3.27 (s, 3H, OMe), 3.22 (s, 3H, OMe), 3.10 (m, 1H, H-1’), 2.27 (m, 1H, H-2’), 1.93 (m, 1H, H-
2’); 13C NMR (101 MHz, CDCl3) δ 155.2 (C=O), 155.2 (C=O), 138.5 (i-Ar), 135.3 (i-Ar), 129.1 
(Ar), 128.7 (Ar), 128.5 (Ar), 128.3 (Ar), 128.2 (Ar), 127.8 (Ar), 102.7 (C-3’), 68.3 (Bn), 65.9 
(C-5), 60.1 (C-4), 53.7 (OMe), 53.0 (OMe), 44.8 (C-1’), 35.2 (C-2’); HRMS (ESI): m/z 
437.1687 [M + Na]+, C22H26N2O6Na requires 437.1689. 
The ee (76%) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 0.4 ml/min, λ = 258 nm); τmajor = 22.16 min, τminor = 31.99 min. 
The dr (68:32) was determined by chiral HPLC using a Chiralpak OD column (n-hexane:i-
propanol = 90:10, flow rate = 0.4 ml/min, λ = 258 nm); τmajor = 22.16 min, τminor = 54.90 min. 
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